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Complex I (NADH:ubiquinone oxidoreductase), located in the mitochondrial inner membrane, 
is a major electron entry point to the respiratory chain. It couples the energy released from 
electron transfer (from NADH to ubiquinone) to the concomitant pumping of protons across 
the membrane, to generate an electrochemical proton motive force. Mammalian complex I is 
composed of 45 subunits, 14 of which comprise its simpler bacterial homologues. It is encoded 
by both the mitochondrial and nuclear genomes, and pathological mutations in both sets of 
subunits result in severe neuromuscular disorders such as Leigh syndrome. Several structures 
of mammalian complex I from various organisms have been determined, but the limited 
resolutions of the structures, which typically refer to poorly characterised enzyme states, has 
hampered detailed analyses of mechanistic features. 
 
The first part of this thesis describes development of a method for purifying complex I from 
the genetically amenable and medically relevant model organism Mus musculus (mouse), in a 
pure, stable and active state. The enzyme from mouse heart mitochondria was then 
comprehensively characterised, to ensure the presence of all the expected subunits and co-
factors, and to define its kinetic properties. 
 
The second part of this thesis describes structural studies by single particle electron 
cryomicroscopy (cryo-EM) on the purified mouse enzyme in two distinct states, the ‘active’ 
and ‘de-active’ states. The active state was determined to 3.3 Å resolution, the highest 
resolution structure of a eukaryotic complex I so far. Subsequently, comparison of the two 
mouse structures, together with previously determined mammalian and bacterial structures, 
revealed variations in key structural elements in the membrane domain, which may be crucial 
for the catalytic mechanism. Moreover, in the high-resolution active mouse complex I structure 
a nucleotide co-factor was observed bound to the nucleoside kinase subunit NDUFA10.  
 
Finally, complex I from the Ndufs4 knockout mouse model, which recapitulates the effects of 
a human mutation that causes Leigh syndrome, was purified and subjected to kinetic and 
proteomic analyses. Following cross-linking and preliminary structural studies, it was 
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Chapter 1: General introduction 
 
1.1 Mitochondria  
 
Mitochondria are often described as the “powerhouses of the cell” because they are the main 
source of adenosine triphosphate (ATP), which is the predominant energy currency in the cell. 
Besides their function in energy metabolism, they also have a plethora of other functions, 
including programmed cell death via the intrinsic pathway (Martinou and Youle, 2011), 
calcium homeostasis (Baughman et al., 2011; De Stefani et al., 2011), iron-sulphur cluster 
biogenesis (Braymer and Lill, 2017) and fatty acid biosynthesis (Hiltunen et al., 2010). 
Mitochondria generate ATP by coupling exergonic electron transfer through respiratory 
complexes I, II, III and IV, mediated by electron carriers such as cytochrome c and ubiquinone, 
to the endergonic translocation of protons by respiratory enzymes I, III and IV. This creates an 
electrochemical gradient, known as the proton motive force (PMF) that is harnessed by ATP 
synthase to drive the synthesis of ATP. This is known as oxidative phosphorylation and the 
enzymes that participate in this process are known as the oxidative phosphorylation enzymes. 
 
Mitochondria are thought to have emerged from an endosymbiotic event between a facultative 
anaerobic α-proteobacterium and a host methanogenic archaebacterium (Embley and Martin, 
2006), resulting in the first eukaryote. Although it is known that not all eukaryotes possess 
mitochondria (Karnkowska et al., 2016), they do contain mitochondria-like organelles, such as 
the hydrogenosome with its own subset of DNA (Boxma et al., 2005). This suggests that the 
acquisition of the ancestral mitochondrion was a prerequisite for the emergence of eukaryotes. 
 
Mitochondria contain their own subset of DNA, the mitochondrial DNA (mtDNA) (Nass and 
Nass, 1963), which over the course of evolution was reduced through horizontal gene transfer 
into nuclear DNA (nDNA)  (Mourier et al., 2001). Human mtDNA only encodes 13 proteins 
(directly involved in oxidative phosphorylation) and 24 RNAs (Anderson et al., 1981), with the 
vast majority of mitochondrial proteins encoded in the nDNA and imported into the 
mitochondria (Wiedemann et al., 2004). The mtDNA is transmitted from mother to offspring. 
Interestingly, in Caenorhabditis elegans embryos, paternal mitochondria are degraded by 
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autophagy (Sato and Sato, 2011), suggesting a functional relevance to the uniparental 
inheritance of mitochondria.  
 
1.2 The architecture of mitochondria 
 
Mitochondria are dynamic structures that are able to undergo fission and fusion depending on 
cellular stimuli, forming either highly dynamic interconnected networks or isolated 
mitochondria (Wai and Langer, 2016).    
 
Mitochondria are made up of two compartments, an oxidising inter-membrane space and a 
reducing matrix, which are separated from the cytosol by a freely permeable outer-membrane 
and a selective permeable inner-membrane (Figure 1.1). The inner-membrane of mitochondria 
also forms invaginations called cristae, which greatly increases the surface area of the 
membrane. The oxidative phosphorylation enzymes are present on the cristae, with the 
respiratory enzymes on the flat surface of the cristae and the ATPase dimers on the ridges of 
the cristae bending the membrane (Kühlbrandt, 2015) (Figure 1.2).  
 
 
Figure 1.1: A cross-section of a Gallus gallus mitochondrion imaged using electron 
tomography. Various features are indicated in the enlarged images. This figure was taken 
from Frey and Mannella (Freya and Mannellab, 2000). 
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Figure 1.2: Organisation of protein complexes on cristae. Respiratory complexes (green) are 
shown in the flat region of the membrane whilst ATPase dimers (yellow) are shown on the 
ridge. The red arrow indicates the proton pathway through the enzymes and the cristae 
junction-forming protein is shown in grey. This Figure was taken from Kühlbrandt (Kühlbrandt, 
2015). 
 
1.3 Energy transduction in mitochondria   
 
The majority of ATP in eukaryotic cells is produced by mitochondria (oxidative 
phosphorylation), with some synthesis occurring by glycolysis in the cytoplasm (substrate-level 
phosphorylation). Reducing equivalents, such as NADH, are generated via the citric acid cycle, 
which is fueled by pyruvate (from glycolysis), amino acids (amino acid degradation) and fatty 
acids (β-oxidation). Import of pyruvate, amino acids, and fatty acids (among other things) is 
facilitated by a class of membrane proteins called mitochondrial carriers (Kunji and Robinson, 
2010) (Figure 1.3). Thereafter, the energy released from oxidizing electron transfer is used to 







Figure 1.3:  A general schematic of the processes that occur in mammalian mitochondria. 
The main metabolic pathways are shown in red. Known and unknown carrier proteins are 
shown in yellow and purple, respectively. Green arrows indicate electron flux, blue arrows 
indicate proton pumping and the curly red arrow indicates oxygen conversion to water. This 
Figure was taken from Kunji and Robinson (Kunji and Robinson, 2010). 
 
There are many pathways of delivering electrons to the ubiquinone pool, such as the one 
through the electron transfer flavoprotein:ubiquinone oxidoreductases (Watmough and 
Frerman, 2010), but the two main electron flux pathways through the respiratory chain that 
result in generation of the proton-motive force that is utilised to produce ATP are the NADH 
to O2 pathway (catalysis complexes I, III and IV) and the succinate to O2 pathway (catalysis by 
complexes II, III and IV) (Figure 1.4). A brief summary of the reactions that occurs in each 
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NADH:ubiquinone oxidoreductase (complex I): Complex I links the oxidation of NADH to 
NAD+ to the reduction ubiquinone to ubiquinol. The energy released from the redox chemistry 
is used to pump four protons across the membrane to maintain a PMF of ~180 mV (Jones et 
al., 2017). The overall reaction is given below. 
 
NADH + ubiquinone + 2H+matrix + 4H+matrix « NAD+ + H+matrix + ubiquinol + 4H+inter-membrane space 
 
Succinate:ubiquinone dehydrogenase (complex II): Complex II is the only enzyme in the 
respiratory chain involved in the citric acid cycle. The flavin adenine dinucleotide (FAD) co-
factor of the enzyme oxidises succinate to fumarate on the matrix side. The electrons are then 
transferred via a chain of three iron-sulphur clusters to reduce ubiquinone to ubiquinol. The 
reaction is not electrogenic, with no transfer of charge across the inner-membrane, and therefore 
dose not contribute to the PMF generation. The overall reaction is given below (also see Figure 
1.5). 
 
succinate + ubiquinone  « fumarate+ + ubiquinol  
 
 
Figure 1.5: The structure porcine succinate dehydrogenase (complex II).  Electron transfer 
occurs from FAD to ubiquinone via three iron-sulphur clusters (all indicated in the structure). 
IMM and IMS denote inner mitochondrial membrane and inner membrane space, 
respectively. This figure was taken from Van Vranken et al., (Van Vranken et al., 2015). 
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Ubiquinol:cytochrome c oxidoreductase (complex III): Complex III operates by a Q-cycle 
mechanism. An ubiquinol binds near the inter-membrane space (Qp site) and passes one 
electron to the Rieske protein, which then passes it to cytochrome c (for the complex IV 
reaction), releasing two protons into the inter-membrane space. The second electron is 
transferred through two haems to a bound ubiquinone near the matrix side (Qn site), reducing it 
to a semi-ubiquinone.  The oxidation of ubiquinol to ubiquinone at the Qp binding site is 
repeated, with an electron transferred to a second cytochrome c through the Rieske protein 
(releasing two protons into the inter-membrane space), and the other electron being transferred 
to the semi-ubiquinone at the Qn site, forming ubiquinol by up taking two protons from the 
matrix side. The overall reaction is given below (also see figure 1.6). 
 
ubiquinone + 2 ubiquinol  + 2H+matrix + 2 cytochrome cox  «  
2 ubiquinone + ubiquinol + 4H+inter-membrane space + 2 cytochrome cred 
 
 
Figure 1.6: Q-cycle reaction scheme of Ubiquinol:cytochrome c oxidoreductase complex III.  
The figure illustrates the successive oxidation of two ubiquinols (A and B), resulting in the 
reduction of ubiquinone and cytochrome c. The proton pathways are indicated with the blue 
arrow. P-side and N-side denote the inter-membrane space (IMS) and the matrix, respectively. 
The electron transfer pathways through the co-factors are shown in red. This figure was taken 





Cytochrome c oxidase (complex IV): Electrons are transferred, one at a time from cytochrome 
cred (reduced by complex III) to copper centre CuA, then haem a and finally to haem-a3-CuB 
centre-haem (Figure 1.7). Consequently, molecular oxygen is reduced to two H2O in each 
catalytic cycle, which requires four protons and four electrons (from four cytochrome cred 
molecules). In the process, four protons are translocated across the membrane for every 
molecule of oxygen reduced (Figure 1.7).  
 
4 cytochrome cred + 8H+matrix + O2 «  
4 cytochrome cox+ 4H+inter-membrane space + 2H2O 
 
 
Figure 1.7: Reaction scheme of both complex III and IV. Electron transfer, catalysis and 
proton translocation for complex III (a) and complex IV (b) are shown. This figure was taken 
from Sazanov (Sazanov, 2015)   
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Overall, the favourable electron transfer from NADH to ½ O2 (catalysis by complexes I, III and 
IV) provides the energy to drive 10 H+ against the proton-motive force into the inter-membrane 
space. 
 
ATP synthase (complex V): The proton-motive force generated by the respiratory chain 
complexes is utilised by ATP synthase to produce ATP from ADP and inorganic phosphate 
(Pi). The c subunits in the complex (8 are present in the mammalian enzyme) which makes up 
the turbine-like structure contain glutamate residues which are protonated through a half-
channel in subunit a on the inter-membrane space (Figure 1.8). The proton motive force induces 
a clock-wise rotation (looking down on the c-ring from the inter-membrane space) of the c-
ring. As rotation occurs, protons are transferred by glutamate residues from the inter-membrane 
space to the matrix (Nakamoto et al., 2008).  
 
Figure 1.8: Production of ATP by ATP synthase. A simple scheme of one of the reactions 
carried out by ATP synthase. The red spheres are glutamates of the c-ring and the yellow and 
green cylinders represent the half-channels in the a subunit where protons are translocated 
from the inter-membrane space (IMS) to the matrix side during ATP synthesis. This figure was 
taken from Nakamoto et al., (Nakamoto et al., 2008) 
 
The rotation of the c-ring causes a like-wise rotation of the central stalk (subunit γ), connecting 
the proton-translocating (Fo) domain to the catalytic (F1) domain. F1 is made up of three 




production. The rotation of subunit γ causes conformational changes in the catalytic F1 domain 
(Figure 1.9). The F1-associated catalytic subunit β is initially in an open confirmation (βE) 
which allows binding of ADP and inorganic phosphate. Following the rotation of subunit γ, 
subunit β changes to a loose (βDP) and then a tight (βTP) conformation, catalysing ATP 
production (Figure 1.9). For every complete rotation of the c-ring, 8 protons are taken up from 
the inter-membrane space and released in the matrix, resulting in the generation of 3 ATP 
molecules. This means that for every 10 H+ pumped into the inter-membrane space by the 
respiratory chain complexes (NADH to ½ O2), complex V generates ~3.8 molecules of ATP 
This does not take into account the proton required for phosphate transfer into mitochondria. 
 
Figure 1.9: ATP production by the F1 domain of ATP synthase. Conformational changes in 
the β subunits result in either synthesis of ATP or its hydrolysis (dependent on the rotational 
direction of subunit γ. This figure was taken from Nakamoto et al., (Nakamoto et al., 2008). 
1.4 Mammalian complex I 
 
Mammalian complex I is a large integral membrane protein (~960 kDa) made up of 45 subunits, 
of which 44 are unique (Vinothkumar et al., 2014). Mammalian complex I shares 14 conserved 
core subunits with its bacterial counterparts, which is about half its mass. These shared core 
subunits constitute the minimal set of proteins required for catalysis by complex I. There are 
differences in the complex I subunit nomenclature between different species (Table 1.1). The 
human complex I subunit nomenclature will be used from here on for simplicity, regardless of 
the species referenced.  
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Mammals Yeast Bacteria 
B. taurus H. sapiens Y. lipolytica E. coli T. thermophilus 
75 kDa NDUFS1 NUAM NuoG Nqo3 
51 kDa NDUFV1 NUBM NuoF Nqo1 
49 kDa NDUFS2 NUCM NuoD* Nqo4 
30 kDa NDUFS3 NUGM NuoC* Nqo5 
24 kDa NDUFV2 NUHM NuoE Nqo2 
PSST NDUFS7 NUKM NuoB Nqo6 
TYKY NDUFS8 NUIM NuoI Nqo9 
ND1 ND1 NU1M NuoH Nqo8 
ND2 ND2 NU2M NuoN Nqo14 
ND3 ND3 NU3M NuoA Nqo7 
ND4 ND4 NU4M NuoM Nqo13 
ND5 ND5 NU5M NuoL Nqo12 
ND6 ND6 NU6M NuoJ Nqo10 
ND4L ND4L NULM NuoK Nqo11 
42 kDa NDUFA10    
39 kDa NDUFA9 NUEM   
18 kDa NDUFS4 NUYM   
15 kDa NDUFS5 NIPM   
13 kDa NDUFS6 NUMM   
10 kDa NDUFV3    
AGGG NDUFB2    
ASHI NDUFB6 NIAM   
ESSS NDUFB11 NESM   
KFYI NDUFC1    
MNLL NDUFB1    
MWFE NDUFA1 NIMM   
PDSW NDUFB10 NIDM   
PGIV NDUFA8 NUPM   
SDAP-α NDUFAB1 ACPM   
SDAP-β NDUFAB1 ACPM   
SGDH NDUFB5    
B22 NDUFB9 NI2M   
B18 NDUFB7 NB8M   
B17.2 NDUFA12 N7BM   
B17 NDUFB6    
B16.6 NDUFA13 NB6M   
B15 NDUFB4 NB5M   
B14.7 NDUFA11 NUJM   
B14.5a NDUFA7 NUZM   
B14.5b NDUFC2    
B14 NDUFA6 NB4M   
B13 NDUFA5 NUFM   
B12 NDUFB3 NB2M   
B9 NDUFA3 NI9M   
B8 NDUFA2 NI8M   
  NUXM   
  NEBM   
  NUNM   
  NUUM   
Table 1.1: Complex I subunit nomenclature from different species. This table was kindly 
provided by Dr. Febin Varghese. 
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1.5 General structure of complex I 
 
Since the first purification of eukaryotic complex I 56 years ago (Hatefi et al., 1962), many 
attempts have been made to solve its structure. The first success came with negatively stained 
complex I from Neurospora crassa, in which its distinguishing ‘L’ shape feature was first 
observed (Guénebaut et al., 1997; Hofhaus et al., 1991). The structure of complex I was shown 
to be comprised of two major domains, a hydrophobic domain that is embedded in the 
membrane and a hydrophilic domain that is protruding orthogonally from the membrane 
domain and into the matrix/cytoplasm. Although the general shape of complex I was 
determined from the structure, the resolution of the reconstructions was too low (~30 Å) to be 
able to observe useful structural information (i.e. subunits location, secondary structure 
features. 
 
1.6 The structure of bacterial complex I 
 
The first high resolution structure for complex I, obtained by X-ray crystallography, was that 
of the hydrophilic domain of complex I from Thermus thermophilus, first at 4.0 Å and then at 
3.3 Å (Hinchliffe and Sazanov, 2005; Sazanov and Hinchliffe, 2006). The hydrophilic arm 
consists of an N-module (the site of NADH oxidation), with subunits NDUFV1, NDUFV2), 
NDUFS1, and the Q-module (the site of quinone reduction), with subunits NDUFS2, NDUFS3, 
NDUFS7 and NDUFS8 (Figure 1.10). In addition, there was an additional supernumerary 




Figure 1.10: Architecture of the hydrophilic domain of complex I from T. thermophilus: (A) 
A side view of the hydrophilic subunits of complex I (cartoon representation), iron-sulphur 
clusters (red and yellow sphere representation) and FMN (magenta sphere representation). 
Q denotes the quinone-binding site. (B) The main electron transfer pathway (arrow) and 
possible electron transfer pathway (green), with centre-to-centre (and edge-to-edge in 
parenthesis) distances in Å. See table 1.1 for complex I subunit nomenclature. This figure was 
taken from Sazanov and Hinchliffe (Sazanov and Hinchliffe, 2006). 
 
The structure shows that all of the catalytically-relevant co-factors, the FMN, and the iron-
sulphur clusters are surrounded by the core subunits of the hydrophilic arm. For example, the 
N-terminal domain of NDUFV1 contains a Rossman-like fold, enabling it to bind the FMN, 
and the N-terminal [FeFe] domain of NDUFS1 binds three iron-sulphur clusters. There are nine 
iron-sulphur clusters (eight in eukaryotes) present in the structure of the T. thermophilus 
hydrophilic arm (Figure 1.10). Seven of the clusters form a chain from the FMN to the base of 
the hydrophilic arm where quinone binds, and they are all within favourable electron transfer 
distance from each other (within 14 Å) (Page et al., 2003). This provides a pathway of electron 
transfer from NADH (via the FMN) to quinone (via N2, the terminal cluster in the chain).  
 
The structure of the membrane domain of complex I, which is the site of proton pumping, was 
solved by X-ray crystallography, at 3.0 Å from Escherichia coli (Efremov and Sazanov, 2011). 
The structure contained six out of the seven core subunits of complex I present in the membrane 
domain, ND5, ND4, ND2, ND4L, ND6 and ND3 (Figure 1.11). The structure lacked ND1 
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because it dissociated during the protein purification. Remarkably, the membrane domain 
contains no co-factors and is too far away from the site of ubiquinone reduction to be coupled 
directly, therefore an indirect mechanism for coupling ubiquinone reduction by NADH to 
proton pumping in the membrane domain has to occur.  
 
 
Figure 1.11: Structure of the membrane domain of complex I from E. coli. A cartoon 
representation of the assigned membrane subunits (labelled), with the predicted span of the 
lipid bilayer indicated. See table 1.1 for complex I subunit nomenclature. This figure was taken 
from Efremov and Sazanov (Efremov and Sazanov, 2011).  
 
Subunits ND5, ND4 and ND2 are homologous to Na+/H+ Mrp antiporters (Mathiesen and 
Hägerhäll, 2002), which suggests that they are involved in proton pumping. The antiporter-like 
subunits are divided into two halves, related to each other by inverted symmetry along the 
membrane plane. Each symmetry-related half contributes a half-channel, in which one half has 
access to the inter-membrane/periplasmic space while the other half has access to the 
matrix/cytoplasm. The two half-channels are disconnected from one another but are linked by 
charged residues and probably water molecules to mediate proton transfer. Each half of the 
antiporter-like subunits possess a discontinuous helix, which is a helix disrupted at its centre 
by a loop (Figure 1.12). This confers flexibility on the helix that may allow it to undergo 
conformational changes during proton pumping (Efremov and Sazanov, 2011). On the 
discontinuous helices are highly conserved charged residues that lie in the middle of the 
membrane, making them ideal candidates for coupling electron transfer to proton pumping. In 
addition, ND5 contains a long C-terminal transverse helix that spans most of the membrane 
domain. The residues of the transverse helix are poorly conserved and while its function is not 
known, it may provide a means of synchronizing proton pumping or improving membrane 
domain stability. Together with the antiporter-like subunits, ND4L and ND6 are said to 
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contribute the fourth distinct proton channel, mediated by a path of conserved charged residues, 
although the exact pathways through these subunits are unclear (Figure 1.13). Although the 
number of channels is consistent with complex I pumping four protons across the membrane 




Figure 1.12: Topology of the antiporter-like subunits ND2, ND4 and ND5. The two symmetry-
related halves are shown in green and magenta. Critical charged residues are shown as red or 






Figure 1.13: Putative proton channels in the membrane domain. Essential charged residues 
predicted to be involved in proton translocation are labelled red. Predicted water molecules 
are shown as red spheres, with the path of proton translocation indicted by blue arrow. This 
figure was taken from Efremov and Sazanov (Efremov and Sazanov, 2011).  
 
The first crystal structure of the entire respiratory complex I at 3.3 Å was solved from T. 
thermophilus (Baradaran et al., 2013). The structure contained all of the core subunits from the 
membrane and hydrophilic domains (Figure 1.14a). The arrangement of the antiporter-like 
subunits in the T. thermophilus structure is similar to that in the E. coli structure. The first half-
channel (cytoplasmic side) subunits have a lysine residue on the discontinuous helix and a 
nearby interacting glutamate residue (Figure 1.14b). The second half-channel of the antiporter-
like subunits have either a lysine or a glutamate at the discontinuous helix. The two half 
channels are connected by either a histidine or lysine. 
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Figure 1.14: Structural overview of complex I from T. thermophilus. (a) A cartoon 
representation of the entire complex I, with the predicted span of the lipid bilayer indicated. 
(b) Predicted channels (blue arrow) by conserved charged residues (labelled).  See table 1.1 
for complex I subunit nomenclature. This figure was taken from Baradaran et al., (Baradaran 
et al., 2013). 
 
A novel feature of the structure is that the predicted ubiquinone-binding chamber, which is long 
and narrow, extends 15 Å above the membrane surface (Baradaran et al., 2013). This was 
partially confirmed by soaking the T. thermophilus complex I crystals in piericidin, which is a 
quinone analogue and potent complex I inhbitor. This long channel means that quinone has to 
‘diffuse’ into complex I to become reduced by electrons from the N2 iron-sulphur cluster. 
Sazanov and co-workers postulated that long-range conformational changes occur by 
electrostatic repulsion of key charged residues across the membrane plane (Figure 1.14b) upon 
quinone reduction, but this has yet to be experimentally shown. 
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1.7 General mechanism of complex I 
 
 
In order for electron transfer to occur in complex I, NADH must first bind in the binding pocket 
of NDUFV1, which catalyses the hydride transfer from NADH to the FMN (Birrell and Hirst, 
2013). The electrons from the reduced FMN are transferred, one at a time through a series of 
iron sulphur clusters (Figure 1.15), with the pathway (shown in figure 1.10) being NADH ® 
FMN ® N3 ® N1b ® N4 ®N5 ® N6a ® N6b ® N2 ® Q, where N and Q denote the clusters 
and quinone, respectively. The transfer of electrons is not rate limiting for catalysis, with two 
electrons sequentially delivered to the terminal N2 cluster in only ~90 µs in E. coli complex I 
(Verkhovskaya et al., 2008).  
 
Following reduction of the clusters, two electrons are sequentially transferred to quinone, with 
its head group ~15 Å above the membrane plane, as inferred from an analogous structure bound 
to the T. thermophilus complex I (Baradaran et al., 2013). Coupled to its reduction, the quinone 
is protonated by nearby tyrosine and histidine residues (note: this is predicted and not 
experimentally determined) (Sharma et al., 2015) that are within hydrogen-bonding distance to 
the quinone head-group.  
 
Electron transfer by the hydrophilic arm of complex I is coupled to the transfer of four protons 
in the membrane arm of the complex I (Jones et al., 2017), most likely through the antiporter 
like subunits (see figure 1.13). How exactly electron transfer is energetically coupled to proton 
pumping has yet to be determined, but a series of charged residues in the central axis of the 
hydrophobic membrane (i.e. in the antiporter-like subunits) are predicted to be involved in 
coupling the reduction of quinone to the pumping of protons, by inducing conformational 
changes in the membrane domain (Figure 1.15) (Efremov and Sazanov, 2011). Further work is 
required to elucidate the coupling mechanism of complex I. 
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Figure 1.15: Proposed coupling mechanism of complex I. Electron transfer and the 
subsequent proton transfer are shown. Charged residues involved in energy coupling are 
shown as spheres, red for acidic and blue for basic residues. See table 1.1 for complex I subunit 
nomenclature. This figure was taken from Sazanov (Sazanov, 2015). 
 
1.8 Active to de-active transition of mitochondrial complex I 
 
Mitochondrial complex I undergoes a transition from an active state to a de-active state. This 
was first observed in horse heart preparations, which exhibited bi-phasic NADH oxidation 
kinetics, characterised by a lag phase transitioning to a more rapid steady-state phase 
(Minakami et al., 1964). It was later shown that the active to the de-active transition of complex 
I is dependent on a lack of substrate and has a temperature dependence (i.e. incubation at 30 °C 
causes deactivation of the enzyme), as observed in bovine heart sub-mitochondrial particles 
(SMPs) (Kotlyar and Vinogradov, 1990). They also found the opposite to be true, where 
incubation of bovine heart SMPs with NADH resulted in the activation of the enzyme (i.e. no 
lag phase present in the kinetic measurements). 
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Proteomic analyses and selective labelling of both active and de-active bovine heart SMPs 
showed that a highly conserved cysteine residue on  the ND3 subunit (cysteine 39 in mammals) 
is a diagnostic for the active to the de-active transition of complex I (Galkin et al., 2008).  The 
cysteine residue is located in a loop between transmembrane helix 1 and 2 of ND3, which in 
the active state is observed to bind in a cavity near the NDUFS2, NDUFS7 and ND1 subunits 
(Figure 1.16). The cysteine-containing loop is believed to become disordered and exposed to 
the matrix when complex I is de-activated (i.e. incubation of mitochondrial membranes at 30 
°C) and the cysteine becomes susceptible to N-ethylmaleimide (NEM) modification, consistent 
with structural and biochemical data (Blaza et al., 2018; Galkin et al., 2008; Zhu et al., 2016).  
 
 
Figure 1.16: Location of cysteine 39 on ND3 loop. Highly conserved cysteine 39 and histidine 
59 (red spheres) are labelled. Disordered regions in the de-active bovine complex I structure  
(5LDW) and the ubiquinone binding channel are shown in red and blue, respectively (Zhu et 
al., 2016). ND1 (green), ND3 (beige), NDUFS7 (light blue), NDUFS2 (pink) and NDUFA9 (gold) 
are shown in cartoon representation. This figure was taken from Blaza et al., (Blaza et al., 
2018). 
 
There are pathophysiological consequences to the deactivation of complex I in ischemia-
reperfusion injury (Chouchani et al., 2014). During ischemia, it is thought that a lack of oxygen 
to complex IV stalls electron transfer through the respiratory chain, resulting in the de-
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activation of complex I (by a lack of substrate turnover) and a buildup of metabolites, such as 
succinate (Chouchani et al., 2014). The re-introduction of oxygen (reperfusion) causes complex 
I to reduce oxygen to superoxide via reverse electron transfer (opposite of the scheme shown 
in Figure 1.15), which is driven by the proton motive force and correlated to succinate buildup 
(Chouchani et al., 2014). It was shown in mouse heart that the injury caused by a surge in 
reactive oxygen, can be protected against by some extent by reversible S-nitrosation of cysteine 
39 of complex I (Chouchani et al., 2013). 
 
It is known that lack of substrates supposedly drives complex I into the de-active state (Kotlyar 
and Vinogradov, 1990), however, the exact mechanism and utility of deactivation is not known, 
nor is the in vivo relevance. Furthermore, bacterial complex I exists only in the active form, 
including Paracoccus denitrificans, which has the conserved ND3 cysteine (unlike E. coli and 
T. thermophilus) (Maklashina et al., 2003), the reason for this is not known. 
 
1.9 The structure of yeast complex I 
 
The first density map to reveal secondary structure features of eukaryotic complex I was that 
of Yarrowia lipolytica at 6.3 Å, using X-ray crystallography. The iron-sulphur clusters are 
apparent, with a similar arrangement to the T. thermophilus complex I (Hunte et al., 2010). 
However, because of its low resolution, no structural model could be built for the fungal 
enzyme. Thereafter, a crystal structure of complex I from the same organism was obtained with 
a resolution of 3.6 Å (Zickermann et al., 2015). Although at a higher resolution, only one 
supernumerary subunit was modelled in (NDUFA9) (Figure 1.17). However, 82 
transmembrane helices have been modelled, with only the transmembrane helices for the core 
subunits (64 helices) having been assigned to their respective subunits. The arrangement of 
core subunits is globally identical to that of previously solved complex I structures (Figure 
1.17). 
 
The enzyme was co-crystallised with 2-decyl-4-quinazolinylamine (DQA), which like 
piericidin, is a quinone analogue. A strong density was modelled as the inhibitor was observed 
adjacent to N2, helping confirm the position of the quinone cavity (Zickermann et al., 2015). 
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Figure 1.17: Structure of complex I from Y. lipolytica.  (B) Complex I is displayed in cartoon 
representation, in which secondary structures care coloured according to their assigned 
subunits, while unassigned secondary structure elements are grey. The N (NADH oxidising 
domain), Q (ubiquinone domain), Pp (proximal membrane domain) and PD (distal membrane 
domain) are indicated on the structure. (C) inset shows the iron-sulphur clusters with centre-
to-centre (edge-to-edge) distances in Å. This figure was taken from Zickerman et al., 











1.10 The structure of mammalian complex I 
 
Solving the structure of the mammalian enzyme by X-ray crystallography has been notoriously 
difficult, with only the membrane domain (subcomplex Iβ) being resolved by this method (Zhu 
et al., 2015). The structure allowed for the assignment of subunits in the distal part of the 
membrane. However, considering the absence of most of the protein, little information could 
be gained about the organisation of the supernumerary subunits or the enzyme mechanism. 
 
The first structure to establish the complete architecture of the eukaryotic complex I was that 
of the bovine enzyme by cryo-EM (Vinothkumar et al., 2014). At a global resolution of 4.95 
Å, secondary structure features such as α helices and β sheets were apparent in the density, 
which led to the assignment of subunits into well-resolved densities (Figure 1.18). In addition 
to the 14 conserved core subunits, 14 supernumerary subunits were identified out of the 31 
present (NDUFA1, NDUFA3, NDUFA5, NDUFA6, NDUFA8, NDUFA9, NDUFA10, 
NDUFA11, NDUFA13, NDUFAB1-α and NDUFAB1-β). The supernumerary subunits 
enclose most of the core subunits. The flavin domain, which is the site of superoxide production 
is exposed, therefore the function of the supernumerary subunits is unlikely to be the mitigation 
of superoxide production. An interesting feature is the presence of two copies of NDUFAB1 in 
the structure, one at the base of the matrix arm, and the other near the end of the membrane 
arm. This explains why NDUFAB1 was found in separate fractions in dissociation experiments 
(Carroll et al., 2003). The reason why there are two copies of NDUFAB1 on complex I is 
unclear at present. Also, amongst the supernumerary subunits modelled in is NDUFA9, which 
belongs to a family of short chain fatty acid dehydrogenases. NDUFA9 has a bound NADPH, 
confirmed by mutational studies on the yeast Y. lipolytica (Abdrakhmanova et al., 2006). The 
function of this nucleotide is unknown. Although abundant in structural information, the 
resolution of the structure (5 Å) precluded the assignment of amino acid residues, with 
exception of bulky aromatic residues. Therefore, most of the residues were modelled in as poly-
alanines, which prevented analysis on key residues in mechanistically important sites. 
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Figure 1.18: Architecture of bovine complex I. (a) The arrangement of supernumerary 
subunits (red) around the core subunits labelled (beige, green and blue). (b) A cartoon 
representation of assigned supernumerary subunits labelled, with core subunits and 
unassigned supernumerary densities shown in beige and grey, respectively. See table 1.1 for 
complex I subunit nomenclature. This figure was taken from Vinothkumar et al., (Vinothkumar 
et al., 2014). 
 
The first complete structure of mammalian complex I was solved using cryo-EM on the bovine 
enzyme (Zhu et al., 2016b). The cryo-EM map was resolved globally to 4.16 Å, which allowed 
the modelling of all subunits into the structure (14 core and 31 supernumerary subunits) (Figure 




densities, improving on the number of assigned residues from the previous bovine structure 
(Vinothkumar et al., 2014).  
 
Interestingly, the supernumerary subunits in the membrane domain form a cage-like structure 
around the core subunits (with many disulphide bonds present in the subunits on the inter-
membrane-space side), whilst the supernumerary subunits in the hydrophilic domain form 
threading structures, probably stabilising the protein by making large surface contacts with the 
core subunits. The contrast in the strategy for stabilisation of the core subunits by the two sets 
of supernumerary subunits may have some relevance in complex I assembly. 
 
 
Figure 1.19: Structural overview of bovine complex I.  (a) A cartoon representation of 
assigned supernumerary subunits (red) and core subunits (blue). (b and c) Positions of the 
supernumerary subunits (cartoon) in different domains of complex I (coloured red on the 
complex I icon), with core subunits presented as surface representations. See table 1.1 for 
complex I subunit nomenclature. This figure was taken from Zhu et al., (Zhu et al., 2016). 
 
Furthermore, 3D classification of the bovine particles resulted in three distinct classes, a minor 
broken class termed ‘class 3’, and two major classes termed ‘class 2’ and ‘class 1’. The class 2 
map (4.35 Å) and class 1 map (4.27 Å) revealed distinguishing features between the two, such 
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as disorder in the ubiquinone binding site and the ND3 loop between transmembrane helix 1 
and 2 in the class 1 map. The regions of disorder in the class 1 map were unexpected considering 
it was of a higher resolution than the class 2 map. Class 1 was therefore proposed to be as the 
de-active state of complex I because of key critical features in the structure that were consistent 
with biochemical assays, such as an exposed cysteine 39 on the disordered ND3 loop, which is 
modified by N-ethylmaleimide (NEM) when complex I is de-active state (Galkin et al., 2008). 
In contrast, the ND3 loop and ubiquinone binding site in were ordered in class 2, including the 
ubiquinone binding site of complex I, therefore this class was proposed to be the active state of 
complex I. This is the first case in which biochemically-defined states were structurally 
described in complex I. This was later confirmed by solving the structure of de-activated bovine 
complex I (Blaza et al., 2018). 
 
Shortly after the bovine complex I structure was solved, the Ovis aries (ovine) complex I 
structure was resolved to 3.9 Å (Fiedorczuk et al., 2016). In the ovine structure, all of the 
subunits were modelled into the structure with the aid of cross-linking mass spectrometry. The 
assignment and organisation of subunits were identical to that of the bovine enzyme. The ovine 
complex I also featured 12 bound phospholipids, which were previously shown to be critical 
for the activity of the enzyme (Sharpley et al., 2006) (Figure 1.20). The authors have suggested 
that the positioning of the lipids between hydrophobic subunits, in particular, cardiolipin, 
compensate for missing helices that are absent in metazoans (Birrell and Hirst, 2010), and 
therefore supposedly act to mitigate proton leak. 
 
Initially, the ovine structure was classified as the de-active state of the enzyme because of the 
loop in NDUFS2 that is precluding ubiquinone access to the N2 cluster, thus preventing 
electron transfer. However, careful inspection of the ovine complex I density map (EMD-4084) 
reveals poor density for NDUFA11, indicative of partial occupancy for that subunit, and there 
is no apparent density for the second-half of the transverse helix in ND5 (Blaza et al., 2018). 
Moreover, comparison between the ovine map and known bovine complex I classes show that 
ovine complex I belongs to the broken state (class 3) of the enzyme. This is confirmed by the 
poor NADH:DQ activity displayed by the ovine enzyme (3.5 µmol min-1 mg-1) compared to its 






Figure 1.20: Positions of phospholipids in ovine complex I. Some co-factors are shown as 
sticks such as PC (phosphatidylcholine), PE (phosphatidylethanolamine), CDL (cardiolipin), 
NADPH, and PPT (phosphopantetheine), whilst Zn (zinc) is shown as a sphere. This figure was 
taken from Fiedorczuk et al., (Fiedorczuk et al., 2016). 
 
1.11 The structure of complex I in respiratory supercomplexes 
 
The arrangement of respiratory complexes I, II and IV into supercomplexes in eukaryotes was 
first demonstrated by BN-PAGE analysis (Schägger and Pfeiffer, 2000). The authors also found 
that the vast majority of complex I in native membranes exists in supercomplexes rather than 
as isolated enzymes. In addition, there are three types of known supercomplexes in mammals, 
one without complex I (complexes III2 and IV), and two with complex I (the respirasome which 
contains complexes I, III2 and IV, and supercomplexes containing only complexes I and III2) 
(Milenkovic et al., 2017). 
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The architecture of the respirasome was solved independently at the same time from both ovine 
and Sus scrofa (porcine) mitochondria at 5.8 Å and 5.4 Å, respectively (Gu et al., 2016; Letts 
et al., 2016a). The structure revealed that complex I interacts with complex III (specifically 
subunit UQCRQ) via NDUFA11 and NDUFB4, both found anchored to the transverse helix of 
ND5, and with complex IV (subunits COX7c and COX8b) via ND5 and NDUFB3, both at the 
tip of the membrane domain (Figure 1.21). In addition, two different conformations of the 
respirasome were found by Sazanov and co-workers, a ‘tight’ conformation where complex IV 
interacted more with complex I and III, and a ‘loose’ conformation where complex IV 
interacted less with complex I and III.  Recently, there have been higher resolution structures 
of the porcine respirasome and the architecture of the human megacomplex has also been 
described (complexes I2, III2 and IV2) (Guo et al., 2017; Wu et al., 2016a). However, the human 
megacomplex has not been previously observed by BN-PAGE.  
 
 
Figure 1.21: The arrangement of complexes in the respirasome. Cryo-EM density map of 
complex I is shown in blue, complex III dimers are shown in green and complex IV is shown in 
pink. The structure was taken from Letts et al., (Letts et al., 2016a). 
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Respiratory supercomplexes have been proposed to be involved in substrate channelling of 
mobile electron carriers (cytochrome c and ubiquinol) between the complexes (Blanchi et al., 
2004), and that the supercomplexes specifically have dedicated pools of electron carriers that 
are not exchanged with other enzymes outside the supercomplex (Lapuente-Brun et al., 2013). 
However, this is not supported by kinetic evidence (Blaza et al., 2014) and it is clear from the 
structure of the respirasome that the cytochrome c and ubiquinone/ubiquinol binding sites are 
accessible to the outside environment, suggesting the electron carriers are free to diffuse (Figure 
1.22). Currently, it is not clear what is/are the function(s) of supercomplexes.  
 
 
Figure 1.22: Ubiquinone and cytochrome c binding sites in the porcine respirasome. (a) The 
transmembrane helices are shown for individual complexes in the respirasome, with the 
ubiquinone/ubiquinol binding sites indicated.  (b) The individual complexes are coloured 
differently with the binding site of cytochrome c indicated. This figure was taken from 
Milenkovic et al., (Milenkovic et al., 2017). 
 
1.12 Mammalian complex I Assembly   
 
Mammalian complex I is a complicated protein requiring many assembly factors to mature. 
Assembly factors are only transiently associated with the nascent complex (Andrews et al., 
2013; Heide et al., 2012). Complex I assembly has been proposed to occur by a sequential 
process, where individual modules, containing subunits from a particular domain are first 
assembled (Tuschen et al., 1990), and then these modules are joined together to form the mature 
complex I (Guerrero-Castillo et al., 2016).  
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Starting from the ubiquinone domain (Q-module), NDUFS2, NDUFS3 and NDUFA5 are the 
first subunits from the hydrophilic domain of complex I to assemble (Andrews et al., 2013; 
Mckenzie and Ryan, 2010). The association of these subunits with each other is consistent with 
their position in the structure. This subassembly is then joined by NDUFS7 and NDUFS8, along 
with assembly factors NDUFAF4, NDUFAF3 and TIMMDC1 (Andrews et al., 2013). The 
subassembly then anchors itself to ND1, following the addition of further subunits (NDUFA3, 
NDUFA8 and NDUFA19). 
 
The second independent assembly module, the proximal membrane module (the membrane 
domain closer to the Q-domain) consists of subunits ND2, NDUFC1, NDUFC2 and assembly 
factors NDUFAF1, ECSIT, ACAD9, TMEM1126B and COA1 (Guerrero-Castillo et al., 2016). 
Mitochondrial encoded subunits ND6, ND4L and ND3 then join the proximal membrane 
domain. 
 
The third independent assembly module, the distal module domain consists of mitochondrial 
encoded ND5 and NDUFAB1, NDUFB7, NDUFB3, NDUFB5, NDUFB9 and NDUFB2. The 
distal membrane module then joins the proximal membrane module, with the aid of assembly 
factors FOXRED1, ATP5LL and TMEM70 (Guerrero-Castillo et al., 2016). This then joins 
with the previously assembled Q-module. 
 
Finally, the maturation of the complex is completed by the addition of the N-module 
(NDUFV1, NDUFV2, NDUFS1, NFUFA2, NUDFS4, NDUFV3, NDUFA12 and NDUFS6), 
and in the process, the assembly factors dissociate (see Figure 1.23 for the assembly scheme of 
mammalian complex I). 
  
Although the stepwise assembly complex I has been characterised, the identification of the 
steps has relied only on BN-PAGE analyses and stable isotope labelling in cell cultures. 
Confirmation of the process will require future structural determination of the different 




Figure 1.23: Stepwise assembly of complex I in human cell culture.  Proteins from different 
domains of complex I are coloured differently, with extrinsic assembly factors coloured 




1.13 Complex I deficiencies 
 
Complex I is encoded on both the nuclear genome and the mitochondrial genome, therefore 
mutations in either can result in complex I deficiencies in patients. In addition, mutations in the 
assembly factors of complex I can be detrimental to the maturation of the enzyme (Fassone et 
al., 2011) Complex I disorders are the most prevalent of mitochondrial disorders, accounting 
for ~30% of all known cases  (Fassone and Rahman, 2012). 
 
The clinical phenotype for complex I mutations vary greatly, making them difficult to diagnose; 
for example, the case of two siblings with the same mutation in NDUFS4 but displaying 
different clinical features (Budde et al., 2003). In this example, the sister suffered from the 
typical neuromuscular phenotype displayed by patients with Leigh syndrome, while the brother 
had cardiomyopathy. 
 
The most prevalent complex I disorder is Leigh syndrome, and it is an early-onset 
neuromuscular disorder, accounting for 39% of cases (Fassone and Rahman, 2012). Primarily, 
as with other complex I deficiencies, Leigh syndrome in patients is marked with the reduction 
in catalytic activity and the content of complex I in mitochondria. As a result, patients typically 
display symmetrical bilateral lesions in the basal ganglia, increased lactic acid in the blood 
plasma, ataxia, lethargy and ultimately death with the progression of the disease (Ortigoza-
Escobar et al., 2016). An example, a homozygous mutation in NDUFS1 (L231V mutation) in 
an 8.5 month-old toddler resulted in bilateral lesions in the brain, ataxia, growth retardation and 
a reduced complex I activity (Martín et al., 2005). 
 
Other less prevalent clinical manifestations of complex I deficiencies include, but not limited 
to, cardiomyopathy, leukoencephalopathy and fatal infantile lactic acidosis, with the latter 
causing death in infancy (Fassone and Rahman, 2012). 
 
Unfortunately, due to the clinical heterogeneity displayed by patients with complex I deficiency 
and the overlap in phenotype with mutations in other mitochondrial proteins (Zhu et al., 1998), 
the only methods of diagnosis are by sequencing the genome(s) of patients to identify possible 
pathogenic mutations, or to perform biochemical and/or protein-content analyses from patient 
samples. In one such case, Mootha and co-workers sequenced a number of candidate genes 
from 103 patients with known complex I deficiency and compared the results to 42 healthy 
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individuals, thus identifying pathological mutations, such as those for complex I assembly 
factors Nubpl and Foxred1 (Calvo et al., 2010). This was confirmed by rescuing complex I 










































1.14 Aims for this thesis 
 
Currently, model systems for complex I studies range from bacterial and yeast systems, which 
are genetically amenable but not medically-relevant, to large mammalian organisms such as 
Bos taurus, which are more closely related to humans but in which gene modification is not 
practical. In this thesis, Mus musculus (mouse) is developed as a system for complex I studies, 
because it is a mammalian, biomedically-relevant model system for human disease, which is 
amenable to genetic manipulation. 
 
• The first part of this thesis describes the purification of complex I from mouse heart in 
a stable, active and pure state  
• The second part of this thesis describes structural studies on the mouse enzyme using 
cryo-EM. 
 
Mutations in complex I, in both the nuclear encoded and the mitochondrial encoded subunits 
lead to a plethora of neurological diseases, such as Leigh syndrome. The ‘NDUFS4’ mouse 
model, from which the NDUFS4 subunit of complex I has been deleted, recapitulates some of 
the effects seen in humans. 
 
• The final part of this thesis aims to characterise the enzyme from the NDUFS4 disease 
model, and determine the effects of the deletion on the structure and activity of the 






















All materials were purchased from Sigma-Aldrich or Thermo Fisher Scientific unless otherwise 
stated. 
 
2.2 Genotyping the NDUFS4 knockout mouse strain 
 
2.2.1 Genomic DNA extraction  
 
DNA was extracted from Mus musculus (mouse) C57BL/6 strain ear biopsies using a 7 well 
Maxwell® 16 DNA Purification cartridge. To start automated genomic DNA extraction, the 
following selections were made sequentially on the Maxwell® 16 Instrument to start the 
program: Run, DNA and Tissue. After 45 min., extracted genomic DNA was transferred into 
300 µL of nuclease-free H2O.   
 
2.2.2 Polymerase chain reaction (PCR) 
 
PCR was performed according to Kruse et al., (Kruse et al., 2008). In a total volume of 25 µL, 
the following additions were made: 5µL of 5X Green GoTaq® Reaction Buffer (Promega), 2 
µL of 2.5 mM dNTPs, 1.25 µL dimethyl sulphoxide (DMSO), 0.6 µL of 20 µM forward primer, 
0.6 µL of 20 µM reverse primer, 13.4 µL H2O, 2 µL DNA and 0.15 µL GoTaq® G2 DNA 
Polymerase. The conditions and primers used for PCR are given below. 
 
The primers used to amplify the undisrupted (wild-type) NDUFS4 gene.  Expected product 
size: ~150 base pairs. 
Forward primer: 5’- AGCCTGTTCTCATACCTCGG-3’ 
Reverse primer: 5’- GCTCTCTATGAGGGTACAGAG-3’ 
The primers used to amplify the modified (deletion of exon 2 resulting in the loss of the protein) 
NDUFS4 gene:  Expected product size: ~200-300 base pairs. 
Forward primer: 5’- AGCCTGTTCTCATACCTCGG-3’ 
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Reverse primer: 5’- GGTGCATACTTATACTACTAGTAG-3’ 
 
PCR cycling parameter setup on the PCR instrument: 
 
1. 95 °C for 3 min. (denaturing). 
2. 95 °C for 30 sec. (denaturing). 
3. 53 °C for 30 sec. (annealing). 
4. 72 °C for 45 sec. (extension). 
5. Repeat steps 2 - 4 an additional 34 times. 
6. 72 °C for 5 min. (extension). 
7. 4 °C indefinitely (storage). 
 
2.2.3 Agarose gel electrophoresis  
 
Gels for electrophoresis were prepared by dissolving 2% (w/v) agarose (BioGene) in Tris-
Borate-EDTA buffer (TBE) by heating the mixture. 2 µL of ethidium bromide was added to 
the solution (50 mL) and left to solidify on a gel tray. 5 µL of the amplified DNA products were 
resolved at 100 V for 30 min. alongside a 1 kb plus DNA ladder (New England Biolabs). The 
fluorescence of ethidium bromide (which intercalates to DNA) was then imaged on a 
ChemiDoc imaging system (Bio-Rad).  
 




Decarboxylating malic enzyme (MaeB) and fumarase C (FumC) from E. coli were expressed 
using plasmids conferring ampicillin resistance (kindly provided by Dr. Andrew Jones), 
pET32:maeB and pASK40:fumC respectively (Bologna et al., 2007; Weaver et al., 1995), in 






2.3.2 E. coli Growth conditions and protein overexpression 
 
Preparation of MaeB and FumC was carried out as described in Jones et al., (Jones and Hirst, 
2013). Bacterial cultures were grown in a flask by shaking overnight at 37 °C in 50 mL of 
lysogeny broth (LB) media supplemented with 50 µg mL-1 of ampicillin. Then, ~1 mL of the 
starter culture was inoculated into 1 L of the same medium, and grown by shaking (150 rpm) 
at 32 °C. The optical density was monitored at 600 nm until an absorbance of 0.6 was reached. 
Protein expression was then induced by addition of 1 mM and 0.1 mM isopropyl-beta-D-
thiogalactopyranoside (IPTG) for FumC and MaeB, respectively. The induced bacterial 
cultures were left to grow overnight at 20 °C, ready for cell harvesting. 
 
2.3.3 Cell harvesting and protein purification  
 
All procedures were carried out at 4 °C. To pellet the cells, bacteria were centrifuged at 7,000 
× g for 15 min. in an RC12-BP centrifuge. Pelleted cells from 4 L cultures were then re-
suspended in ~120 ml of buffer A1 (100 mM NaCl, 25 mM imidazole, 10% glycerol (v/v, 
VWR) and 20 mM Tris-SO4 pH 7.4 at 4 ˚C) and buffer A2 (300 mM NaCl and 50 mM 
potassium phosphate pH 7.8 at 4 °C) for MaeB and FumC, respectively. Three EDTA-free 
protease inhibitor cocktail tablets (Roche) were added to impede proteolysis. Cells were then 
ruptured using a Z-Plus 2.2 kW cell disruptor (Constant Systems) at 30 kpsi, by passing them 
twice through the system. The lysate was then centrifuged at 160,000 × g for 45 min. using a 
Type 45 Ti rotor (Beckman Coulter). The resulting pellet was discarded and the supernatant 
was filtered with a 0.22 µM syringe filter (Millipore). Using a peristaltic pump, the filtered 
supernatant was loaded onto a 2 x 5 mL HisTrap HP column (GE Healthcare) at 2 mL min.-1. 
The column was then attached to an Äkta prime FPLC system (GE Healthcare), and washed 
with buffer A1 and A2 for FumC and MaeB respectively, until the absorbance at 280 nm The 
imidazole concentrations were increased over 40 mL with buffer B1 (buffer A1 + 300 mM 
imidazole) and buffer B2 (buffer A2 + 400 mM imidazole) for MaeB and FumC, respectively. 
The histidine-tagged proteins both eluted in ~75-80% imidazole of the eluent buffers. The 
fractions were pooled and concentrated 10-fold using 50 kDa molecular weight cut-off 
(MWCO) centrifugal filter concentrators (Millipore). The concentrated proteins were then 
dialysed for 12 hr. in buffer B1 (20 mM β-mercaptoethanol, 10% glycerol and 60 mM Tris– 
SO4 pH 7.4 at 4 ˚C) and buffer B2 (5 mM EDTA (VWR) 1 mM 1,4-Dithiothreitol (DTT) and 
10 mM tris–SO4 pH 7.0 at 4 ˚C) for MaeB and FumC respectively. Finally, the proteins were 
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stored at -80 ˚C in 50% glycerol. The yields obtained from 4 L of bacterial culture were 144 
mg and 54 mg of protein for MaeB and FumC, respectively. 
 
 
2.4 Preparation of mitochondrial membranes  
 
2.41 Heart extraction 
 
574 C57BL/6 mice were sacrificed by cervical dislocation, in accord with the UK Animals 
(Scientific Procedures) Act, 1986 (PPL: 7538, approved by the local ethics committee and the 
UK Home Office). Hearts (typically 0.2 g per heart) were surgically removed, then immersed 
in cold AT buffer (10 mM Tris-HCl pH 7.4 at 4 °C, 75 mM sucrose, 225 mM sorbitol 1 mM 
EGTA and 0.1% (w/v) fatty acid-free bovine serum albumin).  
 
2.4.1 Preparation of mitochondria from hearts 
 
Mitochondria were isolated from hearts using methods based on previous protocols 
(Fernández-vizarra et al., 2010; Fernández-Vizarra et al., 2002). In order to ease the 
homogenisation process, hearts were cut into 1 mm, then washed several times with AT buffer 
to remove blood and other hair. Heart pieces were then re-suspended in AT buffer (10 mL per 
g of material) and homogenised to consistency using a Potter-Elvehjem homogenizer fitted 
with a Teflon pestle, by 7 - 10 strokes at ~1,000 rpm (IKA® RW20 Digital overhead stirrer), in 
the case of mouse hearts. The homogenate was centrifuged at 1,000 x g for 5 min. to separate 
the mitochondria from cellular debris. The supernatant was carefully decanted and centrifuged 
at 9,000 x g for 10 min. to pellet crude mitochondria. Mitochondria were re-suspended with 
AT buffer 1/8th of the starting volume and re-centrifuged at ~15,000 x g for 2 min. This process 
was repeated several times to remove fatty acids. Finally, pelleted mitochondria were re-
suspended in mitochondrial re-suspension buffer (20 mM Tris-HCl pH 7.4 at 4 °C, 1 mM 






2.4.2 Isolation of mitochondrial membranes  
 
Mitochondria were thawed and diluted to 5 mg mL-1 with mitochondrial re-suspension buffer, 
then ruptured by three 5 sec. bursts of sonication (with 30 sec. intervals on ice) using a Q700 
Sonicator (Qsonica) at 65% amplitude setting. The membranes were pelleted at 75,000 x g 
using an MLA80 rotor (Beckman Coulter) for 1 hr., then re-suspended in mitochondrial re-
suspension buffer to 2/3rd of the starting volume to give ~5 mg mL-1 of protein. 
 
2.4.3 Origin of Ndufs4 (-/-) mice  
 
Ndufs4 (-/-) mice were generated by Palmiter and co-workers (Kruse et al., 2008). In brief, the 
second exon of the Ndufs4 gene was flanked by loxP sites in AK18.1 mouse embryonic stem 
cells (ESC). The resulting genetically modified mice were then crossed with Mox2-Cre to 
remove the second exon from the Ndufs4 gene. Mice that were heterozygous for truncation in 
the Ndufs4 allele were interbred to produce Ndufs4 (-/-) mice. 
2.5 Protein visualisation techniques 
 
2.5.1 BN-PAGE  
 
The following method was carried out at 4 °C. Heart mitochondrial membranes (5 mg mL-1) 
were solubilised by the addition of n-dodecyl β-D-maltoside (DDM, Glycon) or lauryl maltose 
neopentyl glycol (LMNG, Anatrace), to give a final detergent concentration of 1% (w/v). 
Following a 30 min. incubation, the samples were centrifuged at ~13,000 × g for 30 min. using 
a benchtop microfuge. The resulting supernatant (solubilised membranes) was analysed by blue 
native PAGE (BN-PAGE) according to previous methods (Schägger and von Jagow, 1991; 
Wittig et al., 2006). In brief, solubilised membranes were diluted by 1/4th with 4 x 
NativePageTM sample buffer (Invitrogen), and then Commassie G-250 (Amnesco) was added 
to give a dye/detergent ratio of 1/4. The samples were then loaded onto NativePageTM 3 - 12% 
Bis-Tris gels (Invitrogen). Initially, electrophoresis was carried out at 80 V for 30 min. using 
NativePageTM (Invitrogen) inner chamber buffer (1 x cathode buffer additive and 1 x running 
buffer) and outer chamber buffer (1 x running buffer). After 30 min, the inner chamber buffer 
was exchanged with 0.1 x cathode buffer additive and 1 x running buffer, and then 
electrophoresis was carried out at 180 V for an additional 2 hr. In-gel NADH oxidation was 
visualised by incubating native gels with 0.5 mg mL-1 Nitroblue tetrazolium chloride (NBT) 
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and 100 µM NADH in 20 mM Tris-HCl pH 7.55 at 32 °C for 20 min. NADH oxidation is 
denoted by the appearance of purple bands. Native gels not used for in-gel activity detection 
were stained with 50% methanol (v/v), 7% acetic acid (v/v) and 0.2% Commassie R250 (w/v) 





Samples for SDS-PAGE were incubated in 100 mM DTT, 63 mM Tris-HCl pH 6.8 at 25 °C, 
2% Sodium dodecyl sulphate (w/v, SDS), 10% glycerol and 15 nM bromophenol blue. The 
samples were loaded onto a Novex™ 10 - 20% Tris-Glycine gel (Invitrogen) and subjected to 
electrophoresis at 125 V for 90 min. Gels not used for Western blotting were stained and de-
stained similarly as the native gels.  
 
2.5.3 Western blotting and immunodetection 
 
SDS-PAGE gels were transferred to Immobilon®-FL polyvinylidene fluoride membrane 
(Millipore) using a wet transfer system in 25 mM Tris, 190 mM glycine and 10% methanol at 
300 mA for 1 hr. The membrane was then blocked for 1.5 hr. with the Odyssey (Li-COR 
Bioscience) buffer, then stained overnight at 4 °C with either polyclonal (anti-rabbit) NDUFB9 
antibody (Proteintech: 15572-1-AP, 2000-fold dilution in Odyssey buffer) or polyclonal (anti-
rabbit) NDUFS1 antibody (in-house, 10000-fold dilution in Odyssey buffer) that was kindly 
provided by Dr. Ian Watt from the MRC-MBU, University of Cambridge. The membranes were 
then incubated with a fluorescent secondary anti-rabbit antibody (IRDye® 680RD, Li-COR 
Bioscience) and imaged using a Li-COR imaging system (emission at 694 nm). 
 
2.6 Kinetic activity assays 
 
All kinetics measurements were conducted using a 96-well Spectramax 384 plate reader at 32 
°C. Unless stated otherwise, all reactions were carried out in 20 mM Tris-Cl pH 7.55 at 32 °C 
as described previously (Birrell et al., 2009). An overview of the kinetic assays carried out is 
presented in Table 2.1. 
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Additions HAR FeCN APAD ATP hydrolysis NADH:O2 Succinate:O2 
H2O2 
C1 C2 C3 C4 
Alamethicin 
(µg mL-1) 
15* 15* 15* 15 10 10 15* 15* 15* 15* 
Piericidin 
(µM) 















NADH(µM) 100‡ 100‡ 100‡ 200 100‡ - 30‡ 30‡ 30‡ 30‡ 
NADP+ (mM) - - - - - 2 ‡ - - - - 
Cytochrome c 
(µM) 
- - - - 1.5 1.5 - - - - 
HRP (U mL-1) - - - - - - 10 10 10 10 
SOD (U mL-1) - - - - - - 10 10 10 10 
Amplex Red 
(µM) 
- - - - - - 10 10 10 10 
Catalase (U 
mL-1) 
- - - - - - - 5000 - 5000 
ATP (µM) - - - 200 - - - - - - 




- - - 40 - - - - - - 
Pyruvate 
kinase 
 (µg mL-1) 
- - - 50 - - - - - - 
MgSO4 (mM) - - - 2 - - - - - - 
K2SO4 (mM) - - - 2 - - - - - - 
 
Table 2.1: Overview of kinetic assays. * and † denote additions when membranes or complex  
I are used in the assays respectively. ‡ denotes the initiator of the reaction. C1-C4 represent 
the 4 conditions in the H2O2 production assay. All reactions were monitored at 340 – 380 nm 
(e = 4.81 mM-1 cm-1), except APAD and H2O2, which were monitored at 400 – 450 nm (e = 3.16 






2.6.1 Flavin-site NADH oxidation assays 
 
Flavin-site NADH oxidation reactions were initiated by the addition of 100 µM NADH to the 
assay. Nucleotide-bound dependent HAR (hexaammineruthenium (III) chloride) reduction 
activity by membranes or purified complex I was measured at a final concentration of 1 µg mL-
1 or 0.1 µg mL-1 respectively, using 3.5 mM HAR (Santa Cruz Biotechnology). NADH 
oxidation was monitored at 340 – 380 nm (e = 4.81 mM-1 cm-1). Potassium hexacyanoferrate 
(III) (FeCN) reduction activity by membranes (1 µg mL-1) or complex I (0.1 µg mL-1) using 1 
mM FeCN was monitored similarly by following the NADH absorbance. 3-Acetylpyridine 
adenine dinucleotide (APAD+) reduction activity by membranes (10 µg mL-1) or complex I (1 
µg mL-1) using 0.5 mM APAD+ was monitored by the reduction of APAD+ to APADH at 400 
– 450 nm (e = 3.16 mM-1 cm-1).   
 
2.6.2 H2O2 production  
 
Hydrogen peroxide production was measured using the Amplex Red method according to 
Kussmaul et al., (Kussmaul and Hirst, 2006). To establish protein-specific superoxide 
production, four conditions were set up, all with 10 U mL-1 horseradish peroxidase (HRP), 10 
µM Amplex Red and 10 U mL-1 superoxide dismutase from bovine erythrocytes (SOD).  
 
Condition 1: membranes (20 µg mL-1) or complex I (8 µg mL-1) 
Condition 2: membranes (20 µg mL-1) or complex I (8 µg mL-1) and 5000 U mL-1 catalase from 
Corynebacterium glutamicum. 
Condition 3: No additions. 
Condition 4: Only 5000 U mL-1 catalase. 
 
The reaction was initiated with 30 µM of NADH, and monitored by the oxidation of Amplex 
Red to resorufin at 557 – 620 nm (e = 51.60 mM-1 cm-1). The catalase-sensitive superoxide 
production rate of the protein was calculated using the following equation derived from 
previous work (Kussmaul and Hirst, 2006): catalase sensitive rate = condition 1 – (condition 2 





2.6.3 NADH and succinate:O2 oxidoreduction assays  
 
Membranes (10 µg mL-1) were permeabilised with 10 µg mL-1 alamethicin and supplemented 
with 1.5 µM cytochrome c from horse heart. Activity measurements were carried out in buffer 
K (10 mM Tris-SO4 pH 7.0 at 32 °C and 250 mM sucrose).  NADH:O2 (catalysis by complexes 
I, III and IV) oxidoreduction was initiated with 100 µM NADH and its oxidation monitored at 
340 – 380 nm (e = 4.81 mM-1 cm-1). Succinate:O2 (catalysis by complexes II, III and IV) 
oxidoreduction was carried out according to the spectrally-sensitive and stoichiometric method 
of Jones and Hirst (Jones and Hirst, 2013).  In brief, membranes were assayed with 2 mM 
MgSO4, 2 mM K2SO4, 5 mM succinate (pH ~7), 90 µg mL-1 FumC and 500 µg mL-1 MaeB. 
The reaction was initiated with 2 mM NADP+ and its reduction monitored at 340 – 380 nm (e 
= 4.81 mM-1 cm-1). The reaction steps (and the enzyme in parenthesis) for the succinate:O2 are 
given below:  
 
1. Succinate and ubiquinone are converted to fumarate and ubiquinol (complex II). 
2. Fumarate and H2O are converted to malate (FumC).  
3. Malate and NADP+ are converted to pyruvate, CO2 and NADPH (MaeB). 
 
2.6.4 ATP hydrolysis  
 
ATP hydrolysis was measured according to the method of Pullman et al., (Pullman et al., 1960). 
Membranes (5 µg mL-1) and 15 µg mL-1 alamethicin added to a pre-incubated (~2min.) mixture 
of 200 µM ATP, 400 µM phosphoenolpyruvate (PEP), 50 µg mL-1 pyruvate kinase from rabbit, 
200 µM NADH, 40 µg mL-1 lactate dehydrogenase from bovine heart, 2 mM MgSO4 and 2 mM 
K2SO4. ATP hydrolysis was followed by the oxidation of NADH.  
 
2.7 Purification of complex I 
 
2.7.1 Solubilisation of mitochondrial membranes  
 
All purification steps were carried out at 4 °C unless stated otherwise. The complex I 
purification method was adapted from that for bovine (Sharpley et al., 2006). Thawed 
membranes (5 mg mL-1) were incubated with 0.005% PMSF (w/v) to inhibit proteolysis. DDM 
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(1%) was added to mouse membranes, then stirred on a Thermomixer Comfort (Eppendorf) at 
400 - 600 RPM for 30 min. to solubilize the complexes. In the case of deactivated mouse 
complex I, the membranes (17 mg mL-1) were pre-treated at 37 °C for 30 min., then diluted to 
5 mg mL-1 with buffer C. To clarify the solution, the sample was centrifuged at 48,000 x g 
using an MLA80 for 30 min.  
 
2.7.2 Anion-exchange chromatography  
 
Solubilised membranes were loaded onto a 1 mL Hi-Trap Q HP anion exchange column (GE 
Healthcare), pre-equilibrated with buffer A (20 mM Tris-HCl pH 7.14 at 23 °C, 1 mM EDTA, 
0.1% DDM, 10% ethylene glycol (v/v, VWR), 0.005% asolectin (Avanti) and 0.005% CHAPS 
(Calbiochem). The column was attached to an Äkta micro system (GE Healthcare), then 
washed with buffer A at 0.3 mL min.-1 for 2 min. with absorbance measured at 280 nm and 420 
nm. Initially, the system was washed with 20% buffer B (buffer A + 1M NaCl) for 7 min. to 
remove unwanted proteins, then with 35% buffer B for 10 min. to elute complex I-containing 
fractions, and finally with 100% buffer B for 5 min. to remove the remaining bound proteins. 
Complex I-containing fractions (~1 mL) were pooled and concentrated (~100 µL) using a 100 
kDa MWCO Vivaspin 500 concentrator (Sartorius).  
 
2.7.3 Size-exclusion chromatography  
 
Complex I was further resolved by size-exclusion chromatography, with the absorbance 
measured at 280 nm and 420 nm. Pooled and concentrated Q-sepharose fractions (100 µL) were 
injected onto either a Superose 6TM Increase 3.2/300 column used in the earlier purifications, 
or a Superose 6TM Increase 5/150 (GE Healthcare) column used currently, both pre-equilibrated 
in buffer C (20 mM Tris-HCl pH 7.14 at 23 °C, 10% ethylene glycol, 150 mM NaCl and 0.02% 
DDM). Complex I elutes as a pure monodisperse peak at ~1.39 mL and ~1.65 mL from the 
3.2/300 and 5/150 Superose 6TM Increase columns, respectively. Protein for cryo-EM grid 
preparation was not concentrated before use, but for other uses complex I was concentrated and 
stored in 30% glycerol at -80 °C. Note for cryo-EM preparations; ethylene glycol was omitted 
in buffer C, due to a predicted decrease in image contrast, affecting 3D reconstructions of 
complex I. In addition, the detergent concentration in buffer C was increased from 0.02 to 
0.05% for membranes starting material with 10 mg or more of protein, to maintain reasonable 
detergent to protein ratio, thus avoiding protein aggregation.  
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2.8 Cross-linking experiments 
 
For cross-linking experiments, 0.1 - 1 mM bis(sulfosuccinimidyl)suberate (BS3) were added to 
membranes in mitochondrial re-suspension buffer 5 min. after DDM addition and then 
incubated for 25 min.  
 
2.9 Mass spectrometry 
 
Dr. Michael Harbour and Dr. Shujing Ding from the MRC-MBU, University of Cambridge 
carried out the mass spectrometry experiments. 
 
2.9.1 Data processing  
 
Peptide spectra were recorded in ‘raw files’ by the instrument’s operating software, Xcalibur. 
Proteome Discoverer was then used to open the raw files, collect MS/MS fragmentation 
spectra, and submit them to Mascot 2.4 (Matrix Science Ltd.) for comparison against a given 
database, to assign spectra to peptide sequences and proteins. Only hits with a threshold p < 
0.05 (representing the 95% confidence threshold) were considered. Proteome Discoverer, then 
assigned confidence values for detected peptides, green=high confidence, yellow=medium 
confidence and red=low confidence. The protein database used for protein identification in 
mouse was UP000000589 (January 2016), with 53,106 protein entries from the UniProt server 
(Apweiler et al., 2017). Possible protein isoforms, predicted using Augustus (Stanke and 
Morgenstern, 2005), were manually inspected and added to the databases. 
  
2.9.2 Tryptic digestion  
 
Gel slices were washed thoroughly with 100 µL H2O, then placed into 20 mM Tris-HCl pH 
8.0. The samples were incubated for 1 hr. in 20 mM Tris-HCl pH 8.0 and 50% acetonitrile (v/v, 
Fluka), then in 100% acetonitrile to desiccate the gel for 15 min. To remove all of the liquid, 
to assist absorption of trypsin, the gel was vacuum dried (Savant SPD121P SpeedVac 
concentrator). The proteins in the gel were then digested overnight at 37 °C with 10 µL of 
bovine trypsin (12.5 µg mL-1) in 20 mM Tris-HCl pH 8.0 and 5 mM CaCl2. The digested tryptic 
peptides were extracted from the gel into the tube for 1 hr. using 15 µL of 4% formic acid (v/v) 
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and 60% acetonitrile. The extracted solution was transferred into a new tube, and the gel was 
then re-extracted for 1 hr. and added to the previously extraction solution.  In the case of native 
gels, the extracted solution was further vacuum dried to increase the concentration of peptides 
and remove excess acetonitrile, which would prevent peptides from adhering to the reverse-
phase high-performance liquid chromatography column. Finally, it was re-suspended in 15 µL 
of 2% acetonitrile and 0.1% formic acid.  
 
Protein solution (~200 ng) for digestion were precipitated overnight in 100 µL cold ethanol 
solution at -20 °C. Precipitates were pelleted at 16,000 x g for 5 min. using a microfuge, and 
then re-suspended in 10 µL of 50 mM ammonium bicarbonate. Thereafter, they were digested 
overnight in 10 µL of trypsin (12.5 µg mL-1) in 20 mM Tris-HCl pH 8.0 and 5 mM CaCl2.  
 
2.9.3 Matrix-assisted laser desorption/ionization time-of-flight/time-of-flight (MALDI 
TOF/TOF) 
 
The tryptically-digested solution (0.5 µL) was spotted onto an Opti-TOF 384 MALDI plate, 
and to that 0.5 µL of 10 µg mL-1 α-cyano-4-hydroxycinnamic acid (CHCA) in 60% acetonitrile 
and 0.1% trifluoroacetic acid (v/v) was added.  Once the solution had crystallised, the samples 
(each spot) were analysed sequentially by a 4800 MALDI TOF/TOF™ Analyzer (Applied 
Biosystems/MDS SCIEX). The autolysis products of trypsin and the characteristic signal peak 
of the CHCA matrix were used to calibrate each spectrum. The 7 highest scoring peptides from 
each spot (between 900-4000 m/z, where m/z is the mass to charge ratio) were automatically 
selected by the instrument’s (4000 Series Explorer) software, for collision-based fragmentation 
(with atmospheric air) or collision-induced-dissociation (CID). Fragmentation spectra were 
then used for probability-based identification with the Mascot search engine (see above). The 
Mascot search parameters used against the database were peptide mass tolerance=70 ppm, 
fragment mass tolerance=0.8 Da, variable protein modifications=protein N-terminal 
acetylation, protein N-terminal formylation, methionine oxidation and cysteine propionamide 







2.9.4 Liquid chromatography–mass spectrometry (LC-MS/MS) 
 
Peptides from in-solution digestion were resolved by reverse-phase high-performance liquid 
chromatography (RP-HPLC) on an Acclaim PepMap nanoViper C18 reverse-phase column (75 
µM x 100 mm). With a flow rate of 300 nL min.-1, buffer A (5% acetonitrile and 0.1% formic 
acid) and buffer B (95% acetonitrile and 0.1% formic acid) were used to set up a gradient up 
to 40% acetonitrile over 84 min. Peptides were introduced directly into the linear trap Orbitrap 
XLTM mass spectrometer by electrospray ionisation. The 10 highest scoring peptides detected 
(between 400-6000 m/z) in the survey scan were selected for collision-based fragmentation. To 
avoid repeated fragmentation of a particular peptide, a dynamic exclusion list was made for a 
specified time, to exclude peptides that have already been fragmented from further analyses. 
The Mascot search parameters used against the database were the following: peptide mass 
tolerance=5 ppm, fragment mass tolerance=0.5 Da, variable protein modifications=protein N-
terminal acetylation, protein N-terminal formylation and methionine oxidation, with a 
maximum of 4 missed cleavages. The number of missed cleavages was raised from 1 to 4, to 
increase the number of peptides detected despite also increasing the number of false positives.  
 
2.9.5 Molecular mass measurements 
 
Molecular mass measurements of complex I subunits were performed according to previous 
work on the bovine enzyme (Carroll et al., 2009). Protein mixtures were precipitated overnight 
with cold ethanol solution (20 vol.) at -20 °C. The protein was collected by centrifugation at 
16,000 x g for 5 min., then re-suspended in 30 µL of formic acid/trifluoroethanol/hexafluoro-
propan-2-ol/H2O at a volume/volume (v/v) ratio of 60:15:1:24, with 1 mM tris(2-
carboxyethyl)phosphine hydrochloride. The sample was centrifuged again at 16,000 x g for 5 
min and the supernatant separated on a polymeric reverse-phase column (50 mm x 1 mm i.d., 
50 °C) using an Agilent 1100 series HPLC system. Proteins were eluted with a gradient of 
propan-2-ol at a flow rate of 50 µL min.-1, using the following buffer system; buffer A 
(trifluoroethanol/hexafluoro-propan-2-ol/1 M ammonium formate pH 3.1/H2O at a 
volume/volume (v/v) ratio of 15:1:5:79) and buffer B (trifluoroethanol/ hexafluoro-propan-2-
ol/propan-2-ol/1 M ammonium formate pH 3.1/H2O at a volume/volume (v/v) ratio of 
20:1:70:5:4) were used to set up a gradient up to 100% buffer B over 5 mL. The eluted proteins 
were introduced by electrospray ionisation into a 4000 Q trap mass spectrometer. The 
molecular masses of subunits were calculated from their multiple charged species using 
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PeakView software (SCIEX). Assignment of the measured masses to the mature proteins were 
made with the aid of previous data on the bovine enzyme (Carroll et al., 2009).  
 
2.9.6 Complexome profiling experiments  
 
Complexome analyses was carried out according to Heide et al., (Heide et al., 2012), by 
excising 64 x 1 mm slices from BN-PAGE gels. BN-PAGE was performed as described in 
Chapter 2.5.1, and tryptic digestion carried out as described in Chapter 2.8.2.  Tryptically-
digested peptides were resolved using reverse-phase HPLC and directly introduced into a LTQ 
Orbitrap XLTM mass spectrometer. The 10 highest scoring peptides (between 400 - 2000 m/z) 
in the survey scan were chosen for collision-based fragmentation. To maximise the range of 
peptides detected, a dynamic exclusion list was included to prevent repeated fragmentation of 
the same peptide within a specified time. The Mascot search parameters used against the 
database were the following: peptide mass tolerance = 10 ppm, fragment mass tolerance = 0.5 
Da, variable protein modifications = protein N-terminal acetylation, protein N-terminal 
formylation, methionine oxidation and cysteine propionamide derivatisation, with a maximum 
of 1 missed cleavage. Proteome Discoverer was used to submit the fragmentation spectra to 
Mascot for the identification of the proteins in each gel slice, and then retrieve the results for 
each gel slice, to be compiled into a consensus report. The proteins from each gel slice were 
quantified (relative) based on averaging the intensity values of its 3 highest detected peptides 
(by the intensity of the peptide precursor peaks in the survey scan). Pearson uncentered 
correlation coefficient (PUCC) is then calculated for every possible pair of protein detected. 
The resulting PUCC values are used to cluster proteins according to the single-linkage 
hierarchical cluster method, where initially each protein is a cluster of its own and is thereafter 
added to other protein clusters if the coefficient values are similar. Once a protein is clustered, 
the averaged relative protein abundance value in a given gel slice was then normalised to its 
maximum detection count, which means each protein has a relative abundance score that goes 
up to 1 along the gel. For visualisation, Excel conditional-formatting tool was used to change 
the colour of the cell according to the protein abundance, whereby a value 1 was displayed as 





2.10 Flavin characterisation assays 
 
2.10.1 Preparation of FMN standards  
 
FMN standards were prepared carefully using a metal weighing boat and volumetric flasks. 20 
mg of FMN was weighed out and added to two separate 100 mL volumetric flask, and then the 
empty boat was weighed again, and the difference recorded. Thereafter, Milli-Q H2O was added 
to 100 mL volume (with the bottom of the meniscus on the line) and the flask was shaken to 
dissolve the FMN. The two flasks were labelled A1 and B1 (~0.2 mg mL-1 of FMN). 2.5 g of 
solution from each of A1 and B1 were transferred into two 50 mL volumetric flasks (A10 and 
B10 respectively), and the flasks were filled with Milli-Q H2O to make 10 µg mL-1 FMN 
standards. Standard B10 was exclusively used to verify the accuracy of the weighing of the 
FMN standards. A10 was further diluted (in size-exclusion buffer C without DDM) in 10 mL 
volumetric flasks to make 0.1, 0.2, 0.5, 1 and 2 µg mL-1 of FMN standards to be used in the 
assay. Standards were kept in the dark at 4 °C to prevent photo-degradation of FMN. 
 
2.10.2 Quantification of FMN in complex I   
 
10-16 µL of complex I (10 µg) and 10 µL of FMN standards (0.2 – 10 µg mL-1) in size-
exclusion buffer C without DDM were transferred into a 0.5 mL amber Eppendorf tubes. To 
each tube, 90 µL of 11% trichloroacetic acid (v/v) was added to extract FMN, and vortexed. 
After 15 min. of incubation at room temperature, the solution was centrifuged for 3 min. using 
a microfuge at maximum speed. 40 µL of each supernatant (containing FMN) was transferred 
into a microplate and then mixed with 200 µL potassium phosphate in the wells. The 
concentration FMN bound to complex I was estimated using the fluorescence intensity of 
known FMN standards (excitation at 450 nm and emission at 525 nm). 
 
2.10.3 Thermo flavin assay 
 
This assay was adapted from Forneris et al., (Forneris et al., 2009). 20 µL of standards of 0.1 - 
2 µg mL-1 of FMN (with size-exclusion buffer C without DDM as control) and complex I (0.3 
µg mL-1) were carefully added to an Applied Biosystems MicroAmp 96-Well reaction plate 
and sealed with AB MicroAmp clear adhesive film. The plate was inserted into an Applied 
Biosystems 7900HT PCR machine and calibrated with the FMN standards following the 
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manufacture’s protocol for pure dyes. The machine was programmed to start at 20 °C for 2 
min., and then increase the temperature by 1.5 °C every 30 sec. up to 99 °C. The fluorescence 
data was extracted in an Excel file, where the concentration of FMN bound to complex I was 
calculated from the known FMN standards, and the temperature in which 50% of FMN 




2.11 EPR spectroscopy 
 
John Wright from Queen Mary University of London carried out EPR spectroscopy 
measurements. Samples for electron paramagnetic resonance (EPR) were prepared under 
anaerobic conditions in a Braun UniLab-plus glovebox (O2 < 0.5 ppm, N2 atmosphere) at room 
temperature (22°C). 9 µL of complex I sample (10-20 mg mL-1) was reduced with 2 mM NADH 
and rapidly transferred to a 1.6 O.D. suprasil quartz EPR tube (Wilmad, inner diameter 1.10 ± 
0.05 mm). The sample was then flash-frozen by immersion in an ethanol cold-trap, which was 
cooled externally with a dry ice/acetone slurry. The samples were then transferred to liquid 
nitrogen and removed from the glovebox. EPR measurements were performed using an X/Q-
band Bruker Elexsys E580 Spectrometer (Bruker BioSpin GmbH, Germany) equipped with a 
closed-cycle cryostat (Cryogenic Ltd, UK). All measurements were carried out at X-band using 
an ER 4118X-MS2 resonator (2 mm sample access). EPR measurement conditions were 3.2 
mW power, 100 kHz modulation frequency and 0.7 mT modulation amplitude. Baseline 
measurements of the sample buffer were subtracted.   
 
2.12 CryoEM grid preparation 
 
Cryo-EM grids were prepared alongside Dr. James Blaza from the MRC-MBU, University of 
Cambridge. UltrAuFoil® gold grids (0.6/1, Quantifoil Micro Tools GmbH) were used to 
minimise electron beam induced motion during imaging (Russo and Passmore, 2014), and were 
prepared as described previously (Blaza et al., 2018). The grids (on a glass slide) were made 
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hydrophilic by glow discharging them at 20 mA for 60 sec. under vacuum with an EMITECH 
glow-discharger unit. The thiol-sensitive gold surface on the grids was then modified by 
incubation in 5 mM 11-mercaptoundecyl hexaethyleneglycol (SPT-0011P6, SensoPath 
Technologies) in ethanol for two days in an anaerobic glovebox (Meyerson et al., 2015). 
Following incubation, the grids were washed in ethanol and air-dried prior to use. Using an FEI 
Vitrobot IV and accompanying FEI equipment, 2.5 µL of complex I solution (3 – 5 mg mL-1) 
were applied to each grid at 4 °C in 100% relative humidity and blotted for 8 – 16 sec. at a 
force setting of -10, before plunging the grids into liquid ethane. 
 
2.13 Automated cryo-EM data acquisition 
 
Automated data collections on grids for the active and de-active mouse compelx I datasets were 
carried out by Dr. James Blaza in Astbury Centre for Structural Molecular Biology, University 
of Leeds and by the staff at electron Bio-Imaging Centre (eBIC) - Diamond Light Source, 
Harwell Science and Innovation Campus in Oxfordshire, respectively.  Images for the datasets 
were recorded with EPU software using an FEI 300 keV Titan Krios microscope. The datasets 
were collected in counting-mode, using a Gatan K2 detector and GIF Quantum energy filter in 
zero-energy-loss mode with a slit width of 20 eV, and a 100 µM (C2) objective aperture. Data 
for active complex I was imaged at 1.05 Å/pixel (nominally 1.07 Å/pixel, 47,600× actual 
magnification) and de-active complex I at 1.33 Å/pixel (nominally 1.30 Å/pixel, 37,600× actual 
magnification). The defocus ranges were -1.5 to -3.1 µm for the active mouse dataset, and -2.2 
to -3.4 µm for de-active mouse complex I dataset, with the autofocus routine run every 10 µm. 
Data for the active mouse complex I were collected with a dose rate of 5 electrons Å-2 sec.-1, 
with a 10 sec. exposure captured in 25 frames. Data for de-active mouse complex I were 
collected with a dose rate of 3.25 electrons Å-2 sec.-1, with a 15 sec. exposure captured in 30 









2.14 Image processing 
 
Data for the de-active complex I was processed by Dr. James Blaza. 
 
2.14.1 Hardware and software  
 
Software requiring high computational demand was operated on a Linux (CentOS 6 operating 
system) High-Performance Computing (HPC) cluster comprised of several nodes with a dual-
sledged, hyper-threaded (2x), 16-core central processing unit (CPU) and 256 GB of random 
access memory (RAM). For programs such as Gctf or MotionCor2, or other graphical 
processing unit (GPU)-accelerated applications (such as 3D classification), an 8-core hyper-
threaded (2x) CPU and 256 GB of RAM nodes were used with graphical processing units (4 x 
GeForce GTX 1080 with 8 GB of RAM). All image processing steps were carried out in the 
RELION (version 2.1 patch b1) software suite (Fernandez-Leiro and Scheres, 2017; Kimanius 
et al., 2016).  
 
2.14.2 Whole-frame motion correction and dose weighting 
 
In-plane beam-induced horizontal movements of micrographs and radiation damage were 
modelled and corrected for in all of the datasets using MotionCor2 (version 1.0) (Zheng et al., 
2017). Briefly, unaligned movie stacks in MRC format were processed using all available 
frames in 10 x 10 non-overlapping patches and 5 x 5 patches for de-active mouse complex I. A 
B-factor of 150 was applied to the micrographs. Dose-weighting was also performed at this 
stage with 1.6 electrons Å-2 per frame on images from both datasets. No pre-exposure of 
radiation was accounted for. This produces motion-corrected, summed images suitable for 
further processing. Micrographs with excessive drift were discarded.  
 
2.14.3 Estimating the contrast transfer function (CTF)  
 
Defocus and astigmatism estimates were obtained for each micrograph using Gctf (version 
v1.06_sm_30_cu8.0_x86_64) (Zhang, 2016). The CTF of the non-dose weighted motion-
corrected micrographs were estimated using the following constants: the spherical aberration 
of the microscope (2.7 mm), amplitude contrast of 0.08 and 0.1 for micrographs from the active 
mouse complex I and the de-active mouse complex I datasets, respectively. The resulting fitted 
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CTF models were compared with their experimental power spectra (intensity vs. spatial 
frequency). Any images displaying noticeable astigmatism (evidenced by elliptical power 
spectra) or crystalline ice contamination (an intense white ring in the power spectrum) were 
discarded.  
 
2.14.4 Particle picking and extraction  
 
Particle coordinates for de-active mouse complex I were selected manually in RELION from 
motion-corrected and CTF estimated micrographs. In contrast, particle coordinates for active 
mouse complex I were automatically selected in RELION, with 10 2D class averages of bovine 
complex I used as a reference (kindly provided by Dr. Hannah Bridges from the MRC-MBU, 
University of Cambridge). The references were low-passed filtered to 20 Å to avoid selection 
bias. In the case of the active mouse complex I dataset, the automatically selected coordinates 
were manually curated to discard non-protein (junk) particles. 
 
Particles from selected coordinates were extracted in RELION with a box-size of 364 and 450 
pixels for the de-active mouse complex I and the active mouse complex I datasets, respectively. 
The contrast of each particle was inverted and normalised.  
 
2.14.5 2D Classification 
 
To obtain 2D class averages free from non-complex I particles, extracted particles were 
subjected to reference-free 2D classification in RELION into 100 classes, employing a mask 
diameter of 340 Å. In some cases, such as during the processing of the active mouse complex 
I data, the ‘ignore CTF’s until first peak’ function was utilised to more evenly distribute 
particles into all classes. Usually, several rounds of 2D classification were required to clean the 
datasets.  
 
2.14.6 Movie refinement and particle polishing  
 
Consensus EM maps were first generated using the ‘3D-auto refine’ function in RELION, with 
the bovine cryo-EM map (EMD-2676) as a reference map. The bovine map was low-pass 
filtered to 60 Å to avoid model bias in the reconstruction. Following the generation of a map, 
movie refinement in RELION was carried out on a reduced number of frames for the active 
mouse complex I dataset in an effort to mitigate the effects of radiation damage in later frames 
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(Scheres, 2014), and preserve high-resolution structural information. Movie refinement was 
carried out on the active mouse complex I data with frames 1-12 out of 25 (total dose 24 
electrons Å-2) with a running average window of 3 frames. In contrast, all the frames (30 
frames) from de-active mouse complex I data were used for movie refinement, with a 5 frame 
running average window. Following an initial movie refinement, the particles were subjected 
to ‘Particle polishing” procedure in RELION to account for radiation damage and movement 
(from movie refinement), using default parameters for B-factor weighting (to improve particle 
single to noise ratio), and a soft-mask generated in the ‘Mask create’ function in RELION, 
initially from the bovine complex I model (5LC5).  
 
2.14.7 3D classification and reconstruction of high-resolution cryo-EM maps 
 
In later 3D classifications and high-resolution reconstructions (herein referred to as 3D 
refinement), a map generated from the dataset itself was used as a refinement reference in place 
of the initial bovine map (EMD-2676).  
 
In the case of de-active mouse complex I, 3D classification was performed prior to particle 
polishing. Coarse-grained 3D classification with an angular sampling of 7.5° was used to 
discard particles that do not resemble intact complex I. Following particle polishing, data for 
de-active mouse complex I was subjected to a further round of 3D classification into 5 classes 
with an increasing angular sampling to 0.9°. The resolution of the reconstruction was limited 
to 8 Å in this case, to prevent overfitting. Homogenous de-active classes (maps) were selected 
based on how similar their cross-correlation coefficients (CCC) were to the known de-active 
bovine compex I structure (PDB accession code 5LDW) (Zhu et al., 2016a), by utilising the 
‘fitting’ function in UCSF Chimera (Pettersen et al., 2004a). Data for active mouse complex I 
were subjected to coarse-grained 3D classification using an angular sampling to 3.7, into 5 
classes. As with the de-active mouse complex I, classes were then selected based on their 
similarity to known complex I models using Chimera’s ‘fitting’ function.  
 
The final 3D-refinement for all complexes used solvent-flattened Fourier shell correlation 
(FSC) curves, using masks to cut the volume of solvent considered and increase the orientation 
accuracy. In order to reduce the interference of the disordered detergent belt on resolution 
estimation, post-processing was performed in RELION, with default parameters using masks 
created from fitted coordinate files (using the Molmap command in Chimera and mask creation 
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tools in RELION). The resolution estimates were based on the gold standard FSC = 0.143 
criterion (Scheres and Chen, 2012). 
 
2.15 Model building 
 
Most of the model building for the mouse complex I structures was carried out by Dr. James 
Blaza. The model for active mouse complex I was built in COOT (Emsley et al., 2010), using 
the published model of active bovine complex I (PDB accession code 5LC5) as a template, 
with the sequences converted to the mouse sequences. The atomic co-ordinates were initially 
adjusted into the electron density using local real-space refinement in COOT. Lipids were built 
and fitted into unoccupied density. The nucleotide bound to NDUFA10 was tentatively built as 
ADP because density indicates the presence of a purine ring and two phosphates and ADP is 
highly abundant in the mitochondrial matrix. Post-translational modifications were built using 
data from molecular mass measurements of mouse complex I subunits (Chapter 3.10), such as 
acetylation and hydroxylation of Arg-85. The entire model was then refined against the map by 
real-space refinement in PHENIX (Afonine et al., 2013). The model was then locally refined 
against the map in COOT. Multiple cycles of global refinement, followed by local refinement 
were assessed by MolProbity (Williams et al., 2017). The de-active mouse complex I, was built 
using the final active mouse complex I structure as a template.  
 
2.16 Bioinformatic analyses 
 
Global structure resolutions were estimated from FSC curves in RELION (Scheres and Chen, 
2012), whilst local resolutions were estimated using the Local Resolution function in RELION 
with B-factor setting the same as that obtained in the post-processing step, and with default 
parameters used (sphere of radius 12.5 Å with a soft edge of 25 Å). For individual subunits, 
Chimera was used to extract the resolution at each atomic coordinate and the values were 
averaged. Values calculated by masking individual subunit volumes in the local resolution map 
gave equivalent results. 
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Secondary structures were analysed using DSSP (http://swift.cmbi.ru.nl/gv/dssp/) (Touw et al., 
2015). Surface areas of contacts between subunits were calculated using the PDBePISA server 
(http://www.ebi.ac.uk/pdbe/pisa/) (Krissinel and Henrick, 2007). The ubiquinone-binding 
channel was predicted using CAVER 3.0 (Petrek et al., 2006), with a 1.4 Å probe radius, 
starting from the sidechain oxygen atom of NDUFS2-Tyr108. Protein structure and density 
















































3.1.1 Mouse as a model organism for complex I studies 
 
In order to carry out effective structural and functional studies on complex I, it is imperative to 
first pick a suitable model organism. Currently, the model organisms used for complex I studies 
range from bacteria such as E. coli to mammals such as B. taurus (bovine). Bacterial models 
such as E. coli and T. thermophilus, in which the early structural work on complex I was carried 
out (Baradaran et al., 2013; Efremov and Sazanov, 2011), have the advantage that genetic 
manipulation can be carried out with relative ease allowing for mutation(s) in the enzyme to 
probe critical residues involved in its function.  Although genetically amenable, and with yields 
sufficient for mechanistic studies, the bacterial enzyme is a distant relative to its mammalian 
counterpart. The mammalian enzyme has an additional 31 supernumerary subunits on top of 
the 14 shared core subunits: therefore, studies on assembly and dysfunction by way of 
pathogenic mutations in the supernumerary subunits are precluded by their absence in bacteria.  
 
The yeast Y. lipolytica serves as a more relevant model because its enzyme is more closely 
related to the human enzyme than the bacterial enzyme (Abdrakhmanova et al., 2004). 
Additionally, the nuclear genome can be genetically manipulated, and yields sufficient complex 
I to allow for structural and functional studies (Abdrakhmanova et al., 2006; Zickermann et al., 
2015), and although the yeast enzyme is a good model to study complex I function and 
assembly, its use in a mitochondrial disease context is limited because induced mutations in 
yeast based on known pathogenic mutations in humans cause phenotypes that fail to fully 
recapitulate the effect seen in the human enzyme (Varghese et al., 2015).   
 
The bovine enzyme, due to its high sequence homology to the human enzyme, has provided a 
plethora of information on function, structure and subunit composition that are physiologically 
and pathophysiologically relevant to the human enzyme (Hirst et al., 2003; Kussmaul and Hirst, 
2006; Zhu et al., 2016a). Moreover, greater yields of complex I are easily attainable using 
bovine heart tissue over bacteria and yeast. However, unlike in the bacteria and yeast models, 
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it is not feasible to genetically manipulate the bovine enzyme, therefore preventing studies on 
clinically or catalytically-relevant mutations.  
 
With the use of immortalised human cell lines, research on complex I assembly, amongst other 
things, has been performed on cancer cells (Stroud et al., 2016). A limitation of working with 
human cells is that they have abnormal metabolism and therefore do not reflect normal 
physiology or respiration. Secondly, due to the limitation of material, structural and functional 
work with cell line complex I will prove very difficult.  
 
A good model that fulfils most of the positive criteria discussed here is mouse. First, mouse 
heart is densely packed with mitochondria and can be prepared in sufficient yields and high 
activity to allow for comprehensive studies (Fernández-Vizarra et al., 2010; Fernández-Vizarra 
et al., 2002). Secondly, unlike bovine and other related large mammalian species, mouse is 
more genetically amenable, with available complex I deficiency models, which recapitulate 
some of the clinical phenotypes seen in patients (Kruse et al., 2008). A list of some of the 
complex I deficiency models in mouse are shown below (Table 3.1). With this in mind, mouse 
was explored as a suitable model for complex I studies.  
 
Gene Genetic manipulation Phenotype Reference 
Ndufs4 Whole body knockout Leigh-like 
syndrome 
(Kruse et al., 2008) 
Ndufs6 Heart-specific knockdown Cardiomyopathy (Ke et al., 2012) 
Ndufa5 Neuron-specific conditional knockout Mild chronic 
encephalopathy 
(Peralta et al., 2014) 
Ndufa13 Heart specific conditional knockout Cardiomyopathy (Hu et al., 2017) 
Nd6 Homoplasmic G13997A mutation: P25L Leber hereditary 
optic neuropathy 
(Lin et al., 2012) 
Table 3.1: Available complex I disease models with the corresponding genetic manipulation 
and observed phenotype. The table was adapted from the review of Diaz and co-workers 
(Torraco et al., 2015). 
 
3.1.2 A brief historical perspective on purification of mammalian complex I  
 
Preparation of bovine complex I was first achieved in 1962 using an ammonium sulphate 
precipitation method (Hatefi et al., 1962). The preparation displayed modest inhibitor-sensitive 
activity and retained high amounts of phospholipids, despite the harsh treatment of the enzyme. 
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Moreover, further characterisation showed 1 FMN and 26 non-haem irons per enzyme; 
cofactors required for NADH:UQ10 oxidoreduction. However, using spectroscopic techniques 
on the preparation identified cytochromes as a significant component in the preparation. In 
addition, the purification method resulted in complex I being polydisperse and therefore not 
suitable for structural studies. More than three decades later, the first chromatographic method 
for purifying complex I was developed by Walker and co-workers (Walker et al., 1995). In 
brief, membranes were solubilised with 1% DDM. Then, complex I was enriched by 
ammonium sulphate precipitation. Finally, complex I was further purified using an anion-
exchange column. Although the enzyme was pure, it displayed low NADH:Q1 activity that was 
rotenone insensitive. Further analysis of complex I by SDS-PAGE showed that NDUFA10 was 
substoichiometric compared to the Hatefi preparation (Walker et al., 1995). Complex I prepared 
by this method was used to identify its subunit composition by mass spectrometry.  
Subsequently, Walker and co-workers attempted to modify the protocol, by co-purifying 
complex I and V (Buchanan and Walker, 1996). For the first time, a size-exclusion column was 
used, initially to strip phospholipids off the enzyme (for crystallisation trials) and desalt the 
preparation following ammonium sulphate treatment. Then, two anion-exchange columns and 
a final size-exclusion column further resolved the preparation. Although complex I was pure 
and monodisperse, it again displayed low activity (but rotenone sensitive). As with previous 
attempts to purify complex I, NDUFA10 was still being lost during purification. Later attempts 
to purify complex I by Walker and co-workers (Sazanov et al., 2000), by maintaining the 
ammonium sulphate precipitation step, but using two successive anion-exchange column and a 
size-exchange column resulted in a pure complex I, however, it was devoid of lipids and 
showed low catalytic activity. 
 
As phospholipids were shown to be crucial for complex I catalytic activity (Buchanan and 
Walker, 1996; Sazanov and Walker, 2000; Walker et al., 1995), Hirst and co-workers prepared 
the enzyme with various phospholipid mixtures (Sharpley et al., 2006). They showed that by 
supplementing soybean asolectin (phospholipid mixture) in the anion-exchange buffer, a higher 
activity was recorded than the preparation without asolectin added. Complex I purified using 
this method was pure, monodisperse and was highly active. Furthermore, lipid analyses showed 
that the preparation contained appreciable amounts phosphatidylcholine, 
phosphatidylethanolamine and cardiolipin, reflective of the relative phospholipid composition 
of the inner mitochondrial membrane. Moreover, the length of the protocol was reduced 
significantly from previous purifications, by utilising a single anion-exchange column (instead 
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of two used in the Walker and co-workers preparations), followed by a size-exclusion column. 
Compared to previous bovine complex I preparations, NDUFA10 stoichiometry was increased 
in this purification. This purification methodology served as the foundation for future complex 
I preparation that was essential for structural and mechanistic studies (Jones et al., 2016; 
Vinothkumar et al., 2014; Zhu et al., 2016a).  
 
Recently, complex I was purified from ovine as an alternative model to bovine for structural 
studies (Letts et al., 2016b). In essence, the purification followed that of the bovine enzyme 
(Sharpley et al., 2006), with a single anion-exchange step, followed by size exclusion 
chromatography. The enzyme preparation differed in that LMNG was used to extract the 
complexes from membranes as opposed traditional DDM used in bovine. The authors 
determined the suitability of using LMNG over other detergents by monitoring NADH:DQ (a 
quinone analogue) activities by incubating membranes in various detergents. In the ovine 
complex I purification, lipids were supplemented in the size-exclusion buffer rather than the 
anion-exchange buffer (as done previously (Sharpley et al., 2006), where it is known that lipids 
are lost in the anion-exchange step). The resulting complex I preparation although pure, 
displayed low catalytic activity in comparison to the recent bovine enzyme preparation (Jones 
et al., 2016). Although the detergent Brij-35 was shown to substantially decrease NADH:DQ 
activity in membranes, it was used for the structural studies of ovine complex I (Fiedorczuk et 
al., 2016). 
 
By using previous bovine work as the bases for purification, a scaled-down protocol was 
developed to purify complex I from five different rat tissues (Mohammed PhD thesis, 2015). 
Due to issues of protein stability with DDM, LMNG was explored as an alternative detergent 
for extracting the complexes from membranes. The chromatographic preparation following 
solubilisation was the same as bovine, but with an additional affinity step, utilising ATPase 
inhibitor (IF1) in the column matrix to resolve ATPase from complex I. The preparation was 
relatively pure but had low complex I activity making it impractical for either structural or 






3.2 Aims of this chapter 
 
The work in this chapter aims to: 
 
• Develop a protocol to prepare mouse complex I in a pure, stable and active enzyme, 
which can serve as a basis for structural, functional and clinically relevant studies.  




























3.3 Catalysis by mouse mitochondrial membranes 
 
Prior to complex I purification, coupled mitochondria were isolated from mouse hearts using 
an adapted differential centrifugation method (Fernández-Vizarra et al., 2010; Fernández-
Vizarra et al., 2002). Briefly, Mitochondria were burst open using high-energy sonication, 
followed by ultra-centrifugation to obtain membranes for further experiments, as described in 
Chapter 2.4 To assess the suitability of mouse mitochondrial membranes for studies on 
oxidative phosphorylation enzymes, kinetic assays were carried out (see Chapter 2.6) and 
compared to the current and well-characterised bovine system (Table 3.2). The NADH:O2 rate, 
which is a measure of catalysis by complexes I to IV, revealed a higher activity for mouse 
membranes than bovine membranes. Plausibly, the higher activity may be attributed to the 
shorter preparation time, leading to better preservation of the enzymes (Fernández-Vizarra et 
al., 2010).   
 
Assay Mouse  (µmol min-1 mg-1) 
Bovine 
(µmol min-1 mg-1) 
NADH:O2 1.47 ± 0.08 0.80 ± 0.02 
Succinate:O2 1.22 ± 0.02 0.86 ± 0.07* 
ATP hydrolysis 3.82 ± 0.07 2.28 ± 0.02* 
H2O2 3.53×10-3 ± 0.12×10-3 5.90×10-3  ± 0.20×10-3† 
FeCN 5.13 ± 0.07 n.d. 
HAR 5.71 ± 0.06 4.63 ± 0.20 
APAD 0.75 ± 0.02 n.d. 
Table 3.2: Enzymatic activity measurements on mitochondrial membranes. Enzymatic 
activities were measured according to the protocols described in Chapter 2.6 unless stated 
otherwise. *Succinate:O2 and ATP hydrolysis by bovine samples were measured in 
submitochondrial particles (SMPs) rather than membranes; 2.5 µg mL-1 gramicidin was added 
to collapse the proton motive force. † Rate of H2O2 production by bovine SMPs was obtained 
from Hirst and co-workers (Pryde and Hirst, 2011). n.d. (i.e. not determined). The data are 





Likewise, the stoichiometric and spectrophotometrically sensitive succinate:O2 assay 
(complexes II to IV) displayed higher activity for mouse membranes than bovine membranes, 
albeit it has been previously reported that bovine samples could reach similar rates (Jones and 
Hirst, 2013). ATPase (complex V), a canonical enzyme was tested by ATP hydrolysis. 
Although the activity was higher for mouse membranes than bovine membranes, it is cautioned 
that SMPs and membranes may differ in the relative amount of the proteins present being 
measured (Pryde and Hirst, 2011). To establish NADH oxidation activity by complex I in 
membranes, the flavin-site was probed by artificial oxidants with differing modes of action 
(Birrell et al., 2011). Although the rates of FeCN and APAD reduction (by ping-pong 
mechanisms) were measured in mouse, the equivalent bovine data is not available. 
Nevertheless, the rate of reduction of HAR (by a ternary mechanism) is known for both species 
and is broadly consistent. Lastly, the rate of reactive oxygen species formation was measured 
by monitoring the oxidation of Amplex Red to resorufin, in the presence of NADH. H2O2 
production rates by mouse membranes were almost half those of bovine membranes. As the 
membranes of both species contain a complicated mixture of proteins, and possible extra-
mitochondrial protein contamination, not all of the reactive oxygen species can be confidently 
attributed to complex I. The higher activities (oxidative phosphorylation enzymes) exhibited 
by mouse membranes compared to the already highly active bovine membranes, suggests that 
mouse membranes are suitable for complex I preparation. 
 
3.4 Establishing optimal solubilisation conditions for mouse 
complex I 
 
It was critical to establish a solubilisation condition to maximise the amount of complex I 
yielded by the membranes without compromising stability or causing protein aggregation. BN-
PAGE, SDS-PAGE Western-blot and complex I-specific activity measurements were used to 
assess different detergents and their concentrations. Based on previous work with complex I 
from rat, for which detergent-based issues lead to protein instability and aggregation 
(Mohammed PhD thesis, 2015), mouse membranes were incubated with varying concentrations 
of a mild detergent; LMNG. Following the incubation, stability, yield and activity of complex 
I were assessed (Figure 3.1). BN-PAGE analysis revealed that, although complex I seemed to 
be stable in LMNG, even at higher concentrations, there was also a band with a higher apparent 
molecular weight than monomeric complex I, with equal staining intensity with the redox-
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sensitive NBT dye (Figure 3.1a). This may indicate a higher-order molecular organisation that 
persists under the mild detergent (i.e. a supercomplex) or possible dimerisation of the enzyme. 
To confirm this higher band observed on BN-PAGE is complex I, and not an alternative flavin-
bound protein that is being solubilised using LMNG, soluble and pellet fractions resulting from 
solubilisation (in various detergent concentration) and centrifugation of membranes, were 
separated on SDS-PAGE and analysed by Western blot. Two subunits, present at opposite ends 
of the complex, were investigated (NDUFAB9 and NDUFS1) (Figure 3.1b). As illustrated by 
SDS-PAGE Western blot analyses, an increase in the LMNG concentration is followed by an 
increase in the presence of complex I subunits detected in the soluble fractions and an 
accompanying decrease of those very same subunits in the pellet fractions. Confirmatory to 
this, the complex I-specific activity in the solubilised fractions increased with increasing 
detergent concentration. Therefore, the majority of complex I was not solubilised in its 
monomeric form, making LMNG a non-ideal choice of detergent for purifying monomeric 
complex I. DDM, a mild detergent often used in solubilisation of membranes, which is reported 
to be apparently less stabilising than LMNG, but that can break inter-complex interactions, was 
thus explored (Figure 3.1) (Chae et al., 2010). BN-PAGE analyses show there are no visible 
breakdown products resulting from the solubilisation, and that with more than 1% DDM 
concentration, complex I exists mostly as a monomer (Figure 3.1a). As with LMNG, SDS-
PAGE Western blot shows an increase in detergent concentration led to an increase in the 
complex I subunits detected in the solubilised fractions (Figure 3.1b). In addition, beyond 0.5% 
detergent concentration, total complex I activity in the solubilised fractions were greater for 
DDM than LMNG, correlating to a greater yield for DDM. Careful consideration of both 
detergents suggests that DDM is superior to LMNG by both increasing the yield of complex I 
obtained from membranes and solubilising complex I as a monomer without having an adverse 
effect on the stability of the enzyme. After careful consideration, DDM was deemed a suitable 











Figure 3.1: Evaluating solubilisation conditions on mitochondrial membranes. Visualisation 
and assays were carried out with an equal volume of material (i.e. the pellet was re-suspended 
to the same volume as the supernatant). (a) Solubilised membranes were analysed by BN-
PAGE and monomeric complex I (indicated as complex I) stained with 0.5 mg mL-1 NBT and 
100 µM NADH. (b) Solubilised and pellet fractions from the solubilisation process, were 
subjected to SDS-PAGE and Western blotting by incubation with anti-NDUFS1 (FS1) and anti-
NDUFB9 (FB9) antibodies. Stained proteins were imaged using a LI-COR imaging system. (c) 
The NADH:HAR activity measurements using 100 µM NADH and 3.5 mM HAR were carried out 
on supernatant and pellet fractions, with rates of supernatants (%) normalised to the sum of 
both rates (i.e. pellet and supernatant). The data are presented as mean values with error 
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3.5 Elution of complex I using an anion-exchange column 
 
Anion-exchange purification relies on the negatively charged surface of a protein binding to 
the positively charged groups present on the column matrix. The change in the surface charge 
of a protein is in turn modulated by the pH of the buffer, through the protonation and de-
protonation of solvent-exposed amino acid side chains. Despite sharing high sequence 
homology with its bovine counterpart, slight changes in the sequences of the solvent-exposed 
amino acids in mouse complex I may alter the surface charge properties of the protein, thus 
affecting its binding property and ultimately, its elution from the column. Initially, solubilised 
membrane proteins were loaded onto a HiTrapTM Q HP column, pre-equilibrated with buffer 
containing a lower concentration of DDM (0.1%) than previous bovine preparations (0.2%) to 
reduce complex I delipidation, and supplemented with an asolectin (phospholipid mixture) 
from soybean to further minimise delipidation of the enzyme (Sharpley et al., 2006). To 
establish the elution profile of the enzyme, the salt concentration (NaCl) was adjusted in a 
stepwise manner and protein elution monitored using an Äkta micro system (Figure 3.2a). Five 
protein-containing peaks eluted from the column in various salt concentrations, with the highest 
peak eluting at ~320 mM NaCl. The first peak (~ 1 mL) was not considered as it lacked 
colouration and was therefore unlikely to contain complex I. NADH:HAR measurements on 
the remaining eluted peaks showed that complex I mainly eluted at ~320 mM NaCl, with 
residual amounts of the protein found elsewhere (Figure 3.2b). Complex I from mouse thus 
elutes from the column in an equivalent concentration of salt to the bovine enzyme (Sharpley 
et al., 2006). In light of the obtained elution profile (Figure 3.2), in later preparations, complex 














Figure 3.2: Complex I elution profile from an anion-exchange column.  The Äkta micro system 
and the attached 1 mL HiTrapTM Q HP column were washed and equilibrated at a flow rate of 
0.3 mL min-1 with buffer A (20 mM Tris-HCl pH7.14 at 23 °C, 1 mM EDTA, 0.1% DDM, 10% 
ethylene glycol, 0.005% asolectin and 0.005% CHAPS), and proteins were eluted with buffer B 
(buffer A + 1 M NaCl). (a) Solubilised membranes (1 mg) were separated with an increasing 
concentration of NaCl (green broken line), and the eluents absorbance measured at 280 nm 
(blue solid line) and 420 nm (red broken line). (b) NADH:HAR activity measurements were 
carried out using 5 µl of each peak fraction with 100 µM NADH and 3.5 mM HAR. The total 
activity was calculated by taking into account the total volume in each fraction. The data are 
presented as mean values of technical replicates with error bars for the standard error of the 
mean (n ≥ 3). 
 
3.6 Isolation of pure and highly active complex I 
 
Although anion-exchange purification yields a complex I-enriched fraction, it does not 
guarantee that the eluent will be pure, because proteins of different masses but with similar 
charges will elute together. Thus a size-exclusion column was utilised to further purify complex 
I in a size-dependent manner (Figure 3.3). Moreover, the size-exclusion column also behaves 
like a buffer exchange system, ideal for decreasing both salt and detergent concentration for 
future structural work. Complex I elutes from the size–exclusion column as a monodisperse 
peak at ~1.36 mL, followed by complex IV at ~1.65 mL (Figure 3.3a), with minimal overlap 

































































between the two peaks. In addition, proteins at the intersecting regions were excluded when the 
complex I-containing fractions were pooled and concentrated, avoiding possible 
contamination. Following purification, complex I-containing fractions from each step were 
further inspected by BN-PAGE to visually assess their purity (Figure 3.3b).  The complex I 
sensitive dye shows that during purification, the purity of the sample increases with each step, 
accompanied by a noticeable decrease in the level of contaminating proteins, resulting in a 
visibly pure enzyme that can be further characterised. To accurately quantify the recovery of 
complex I during the purification procedure, the NADH:DQ rates of each purification step 
fraction (containing complex I) was measured (Table 3.3).  In agreement with the BN-PAGE 
analyses, with purification, there is an enrichment of complex I, as illustrated by an increase in 
specific activity. Although the preparation seems pure and highly active, in comparison to 
previous mammalian preparations (Letts et al., 2016b), the final complex I yield recorded was 
~16%, by normalising the total activity of the purified sample to the total activity measured in 
membranes. The low yield could be explained by considering that during purification, a 
significant amount of each fraction was removed to ensure accurate estimation of protein 
content and to measure NADH:DQ rates. Taking into account that the starting material was 
only 2.5 mg of protein, removing fractions for analyses affects the yield of complex I 
substantially. In later preparations that have not been so heavily analysed, the complex I 
recovered was ~30 - 40%, based on total complex I content in the membranes used for 
purification. Bearing in mind that the starting material for bovine complex I preparations (~2 
kg per heart) is ×10,000 greater than for mouse (~0.2 g per heart), this purification has 
facilitated the efficient recovery of pure and highly active mouse complex I, despite the 







Figure 3.3: Chromatographic purification and visualisation of complex I. The Äkta micro 
system was operated at a flow rate of 0.03 mL min-1 with buffer C (20 mM Tris-HCl pH 7.14 at 
23 °C, 10% ethylene glycol, 150 mM NaCl and 0.02% DDM), using a Superose 6TM Increase 
3.2/300 column (a) Pooled and concentrated Q-sepharose fractions were loaded and proteins 
were separated by size-exclusion chromatography, resulting in a size-based separation of 
complex IV and I. (b) Collected fractions: size-exc. (5 µg), Q-seph. (10 µg) and supernatant (10 
µg) were visualised on BN-PAGE by staining with 0.5 mg mL NBT and 100 µM NADH. 
 
 




(µmol min-1 mg-1) 
Activity 
recovered (%) 
Membrane 2.96 ± 0.03 2500 1.18 ± 0.01 100 
Supernatant 2.06 ± 0.06 2070 1.00 ± 0.03 70 
Q-sepharose 0.64 ± 0.02 234 2.75 ± 0.09 22 
Size-exclusion 0.47 ± 0.01 46 10.38 ± 0.25 16 
Table 3.3: NADH:DQ activity measurements on the fractions from a mouse complex I 
preparation. Rates for membranes (3 µg mL-1), solubilised supernatant (3 µg mL-1), Q-
sepharose fraction (3 µg mL-1) and complex I (0.5 µg mL-1) were measured with 100 µM DQ in 
0.075% (w/v) asolectin, 0.075% (w/v) CHAPS and 100 µM NADH, in 20 mM Tris-HCl pH 7.55 at 
32 °C. The data are presented as mean values with error bars for the standard error of the 
mean (n ≥ 3). 

























3.7 Activity measurements on purified mouse complex I 
 
To validate mouse complex I as a suitable model for future work, it was necessary to kinetically 
characterise and compare the enzyme to the well-established bovine model. The rates of 
reactive oxygen species production, flavin-site reactions and reduction of a quinone analogue 
(DQ) were investigated (Table 3.4). The catalytic rate of NADH:DQ oxidoreduction is twice 
as high in bovine as in the mouse. In later preparations of mouse complex I, a superior size-
exclusion was used (Superose 6TM Increase 5/150 column) to reduce the time during 
purification, by using a faster flow rate. NADH:DQ activity measurements from this size-
exclusion column reached ~15 µmol min-1 mg-1 (Yin, personal communication). Nevertheless, 
the mouse enzyme exhibits a far higher activity than the current ovine complex I preparation 
(Letts et al., 2016b), which may be attributed to the supplementation of lipids early on in the 
preparation (Sharpley et al., 2006). Looking at the H2O2 production between the two species 
there is an appreciable difference in the level of reactive oxygen species produced, with 
complex I from mouse having a lower activity than its bovine counterpart. The reason for 
mouse displaying a low rate of reactive oxygen species was not explored, due to the limitations 
from the scarcity of the material. For example, it would be necessary to vary the total nucleotide 
concentration and adjust the NADH/NAD+ ratio, to better characterise the reaction by altering 
the rates observed (Kussmaul and Hirst, 2006), and therefore these experiments would require 
large amounts of enzyme. Interestingly, the difference in the rates observed here, under similar 
conditions, may underlie a subtle physiological or pathophysiological difference in superoxide 
production by the two species. Finally, the flavin-site activities, with artificial flavin oxidising 
substrates that display both ping-pong (FeCN) and ternary (HAR) mechanisms were compared 
(Birrell et al., 2009). Both the HAR and FeCN rate was significantly greater for bovine than 
mouse. This is strange, considering that NDUFV1 (i.e. site of flavin reaction) is highly 
conserved (96% sequence identity) between the two species. Although this difference in flavin-
site activities is not yet clearly understood, the mouse enzyme displays high rate of 








Assay Mouse (µmol min-1 mg-1) 
Bovine 
(µmol min-1 mg-1) 
NADH:DQ 11.99 ± 0.11 ~24* 
H2O2 15.30 ×10-3  ± 0.19 21.10 ×10-3  ± 2.90† 
FeCN 32.87 ± 1.74 ~72‡ 
HAR 47.38 ± 1.49 ~90‡ 
APAD 4.46 ± 0.09 - 
Table 3.4: Kinetic characterisation and comparison of purified complexes I.  Rates for the 
purified enzyme were measured according to the protocols in chapter 2.6 * NADH:DQ activity 
was measured on purified bovine complex I (0.5 µg mL-1)  using 200 µM NADH and 200 µM 
DQ, instead of the 100 µM NADH and 100 µM DQ used for purified mouse complex I (Blaza 
et al., 2018). † H2O2 production was measured on purified complex I with 30 µM NADH, 2 
units mL-1 HRP and 10 µM Amplex Red (Kussmaul and Hirst, 2006). ‡ Rate measurements 
were carried on purified complex I with 100 µM NADH, 1 mM FeCN and 3.5 mM HAR 
(Birrell et al., 2009).  The data are presented as mean values of technical replicates with the 
error represented as the standard error of the mean (n ≥ 3). 
 
3.8 Estimating the flavin content of purified mouse complex I 
 
The flavin-site reactions described in (Table 3.4) represent the initial step of the proton-coupled 
NADH:UQ10 oxidoreduction reaction and require a tightly bound FMN to function properly. 
As mentioned previously, there were significant differences in the flavin-site activities between 
mouse and bovine complex I (Table 3.4). To investigate whether these changes were due to 
complex I losing flavin during purification, the FMN content of purified mouse complex I was 
measured by reference to a set of prepared FMN standards (Figure 3.4). The flavin bound to 
complex I was found to be essentially stoichiometric relative to the total enzyme content 
(Figure 3.4a), therefore the low flavin-site activities were not due to loss of flavin during 
purification. In addition, in the same assay, the release of flavin bound to complex I upon 
increasing temperature was monitored (Figure 3.4b). The assay works by measuring the 
emission of photo-excited flavin. Under native conditions, the surrounding protein absorbs the 
energy from the excited flavin, quenching the measured signal. Under denaturing conditions 
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(i.e. increased temperature), the flavin is released, and once solvent exposed, the emission is 
unimpeded and is reflected by an increase in fluorescence intensity. Identifying the point at 
which 50% of the FMN is detectable (Tm50) is important in understanding the tightness of the 
association between complex I and FMN, and allows for interspecies comparison, and 
comparisons between wild type and disease-related models. Across a wide selection of 
organisms, complex I Tm50 values for FMN range from 42.7 °C in Pichia pastoris to 94.7 °C 
in T. thermophilus to 60.1 °C in bovine (Bridges and Hirst, unpublished). The bovine enzyme 
binds significantly more tightly to FMN than its mouse counterpart (Tm50=51.23) (Figure 3.4). 
It is currently unclear what the relationship is between the binding affinity of FMN to complex 




Figure 3.4: Flavin content and binding properties of mouse complex I. Details of the methods 
employed are described in Chapter 2.10 (a) Flavin quantification: The concentration of FMN 
bound (closed red triangle) to purified complex I (~6 µg) was estimated by reference to a set 
of known standards (closed circle) ranging from 0.1 – 2.0 µg mL-1. The number of FMN per 
complex I (FMN:CXI) was calculated and displayed (n=3). (b) Flavin binding: purified complex 
I was exposed to increasing temperature from 20 – 80 °C, and the fluorescence signal of FMN 
was measured. Tm50 is the temperature at which 50% FMN is detectable measured using the 



























































3.9 EPR measurements on the Iron-sulphur clusters in mouse 
complex I 
 
A crucial feature in the function of complex I is the ability to transfer electrons from NADH to 
ubiquinone, across the peripheral arm. To facilitate efficient electron transfer a chain of iron-
sulphur clusters are embedded in the protein, within favourable electron transfer distance of 
one another (Page et al., 2003). In order to observe and characterise the iron-sulphur clusters, 
continuous wave X-band EPR spectroscopy was employed. In essence, EPR looks at how 
unpaired electrons in co-factors or radical amino acid side chains behave when a changing 
external magnetic field and a fixed microwave frequency is applied. When the magnetic field-
induced energy gap between the two spin states resonates with the microwave frequency, the 
unpaired electron jumps to a higher energy state and subsequently relaxes, resulting in 
microwave absorbance. To measure EPR spectra for the iron-sulphur clusters, complex I was 
reduced with NADH (oxidised 2Fe and 4Fe clusters are diamagnetic and therefore are invisible 
in EPR spectroscopy), and immediately frozen. EPR signals were readily assigned to known 
clusters based on previous work on the bovine enzyme, and their positions are indicated in the 
structure (Figure 3.5a, b) (Wright et al., 2016). As with the bovine enzyme, the signals observed 
for the iron-sulphur clusters are temperature dependent; for example, N2 cluster has a 
maximum signal detected between 18 - 20 K, whilst N1b, N4 and N3 have a maximum signal 
between 10 – 15 K. Present in the bovine enzyme, but absent from the mouse enzyme, is the 
signal from cluster N5, which is only observable at 4 K because it is fast relaxing, (Reda et al., 
2008a). Also, as with the bovine enzyme, not all of the iron-sulphur clusters present in mouse 
complex I were detected (4 out of 8). Using Mössbauer spectroscopy, Hirst and co-workers 
showed that the EPR-silent clusters remain oxidised when the enzyme is reduced by NADH 
(Bridges et al., 2012). Although the chain of clusters is partially oxidised, the first cluster to 
accept electrons from reduced FMN (N3) and the terminal cluster (N2) involved in quinone 
reduction, both show up clearly in the spectra suggesting the chain of iron-sulphur clusters is 
fully functional. EPR data shows a close match between the mouse enzyme and the highly 
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                              b 
 
Figure 3.5: X-band continuous wave EPR spectra of mouse complex I.  (a) Detailed conditions 
of the EPR measurements are given in Chapter 2.11. 9 µl of complex I (180 µg) were reduced 
by 2 mM NADH and the first derivative of the absorbance of the reduced iron-sulphur clusters 
(labelled) were detected under varying temperature and the applied magnetic field, but a 
fixed microwave frequency (~9 GHz).  (b) The structure of bovine complex I (brown: core 
subunits and grey: supernumerary subunits) is depicted with the iron-sulphur clusters labelled 
according to their signals (yellow-orange spheres).  This figure is taken from Wright et al., 
(Wright et al., 2016). 
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3.10 Protein analyses of purified mouse complex I 
 
Complex I was previously assessed for its catalytic properties relating to the core subunits (i.e. 
kinetics, flavin quantification and EPR spectroscopy), which only rely on 14 out of 44 unique 
subunits. Therefore, in order to analyse the protein content of the purified sample and determine 
whether the protein composition is conserved from the bovine enzyme, mass spectrometry was 
employed.   
 
First, purified mouse complex I was resolved by SDS-PAGE and visualised by staining the gel 
with Coomassie Blue. The gel was excised into equal-size bands along the gel and the proteins 
were identified by peptide mass fingerprinting after tryptic digestion and analysis using a 
MALDI TOF/TOF mass spectrometer (Figure 3.6 and Table 3.5). This technique has the 
advantage of identifying a protein band directly and matching its relative position to the 
molecular size markers (Figure 3.6), ensuring that the peptides observed do not originate from 
a proteolysis product. 33/44 unique subunits of complex I were identified using this method, of 
which 9 are core and 24 are supernumerary subunits. Of those core subunits detected, 2 are 
mitochondrial-encoded: ND5 and ND4 both show relatively low sequence coverage and low 
number of peptides detected. This is owing to the lack of suitable peptides generated by tryptic 
digestion due to the hydrophobicity of those proteins. Also detected in the preparation by the 
MALDI TOF/TOF analyses are proteins of other function that are not considered complex I 
subunits (Table 3.6). 
 
The subunit composition of the mouse complex I preparation was also examined by LC-MS.  
In brief, a purified complex I sample was digested with trypsin in solution, then peptides were 
separated on a reverse-phase HPLC column and introduced directly into the MS using 
electrospray ionisation. Thereafter, their masses were measured, followed by peptide 
dissociation and measurement of peptide fragments (Table 3.5).  After LC-MS analyses, 39 
complex I subunits were detected, of which 10 are core and 29 are supernumerary subunits.  As 
with the MALDI TOF/TOF analysis, only 3 mitochondrial-encoded subunits were detected 
(ND5, ND4 and ND1), again owing to the poor peptides generated by tryptic digestion. 
 
Complex I subunits have various post-translational modifications, ranging from the removal of 
N-terminal import sequences to N-terminal acetylation (Carroll et al., 2009). Therefore, in order 
to observe the post-translational modifications present in mouse complex I, and to see if 
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modifications are conserved when compared to bovine, subunits were first separated by 
reverse-phase HPLC (Figure 3.7) and the molecular masses of the individual subunits were 
measured by ESI-MS. The measured masses were tentatively assigned to subunits of complex 
I, with the aid of previous work on the bovine enzyme (Carroll et al., 2009). Masses were 
assigned to 37 subunits (Table 3.7). Comparison of measured and predicted mass data suggest 
that of the 37 subunits identified, 11 are N-terminal acetylated, 3 are N-terminal formylated, 14 
have the import sequence removed, 1 is hydroxylated, 13 have the initiator methionine 
removed, 1 is dimethylated, 2 have acyl lipid modification modifications and 1 is unmodified. 
Some subunits contain more than one modification (Table 3.7). Four subunits have been more 
cautiously assigned to measured masses, as there is a considerable deviation from the expected 
mass: NDUFV1, NDUFS2, ND4 and ND2. This may be due to a poorer quality signal, sequence 
discrepancy to the sequence in the database or different modifications than those observed in 
the bovine enzyme. Nevertheless, their assignment was aided by comparison of the reverse-
phase HPLC elution profile of the subunits with data from that of the bovine enzyme (Carroll 
et al., 2009).  
 
In total, using mass spectrometry, 42/44 unique subunits were identified; all of the 
supernumerary subunits and most of the core subunits (with the exception of ND3 and ND6, 
again, due to the poor peptides generated by these proteins). Owing to the full catalytically 
competency of the enzyme, it can be in no doubt that the full complement of subunits are 
present. Although contaminating proteins were detected in the preparation, size-exclusion 
chromatography by way of a monodispersed peak, and BN-PAGE analyses showed that by far, 
the major component in this in preparation is complex I. In conclusion, this preparation is 
relatively pure, with most of the subunits identified and all of them inferred, and it is a suitable 







Figure 3.6: SDS-PAGE of purified mouse complex I. Complex I subunits (9 µg) were separated 
by SDS-PAGE and then were stained with Coomassie Blue. Subunits were identified by peptide 
mass fingerprinting using a MALDI-TOF/TOF mass spectrometer. * Indicates proteins not 














































Subunit Number of residues 









NDUFA1 70 1 14% 66/34 7 42% 227 
NDUFA2 98 5 38% 191/33 12 78% 538 
NDUFA3 83 2 21% 74/34 5 61% 105 
NDUFA5 115 3 45% 209/33 13 86% 650 
NDUFA6 130 4 33% 203/32 24 96% 1255 
NDUFA7 112 - - - 32 100% 1880 
NDUFA8 171 5 39% 275/33 13 52% 553 
NDUFA9 342 12 41% 836/34 28 72% 1988 
NDUFA10 320 11 44% 723/33 21 45% 1343 
NDUFA11 140 - - - 2 10% 236 
NDUFA12 145 2 6% 59/34 18 86% 1069 
NDUFA13 143 3 22% 138/34 22 85% 2347 
NDUFAB1 88 4 37% 216/34 1 20% 71 
NDUFB1 56 2 32% 85/34 5 51% 130 
NDUFB2 72 2 12% 52/33 1 12% 80 
NDUFB3 103 2 14% 51/34 9 37% 171 
NDUFB4 128 6 46% 298/34 18 70% 1053 
NDUFB5 143 3 37% 114/34 10 50% 568 
NDUFB6 127 5 40% 175/34 17 76% 773 
NDUFB7 136 2 10% 134/30 7 51% 787 
NDUFB8 157 7 58% 449/33 11 57% 867 
NDUFB9 178 - - - 20 68% 716 
NDUFB10 175 4 26% 235/33 14 60% 756 
NDUFB11 122 - - - 15 76% 690 
NDUFC1 49 - - - - - - 
NDUFC2 120 4 27% 166/34 12 60% 694 
NDUFS1 704 12 21% 653/33 54 51% 4537 
NDUFS2 430 10 33% 729/33 24 53% 1564 
NDUFS3 228 12 57% 818/33 22 55% 1448 
NDUFS4 133 6 39% 449/33 13 49% 506 
NDUFS5 105 1 9% 85/34 11 49% 309 
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NDUFS6 96 4 39% 278/33 8 73% 827 
NDUFS7 189 5 17% 217/33 12 38% 733 
NDUFS8 178 4 29% 318/33 9 44% 350 
NDUFV1 444 11 28% 574/34 32 47% 1522 
NDUFV2 217 5 29% 311/34 13 51% 1504 
NDUFV3 69 - - - 8 71% 222 
ND1 318 - - - 3 8% 140 
ND2 345 - - - - - - 
ND3 115 - - - - - - 
ND4 459 3 7% 149/33 3 7% 118 
ND4L 98 - - - - - - 
ND5 607 3 7% 84/32 5 8% 253 
ND6 172 - - - - - - 
Table 3.5:  Peptide-based protein identification. The number of peptides detected from each 
subunit is given together with the sequence coverage of the mature protein (number of 
residues column). For the two analysis methods, the score given for each of the subunits is 
the sum of the peptide score with denominator (denominator value for LC-MS score is 21) 


















Protein Number of residues 
MALDI TOF/TOF MS/MS 
Number of 
peptides Sequence coverage Score 
SLC4A1 929 4 5% 180/33 
ACADVL 656 12 25% 796/33 
ATP5A1 503 6 16% 172/33 
DLST 454 2 5% 63/33 
COX2 227 1 4% 52/34 
PLCG1 132 2 7% 63/32 
COX4I1 169 4 25% 158/34 
COX7A1 80 1 16% 91/34 
COX7C 63 1 14% 44/34 
NDUFAF2 168 4 23% 80/33 
Table 3.6: Identification of contaminants in complex I preparation. The number of peptides 
detected from each subunit is given together with the sequence coverage of the protein. The 
score given for each of the subunits is the sum of the peptide score with denominator 



















Figure 3.7: Analysis of mouse mitochondrial complex I by LC-MS. Complex I (~100 µg) 
subunits were separated by reverse-phase HPLC and detected by ESI-MS. The ion intensities 
of the eluents are indicated, and complex I subunits are identified and numbered according 





















































1, 9, 13, 15, 26, 33












1. NDUFA1 8138.5 8138.9 0.4 - 
2. NDUFA2 10826.5 10826.2 -0.3 -Met, +N-acetyl 
3. NDUFA3 9241.7 9242.2 0.5 -Met, +N-acetyl 
4. NDUFA5 13270.5 13270.9 0.4 -Met, +N-acetyl 
5. NDUFA6 15193.6 15193.8 0.2 -Met, +N-acetyl 
6. NDUFA7 12486.4 12487.1 0.7 -Met, +N-acetyl 
7. NDUFA8 19852.9 19852.9 0.0 -Met, +4×Cys-Cys 
8. NDUFA9 38825.8 38829.1 3.3 -∆Import (1-35) 
9. NDUFA10 36943.0 36947.7 4.7 -∆Import (1-35) 
10. NDUFA11 14851.1 - - - 
11. NDUFA12 17128.4 17129.2 0.8 +N-acetyl 
12. NDUFA13 16770.4 16770.9 0.5 -Met, +N-acetyl 
13. NDUFAB1 10662.1 10661.3 -0.8 -∆Import (1-68), +4PP-acyl 
chain 
14. NDUFB1 6822.9 6823.3 0.4 -Met 
15. NDUFB2 8491.4 8491.4 0.0 -∆Import (1-33) 
16. NDUFB3 11561.0 - - - 
17. NDUFB4 14992.1 14992.4 0.3 -Met, +N-acetyl 
18. NDUFB5 16858.4 16858.6 0.2 -∆Import (1-46) 
19. NDUFB6 15425.9 15426.1 0.2 -Met, +N-acetyl 
20. NDUFB7 16405.8 16406.4 0.6 -Met, +N-myristoyl, +2×Cys-
Cys 
21. NDUFB8 18745.1 18746.8 1.7 -∆Import (1-29) 
22. NDUFB9 21894.9 21892.5 -2.4 -Met, +N-acetyl 
23. NDUFB10 20888.6 20889.7 1.1 -Met, +2×Cys-Cys 
24. NDUFB11 14343.0 14343.9 0.9 -∆Import (1-29) 
25. NDUFC1 5752.6 5753.1 0.5 -∆Import (1-27) 
26. NDUFC2 14205.7 14206.8 1.1 +N-acetyl 
27. NDUFS1 77210.6 - - - 
28. NDUFS2 49257.6 49278.9 21.3 ∆Import (1-27), +dimethyl-R85 
29. NDUFS3 26479.0 26479.9 0.9 -∆Import (1-35) 
30. NDUFS4 15325.3 15325.4 0.1 -∆Import (1-42) 
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31. NDUFS5 12512.5 12514.4 1.9 -Met, +2×Cys-Cys 
32. NDUFS6 10777.0 10775.8 -1.2 -∆Import (1-20) 
33. NDUFS7 21032.5 21033.6 1.1 -∆Import (1-35), +Hydroxyl-
R87 
34. NDUFS8 20442.2 20439.5 -2.7 -∆Import (1-35) 
35. NDUFV1 48626.5 48647.7 21.2 -∆Import (1-20) 
36. NDUFV2 23847.4 23846.8 -0.6 -∆Import (1-31) 
37. NDUFV3 8027.8 8029.0 1.2 -∆Import (1-35) 
38. ND1 36087.3 - - - 
39. ND2 38780.4 38794.7 14.3 +N-formyl 
40. ND3 13246.9 - - - 
41. ND4 51909.8 51924.5 14.7 +N-formyl 
42. ND4L 10634.7 10633.6 -1.1 +N-formyl 
43. ND5 68502.8 - - - 
44. ND6 18654.2 - - - 
Table 3.7: Molecular mass measurement of complex I subunits. Measured masses were 
assigned to complex I subunits according to the mass discrepancy between the observed 
masses and calculated masses (mature protein with known modifications), as shown in 
previous work (Carroll et al., 2009). Modification of the observed masses includes (-) cleavage 
of import sequences or residues, or (+) or addition of post-translation modifications. 

















3.11.1 Comparison to other preparations of mammalian complex I 
 
Although the mouse enzyme displayed a higher catalytic rate compared to the ovine enzyme 
(Letts et al., 2016b), it was substantially less active than the current preparation of the bovine 
enzyme (Blaza et al., 2018). The reason for this difference in activity is unclear at present. Just 
as the bovine complex I preparation was improved over time, the current mouse complex I 
preparation could be improved, by changing various parameters, such as pH, lipid composition 
and buffer used. 
 
Molecular mass measurements of individual subunits of mouse complex I reveal post-
translational modifications, with many examples confirmed by peptide evidence in LC-MS that 
were identical to that of the bovine and rat enzymes (Bridges et al., 2017; Carroll et al., 2009). 
In agreement with previous work in rat (Bridges et al., 2017), peptide-based identification 
showed that no evidence for alternative isoforms of mouse heart complex I subunits were 
present, and NDUFV3 was only present it is canonical 10 kDa form. 
 
Another complication in this preparation is the presence of trace contaminants that may hinder 
accurate kinetic characterisation. The preparation contained components of complex IV and 
complex V (Table 3.6). These contaminant proteins constitute minor components in the 
preparation as shown by BN-PAGE (Figure 3.3).  
  
Complex I from ovine was explored as an alternative to the bovine model for structural studies 
by another group (Letts et al., 2016b).  Their preparation resulted in a complex I, of comparable 
purity to the mouse enzyme. However, the catalytic activity was lower than both the bovine 
and mouse complexes I. Moreover, the detergent (LMNG) explored in the solubilisation of 
ovine membranes does not result in mostly monomeric complex I in mouse (Figure 3.1), thus 
affecting the yield of complex I obtained. 
 
Complex I has also been purified from the genetically amenable rat model (Bridges et al., 
2017). Unlike mouse complex I, however, the rat enzyme is unstable in DDM and therefore 
was purified in LMNG. Furthermore, due to ATPase contamination in the preparation, an 
additional affinity chromatography (IF1 present in the matrix of the column) step was included 
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(compared to the mouse purification) to remove the contaminant.  Finally, the catalytic activity 




In this latest preparation, mouse complex I was purified similarly to the bovine enzyme, but 
scaled-down significantly. In summary, membranes were solubilised in DDM, followed by 
resolving the complexes in an anion exchange column (supplemented with phospholipids) and 
finally, complex I was separated from complex IV in a size-exclusion column. The resulting 
mouse complex I was pure and highly active, with characteristic spectroscopic features 
indistinguishable from those of the well-characterised bovine enzyme. In conclusion, mouse 
complex I prepared according to this method provides a promising new model for future 
structural and mechanistic studies to understand complex I function, and dysfunction (through 
the use of disease model) in relation to human pathologies. 
 
3.11.3 Future prospects  
 
The main advantage of working with mouse as a model for complex I studies rather than other 
mammalian systems, is that genetic manipulation can be easily carried on mouse, trapping the 
enzyme in catalytically-relevant or assembly-stalled states (see table 3.1).  
 
During the protein content analyses of the preparation, it became clear that NDUFS6 subunit 
of mouse complex I possess a tri-histidine motif at its N-terminus, which is not present in the 
bovine enzyme (Figure 3.8). Therefore it may be possible to use Ni-exchange chromatography 
to purify the complex I, as already done in complex I of Pichia pastoris, which also has a 
naturally occurring tri-histidine tag. This may prove crucial in the future for purifying complex 
I from assembly intermediates that have altered behaviours on anion-exchange chromatography 
or to improve purity. This may be particularly relevant, as discussed in chapter 6, for the 
problematic purification of complex I from the NDUFS4 subunit deletion mouse strain (Kruse 
et al., 2008). Complex I from this strain is reported to be either destabilised or to form a stalled 
assembly intermediate (Calvaruso et al., 2012). Therefore, it would be ideal to have an 
alternative purification method, in case the one discussed in this chapter is not suited for 
complex I mutants. 
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Figure 3.8: Representation of mouse complex I with highlighted NDUFS6. The structure is 
discussed in detail in chapter 4 (a) Complex I presented as spheres with NDUFS6 as blue and 
the rest of the enzyme as orange. NDUFS6 is in cartoon representation showing the position 
of two modelled solvent-exposed histidines (indicated). The modelled structure depicted is of 





























Chapter 4: Structures of mouse complex I by cryo-EM 
 
 4.1 A brief Introduction to cryo-EM 
 
Cryo-electron microscopy (cryo-EM) is a technique used to image thin frozen specimens using 
electrons from a transmission electron microscope. Recent developments in cryo-EM (e.g. new 
detectors and better software algorithms for 3D reconstruction of cryo-EM maps) has resulted 
in an exponential increase in the number of new structures available in the protein data bank. 
As of the 6th of March 2018, there have been a total of 1991 structures released using this 
method (Figure 4.1). 
 
Figure 4.1: Number of structures released that were determined using cryo-EM. The values 
are taken from the protein databank (Berman et al., 2000). 
 
Cryo-EM has facilitated the determination of new high-resolution structures, which were 
previously only attainable by X-ray crystallography and NMR, such as the 2.2 Å resolution 
structure of β-galactosidase (Bartesaghi et al., 2015), or the structure of glutamate 
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dehydrogenase at 1.8 Å resolution (Merk et al., 2016). Although X-ray crystallography remains 
the most widely used technique for high resolution structural determination, it is limited by 
how readily a protein crystallises. Countless parameters have to be adjusted and optimised to 
attain protein crystals (e.g. salt concentrations, precipitants and other additives), and as a 
consequence, the structure observed may diverge from the native structure. Attempts to 
crystallise mammalian complex I in this laboratory failed for many years, with a membrane 
subdomain of bovine complex I at only 6.8 Å resolution being the sole structure solved by this 
method (Zhu et al., 2015). 
 
The key advantage that has allowed single particle cryo-EM to propagate as a common 
technique to obtain near-atomic resolution structures is its simple work flow (Figure 4.2). A 
small volume of purified protein is added to a grid and then blotted to create a thin film of liquid 
that is then plunge-frozen in liquid ethane, leaving the protein embedded in vitreous ice. The 
frozen samples are then imaged with a 300 keV microscope producing 2D experimental 
projections on a direct electron detector. The resulting experimental projections are then 
processed computationally to construct 3D density maps. Finally, a coordinate model is built 







Figure 4.2: A schematic workflow for a typical cryo-EM project. This figure was taken from 
Fernandez-Leiro and Scheres (Fernandez-Leiro and Scheres, 2016). 
The first major advance in single particle cryo-EM involved the preservation of biological 
samples. Prior to cryo-EM, biological samples were first coated with heavy salts such as uranyl 
acetate. This coat increased the contrast of the images of the specimen against the background 
by increasing its scattering potential. However, all internal features of the samples were lost 
because only the heavy salt stain envelopes were being imaged. Also, protein samples are 
hydrated in their native states, therefore removing water by this staining method may lead to 
changes in structure that do not reflect the native state (Thompson et al., 2016). 
 
Dubochet and co-workers devised a protocol for rapidly freezing biological samples and thus 
avoiding the formation of ice crystals, which are damaging to cells and their proteins (Adrian 
et al., 1984). The process first developed, on viruses, was termed vitrification and it uses liquid 
ethane (liquefied by liquid nitrogen), which has a greater freezing efficiency than liquid 
nitrogen to freeze samples. The method works because the rate of sample freezing exceeds the 
rate at which the hydrogen bonding networks formed by water molecules during ice formation 
can rearrange. Thus, the molecules are trapped in an amorphous or vitreous state of non-
crystalline ice. In the vitreous ice a) the proteins are in a hydrated state, b) the internal structures 
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in the protein become visible (unlike in negative stain) and c) the cryogenic temperatures used 
mitigate radiation damage by incident electrons (Henderson, 1990).  
 
Another major recent advance was the development of new direct electron detectors that 
increased the detection efficiency of the detectors. Previously, either film or charge coupled 
device (CCD) camera were used for detection of electrons. The main disadvantage of the CCD 
camera was that electrons could not be detected directly, but the signal had to be first converted 
to light by a scintillator, then transferred to the CCD camera to digitise and transfer the signal 
(Figure 4.3). High energy electrons are first converted to photons because they are damaging 
to the detector, and as a consequence of this, information is lost first in the conversion and 
second by deviation in the pathways of the photons (McMullan et al., 2016), causing a spread 
in the image information (blurring). Alternatively, electrons can be detected directly with film. 
However, the film has to be processed after data collection, therefore settings such as exposure 
and astigmatism, which are critical for obtaining high-resolution structures, cannot be 




Figure 4.3: A schematic of how electrons are detected by CCD sensors and direct electron 
detectors. This figure was taken from Direct Electron (www.directelectron.com/products/lv-
series). 
 
 The direct electron detector detects electrons directly using active pixel in the immediate 
vicinity of the electron pathway, thus avoiding information loss from converting the electron 
signal into photons. The exact mechanism of how direct electron detectors function is described 
in McMullan et al., (McMullan et al., 2016). The technological advancement in these direct 
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detectors is reflected by their improved quantum efficiency over film and CCD cameras 
(McMullan et al., 2014). In addition, because of the fast readout of the electron signal by the 
direct detector, successive frames for each exposure or movie can be used to correct for beam-
induced motion and radiation damage (Glaeser, 2016). 
 
Another major advance in electron microscopy was the development of reconstruction 
algorithms that allowed for the generation of 3D cryo-EM maps from 2D experimental 
projections (Orlova and Saibil, 2011). In order to do this, a) protein ‘particles’ must be 
randomly orientated in vitreous ice to allow 3D information to be gained from the experimental 
projections and b) the relative orientations of these projections must be known.  
 
The main method used for cryo-EM reconstruction is called projection matching (Figure 4.4). 
The process requires an initial reference map that is used to generate model projections along 
the structure, and these are then used as references against which experimental projections are 
compared (Orlova and Saibil, 2011). Once the experimental projection agrees with the model 
projections, then relative orientations can be assigned to the experimental projections, which 
are then back-projected into a 3D volume, thus generating a new map. The new map is then 
used iteratively for projection matching, refining the model until there are no further 
improvements in the accuracy of the orientational assignments. 
 
Current programs such as RELION do not work by matching one experimental projection to 
one reference projection, but rather use a statistical method to assign weighted probabilities to 
all the reference projections for a given experimental projection (Scheres, 2016). With each 
successive iteration, the weighted probability values change such that an experimental 
projection overwhelmingly matches a single reference projection. This method is useful 
because the experimental projections are inherently noisy (i.e. low signal to noise) and therefore 
a single projection may be assigned incorrectly to a model projection. Furthermore, RELION 
guides the reconstruction by calculating a probability-based score for the different possible 
orientations of an experimental projection based on prior knowledge (i.e. signal and noise 
follow a normal distribution) (Scheres, 2016).  
 
A minor point is that the reconstruction in RELION is performed in Fourier space (amplitude 
vs. spatial frequency). A real space 2D projection is a 2D slice (perpendicular to the projection 
view) of a 3D transform of the object (Scheres, 2016). This is because it is computationally less 
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expensive to work in Fourier space and reverse transform the volume into a real space map than 
it is to work in real space, for reasons which are beyond the scope of this thesis. The results are 




Figure 4.4: Projection matching.  An initial model is used to make 2D reference projections, 
which are then matched to experimental projections. With defined orientations, the 
experimental projections are then used to make a new 3D map. In subsequent refinement 
steps, the new map is then iteratively re-projected and compared to the experimental 
projections to ascertain more accurate orientation assignment and thus a better map. This 










 4.2 Aims of this chapter  
 
The work in this chapter aimed to: 
• Purify mouse complex I in two different states, ‘active’ and ‘de-active’ for cryo-EM 
data collection. 
• Generate high-resolution maps from cryo-EM data using the current data processing 
software (RELION) for model building. 
• Analyse and compare the structures in the two defined states, in order to identify 



























4.3 Image processing 
 
Active and de-active complex I (4-5 mg mL-1) were purified from mouse heart (as described 
in Chapter 2.7). The proteins were applied to onto PEGylated gold grids and then plunge 
frozen in liquid ethane (Blaza et al., 2018; Meyerson et al., 2015; Russo and Passmore, 
2014). The grids were imaged using a Titan Krios microscope with a K2 detector at a 
calibrated pixel size of 1.05 Å and 1.33 Å for the active and de-active mouse complex I, 
respectively (described in Chapter 2.13). 
 
Unless stated otherwise, the image processing steps described are for the data of the active 
mouse complex I.  
 
The electron beam from the microscope causes in-plane motion and radiation damage to 
the sample, which ultimately affects the retention of high-resolution information in the 
micrographs (Glaeser, 2016). Therefore, in order to account and correct for this, 
MotionCor2 was used on whole micrographs (Zheng et al., 2017). Following motion 
correction, the contrast transfer function (CTF) of the micrographs were estimated using 
Gctf (Zhang, 2016), in order to correct for aberrations in the microscope that results in the 
degradation of information (i.e. blurring of the images on the micrographs). Protein 
‘particle’ coordinates were automatically selected using ten bovine complex I 2D class 
averages as (kindly provided by Dr. Hannah Bridges), which were low passed filtered to 20 
Å to prevent picking bias, and then manually curated (Figure 4.5). As seen in the 
representative micrograph, the particles are well distributed on the grid and randomly 
orientated, with no noticeable preferential orientation. This makes it ideal for 3D 










Figure 4.5: A representative micrograph of mouse complex I imaged on a PEGylated gold 
grid. A few examples of complex I particles to be selected are shown in red. A scale bar is 
shown below for reference. The image was low passed filtered to 20 Å in RELION to 
increase the contrast between the protein and the solvent (Kimanius et al., 2016). 
 
Once particle coordinates had been selected, the particles were extracted and normalised, 
with the contrast of the particles inverted (background is black and protein particles are 
white). The extracted particles were then subjected to several rounds of reference-free 2D 
classification. This procedure requires that the number of classes ‘clusters’ to be set (e.g. 
100) and that those particles that have similar in-plane orientations are averaged together, 
enhancing the signal to noise of the particles (Frank, 1975) (Figure 4.6). This procedure is 
useful in removing non-complex I particles from the dataset, as they do not form large 
clusters and therefore have low single to noise features. 
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Figure 4.6: An example of a set of 2D class averages.  Good classes are highlighted by the 
red box whilst bad/ambiguous classes are not. The 2D class averages were generated in 
RELION (Kimanius et al., 2016). 
 
First, averaged particles that resembled complex I were selected over those that did not. Second, 
‘Good classes’ of complex I particles were easily distinguished from ‘bad classes’ by the 
presence of secondary structure elements in the 2D class averages (Figure 4.6). In good classes, 
transmembrane helices are clearly visible, whilst they are not visualised in bad classes. 
Furthermore, the contrast between the averaged particles and the solvent is enhanced in good 
classes, because the classes are more homogenous and therefore the signal relative to the 
disordered solvent is improved. In contrast, bad classes are blurred in the images, which is an 
indication of either a lack of homogeneity or broken protein (Scheres, 2016). Classes were 




Following movie refinement, which tracks the movements of selected particles, the RELION 
‘polishing’ procedure, was applied using default parameters for B-factor weighting to correct 
for per particle beam-induced motion, and radiation damage by appropriately down-weighting 
the contribution of later frames (Kimanius et al., 2016). In addition, only frames 1 –12 out of 
25 were considered for further refinement (total dose 24 electrons Å-2), as they are less radiation 
damaged than later frames. 
 
In order to obtain a homogenous complex I class The particles were then subjected to 3D 
classification (with an angular sampling to 3.7°), with 5 classes provided (Figure 4.7). The two 
major classes (containing 70% of the particles,) were indistinguishable by using the ‘Fit in 
Map’ function in UCSF Chimera (Pettersen et al., 2004b). The other minority classes are low-
resolution structures, as evident by their apparent lack of secondary structure features. 
Therefore, only the two selected classes were combined and taken forward to a final 3D auto-
refinement.  
 
Figure 4.7: 3D classification of particles. 3D classes are shown with their respective class 
distribution and resolution. The good classes taken further for the final refinement are 
indicated. 
 
Finally, selected 3D classes were subjected to a final 3D refinement using solvent flattened 
Fourier shell correlation (FSC) curves with a mask to remove the influence of the solvent and 
improve the accuracy of orientational assignments. Post-processing was performed on the 
generated map to yield a resolution of 3.3 Å based on the gold standard FSC = 0.143 criterion 
(Scheres and Chen, 2012). Below is an overall scheme of the classifications and refinements 
carried out on both the active and de-active mouse complex I datasets, with the latter carried 
out by Dr. James Blaza (Figure 4.8). 
 34%  35%  11% 7% 12%
Good classes 




Figure 4.8: Classification and refinement scheme for the active and de-active mouse 






 4.4 Structure of mouse complex I 
 
The determined 3.3 Å resolution of the cryoEM density map for active mouse complex I 
allowed for a near complete atomic model of the enzyme to be built (Figure 4.9). Most of the 
model building was carried out by Dr. James Blaza (MRC-MBU, University of Cambridge), 
based on the previous structure of the bovine enzyme (Blaza et al., 2018). Globally, the subunits 
organisation of the mouse complex is identical to that of the bovine, ovine, porcine and human 




Figure 4.9: Overview of the structure of mouse complex I. The fourteen core subunits are in 
colour and labelled accordingly and the 26 supernumerary subunits are in white. The positions 
of the flavin mononucleotide, at the NADH binding site, and FeS cluster N2, the immediate 
electron donor to ubiquinone, are indicated. The structure of the cofactor chain, together 
with the modelled structure of ubiquinone-10 (Fedor et al., 2017), is shown separately in the 
inset also.   
 
The structure contains many well-defined features and side chain densities (Figure 4.10). This 
enabled confident assignment and modelling of residues with side chains. In total, 96% of the 
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residues have been modelled in the structure, of which 98% have been modelled in the 14 core 
subunits and 94% in the 31 supernumerary subunits (Table 4.1). However, there are several 
stretches of more than 10 residues that are unresolved in the structure, plausibly because of 
their inherent flexibility, such as the amino and carboxy termini of NDUFS1, NDUFS3, 
NDUFS7, NDUFA2, NDUFA6, NDUFB3, NDUFB7, NDUFB11 and NDUFV3 (Table 4.1). 
In addition, 28 residues in the middle of NDUFB6 are poorly resolved and therefore not 
modelled in. The model also contains known amino-acid modifications, aided by previously 
measured molecular masses of complex I subunits in mouse (Table 3.7), such as formylation 
and acetylation of N-terminal residues, disulphide bonds between cysteine residues, dimethyl-
Arg85 in NDUFS2, and acyl groups attached to subunits NDUFAB1α and NDUFAB1b (Table 
4.1). The supernumerary subunits also contain bound zinc (NDUFS6), and two nucleotides in 
NDUFA9 and NDUFA10. Finally, there are 20 phospholipids scattered around the structure.  
 
Data for the de-active mouse complex I were processed by Dr. James Blaza. All of the 
processing steps were performed according to the RELION pipeline procedure (Fernandez-
Leiro and Scheres, 2017), as described in Chapter 2.14. The global resolution of the map was 
estimated to be 3.9 Å according to the gold standard FSC threshold (0.143) (Scheres and Chen, 
2012).  
 
The de-active mouse complex I model was produced by Dr. James Blaza, using the active 
mouse complex I structure as a template (Table 4.1). A comparison of the refinement statistics 
of active and de-active mouse complex I are presented in Table 4.2.  As an additional measure 
of validation, both the active and de-active mouse complex I models were compared to their 
respective maps, and there is a clear agreement between the maps and the models (i.e. the map 





Figure 4.10: Example densities drawn from different parts of the map of active mouse 
complex I. Densities were carved at 2 Å radius with threshold level of 0.065 and 0.04 for the 










NDUFV1 51 kDa, Nqo1, NuoF F 444 10-437 96.4 FMN, 4Fe4S 
NDUFV2 24 kDa, Nqo2, NuoE E 217 5-216 97.7 2Fe2S 
NDUFS1 75 kDa, Nqo3, NuoG G 704 6-693 97.7 2Fe2S, 2 x 4Fe4S 
NDUFS2 49 kDa, Nqo4, NuoCD D 430 1-430 100 
Dimethyl-Arg85. No 
sidechains 40-42 
Deactive: 52-60 absent 
NDUFS3 30 kDa, Nqo5, NuoCD C 228 8-213 90.4  
NDUFS7 PSST, Nqo6, NuoB B 189 35-189 82.0 4Fe4S 
NDUFS8 TYKY, Nqo9, NuoI I 178 1-178 100 No side-chains 8-14, 2 x 
4Fe4S 
ND1 Nqo8, NuoH H 318 1-318 100 N-formyl. Deactive: 204-215 absent 
ND2 Nqo14, NuoN N 345 1-344 99.7 N-formyl 
ND3 Nqo7, NuoA A 115 1-115 100 N-formyl. Deactive: 28-48 absent 
ND4 Nqo13, NuoM M 459 1-459 100 N-formyl 
ND4L Nqo11, NuoK K 98 1-98 100 N-formyl 
ND5 Nqo12, NuoL L 607 1-606 99.8 N-formyl 
ND6 Nqo10, NuoJ J 172 1-171 99.4 
N-formyl 
Deactive: no sidechains 
84-118 
 
NDUFV3 10 kDa s 69 29-68 58.0  
NDUFS4 18 kDa Q 133 9-133 94.0  
NDUFS5 15 kDa e 105 1-104 99.0 2 x Cys-Cys 
NDUFS6 13 kDa R 96 1-95 99.0 Zn2+ 
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NDUFA1 MWFE a 70 1-67 95.7  
NDUFA2 B8 S 98 13-95 84.7  
NDUFA3 B9 b 83 1-83 100 N-acetyl 
NDUFA5 B13 V 115 4-115 97.4  
NDUFA6 B14 W 130 17-130 87.7  
NDUFA7 B14.5a r 112 1-76, 90-
122 
89.3 N-acetyl 
NDUFA8 PGIV X 171 1-171 100 4 x Cys-Cys 
NDUFA9 39 kDa P 342 1-342 100 
Deactive: 186-196, 251-
278, 324-335 absent, 
NADPH  
NDUFA10 42 kDa O 320 1-320 100 ADP 
NDUFA11 B14.7 Y 140 1-140 100 Cys-Cys 
NDUFA12 B17.2 q 145 1-144 99.3 N-acetyl 
NDUFA13 B16.6 Z 143 5-143 97.2  
NDUFAB1a SDAPa T 88 8-82 85.2 4’-phosphopantethine + 3-hydroxyundecanoate 
NDUFAB1b SDAPb U 88 1-88 100 4’-phosphopantethine + 3-hydroxydodecanoate 
NDUFB1 MNLL f 56 4-54 91.1  
NDUFB2 AGGG j 72 6-65 83.3  
NDUFB3 B12 k 103 20-91 69.9  
NDUFB4 B15 m 128 5-128 96.9  
NDUFB5 SGDH h 143 6-142 95.8  
NDUFB6 B17 i 127 1-35, 62-127 79.5 
N-acetyl. No sidechains 
62-65, 124-126. 36-61 
absent 
NDUFB7 B18 o 136 12-116 77.2 2 x Cys-Cys 
NDUFB8 ASHI l 157 3-154 96.8  
NDUFB9 B22 n 178 1-176 98.9  
NDUFB10 PDSW p 175 2-171 97.1 2 x Cys-Cys 
NDUFB11 ESSS g 122 21-121 82.7  
NDUFC1 KFYI c 49 2-48 95.9  
NDUFC2 B14.5b d 120 1-119 99.2  




 Active Deactive 
Data Collection   
Pixel size (Å) 1.05 1.33 
Defocus range (μm) 2.2-3.4 2.2-3.4 
Voltage (kV) 300 300 
Number of particles in 
refinement 
20,370 17,066 
Estimated accuracy of 





Resolution (Å) 3.30 3.93 
B-factor used for map 
sharpening (Å2) 
-63 -62 
Model statistics   
Non-hydrogen atoms 66,812 64,925 
Protein residues 8,164 8,072 
% of total 95.9 94.8 
Core subunit residues 4,408 4,366 




% of total 93.6 92.3 
Residue with sidechains 8,148 8,020 
% of total 95.7 94.2 
RMS deviations   
Bonds (Å) 0.0071 0.0130 
Angles (°) 1.36  1.36 
Validation   
Molprobity score 2.08 2.19 
Clashscore, all atoms 7.76 8.95 
EMringer score 3.56 2.10 
Ramachandran plot   
Favored (%) 85.3 81.8 
Outliers (%) 0.22 0.45 
Table 4.2: Data collection, refinement, and model statistics for the structures of active and 





Figure 4.11: Resolution estimations of the maps for the active and de-active states of mouse 
complex I. a, b: data on the active complex. c, d: data on the deactive complex. The estimated 
resolutions, defined where the line at FSC = 0.143 crosses the red curve, are 3.3 Å for the 
active complex (a) and 3.9 Å for the deactive complex (c). In both cases the refined models 
agree well with the maps, as shown by the map vs. model FSC curves (blue). In b) and d), local 
resolutions were estimated using the Local Resolution function in RELION with default 
parameters and plotted using UCSF Chimera. 
 
4.5 Local resolution of the cryo-EM maps of mouse complex I  
 
The local resolution of both the active and de-active complex I cryo-EM maps varies 
throughout the structure, particularly between the core and supernumerary subunits (Figure 
4.13). The central core subunits are well-resolved, as evident by their relatively high resolution, 
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whilst the tip of the membrane arm (ND5) and matrix arm (NDUFV1, NDUFV2 and the large 
domain of NDUFS1) have relatively poor resolution and therefore are not well-resolved (Figure 
4.12). The resolution decrease towards the end of each core domain can be explained well by 
considering the surface area contact each subunit makes with the rest of the protein (Table 4.3). 
Noticeably, the relative surface area contact of each subunit generally coincides with its local 
resolution, meaning proteins that have relatively few surface contacts with the rest of the 
complex, such as ND5 (49%), NDUFV2 (36%), NDUFV1 (31%) and the large domain of 
NDUFS1 (30%) display a lower resolution compared to the rest of the core subunits, which on 
average has relatively more surface area contact 69 ± 6% (Table 4.3). This may be because a 
lower surface contact area of a given protein with the rest of the complex results in a distribution 
of orientations for that protein compared to the rest of the structure, thus displaying a lower 
resolution because of its flexibility. Similarly, the supernumerary subunits display a lower 
resolution than the core subunits, again owing to the relatively low contact areas of the 
supernumerary subunits (42 ± 12%) compared to the rest of the complex. Interestingly, the 
resolution is asymmetric across the membrane domain of complex I instead of the extremities 
of the complex, which is common in image processing. This suggests that the surface-area 
effect is substantial and variations are not due to imperfect particle alignment (Figure 4.12). 
The origin of the resolution asymmetry is unclear, although the better-resolved side contains 
the ND5 transverse helix and contacts with complex III in the respirasome (Letts et al., 2016a; 
Wu et al., 2016a), hinting that inter-complex contacts may have affected rigidity. Finally, 
supernumerary subunits distant from the core tend to have particularly low local resolutions. 
For example, subunits NDUFA2 and NDUFAB1a, which contact only the large domain of 
NDUFS1 (25% contact area) and NDUFA6 (15% contact area), respectively are clearly 
noticeable in Figure 4.12, and NDUFC1, which is bound peripherally to the complex by 
supernumerary subunit NDUFC2, has the lowest local resolution estimate of any subunit (Table 
4.3). The concept of low surface area contacts producing decreased resolution through 
increased structural dispersion may thus help to explain how the resolution varies through the 
complex, particularly for the supernumerary subunits, which rely less on tight and specific 










Figure 4.12: The resolution of densities for the core and supernumerary subunits in the 3.3 
Å resolution map of active mouse complex I. Local resolutions were estimated using the Local 
Resolution function in RELION with default parameters. The figure was created using UCSF 




Surface area Local 
Resolution 
(Å) 






Buried Core subunits Supernumerary subunits 
NDUFV1 18,800 6,100 33 3.9 ± 0.4 NDUFV2, NDUFS1 NDUFV3, NDUFS4, NDUFA7 
NDUFV2 13,600 4,900 36 3.7 ± 0.3 NDUFV1, NDUFS1 NDUFV3, NDUFS4, NDUFS6 
NDUFS1 28,500 10,100 35 3.6 ± 0.2 NDUFV1, NDUFS2, 
NDUFV2, NDUFS3, 
NDUFS8 
NDUFS4, NDUFA2, NDUFA12, NDUFA6, 
NDUFA7, NDUFS6, NDUFA9, NDUFV3 
NDUFS1 
(small) 
12,200 7,100 58 3.6 ± 0.2 (NDUFS1 large), NDUFV1, 
NDUFS2, NDUFV2, 
NDUFS3, NDUFS8 




19,100 5,600 30 3.5 ± 0.3 NDUFS1 (small), 
NDUFS3, NDUFS8 
NDUFA2, NDUFS4, NDUFA12, NDUFA6, 
NDUFA9, NDUFV3 
NDUFS2 21,300 14,400 68 3.4 ± 0.2 NDUFS3, NDUFS8, 
NDUFS7, ND1, ND2, 
NDUFS1, ND3, ND4, 
ND4L, ND5 
NDUFA7, NDUFA13, NDUFA10, NDUFA5, 
NDUFS6, NDUFB11, NDUFA6, NDUFS4, 
NDUFA12 
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NDUFS3 14,500 10,200 70 3.4 ± 0.1 NDUFS2, NDUFS7, 
NDUFS1, NDUFS8, ND3 
NDUFA5, NDUFS4, NDUFA7, NDUFA6, 
NDUFA9 
NDUFS7 9,000 6,300 70 3.3 ± 0.1 NDUFS2, ND1, NDUFS8, 
NDUFS3, ND3 
NDUFA9, NDUFA12, NDUFA6, NDUFA7, 
NDUFS4 
NDUFS8 13,100 9,600 73 3.4 ± 0.0 NDUFS2, NDUFS7, ND1, 
NDUFS1, NDUFS3 
NDUFA12, NDUFS6, NDUFA7, NDUFA13, 
NDUFA3, NDUFS4, NDUFA1, NDUFA9, 
NDUFA5 
ND1 16,000 10,700 67 3.5 ± 0.1 ND3, NDUFS7, NDUFS2, 
ND6, NDUFS8 
NDUFA1, NDUFA13, NDUFA3, NDUFA8, 
NDUFA9, NDUFA12, NDUFA7 
ND2 15,200 9,800 65 3.4 ± 0.1 ND4L, ND4, ND5, 
NDUFS2, ND6, ND3 
NDUFA10, NDUFC2, NDUFS5, NDUFA11, 
NDUFB5, NDUFA8, NDUFB11 
ND3 11,000 7,400 67 3.5 ± 0.1 ND1, ND6, NDUFS2, 
NDUFS7, ND4L, ND2, 
NDUFS3 
NDUFA3, NDUFA6, NDUFA9, NDUFA13, 
NDUFS5, NDUFA1 
ND4 18,200 11,000 60 3.5 ± 0.1 ND5, ND2, NDUFS2 NDUFB11, NDUFB4, NDUFB5, NDUFB1, 
NDUFB10, NDUFB8, NDUFB9, NDUFA8, 
NDUFC2, NDUFA11, NDUFA10 
ND4L 7,000 5,700 83 3.4 ± 0.1 ND6, ND2, ND5, ND3, 
NDUFS2 
NDUFS5 
ND5 28,600 13,900 49 3.6 ± 0.1 ND4, ND2, ND4L, 
NDUFS2 
NDUFB8, NDUFB2, NDUFB9, NDUFB10, 
NDUFB6, NDUFB4, NDUFB7, NDUFB3, 
NDUFA11, NDUFAB1b, NDUFB5, NDUFB11 
ND6 13,000 8,300 64 3.5 ± 0.1 ND4L, ND3, ND1, ND2 NDUFA13, NDUFS5, NDUFA1, NDUFA9, 
NDUFA3, NDUFA6 




NDUFA6, NDUFA9, NDUFV3, NDUFA12, 
NDUFS6, NDUFA5 
NDUFS5 9,600 5,400 56 3.6 ± 0.2 ND2, ND6, ND4L, ND3 NDUFA13, NDUFB5, NDUFA8, NDUFC2, 
NDUFA1, NDUFA3 
NDUFS6 7,500 3,000 40 3.4 ± 0.1 NDUFS8, NDUFS1, 
NDUFS2, NDUFV2 
NDUFA9, NDUFA12, NDUFS4 
NDUFA1 6,200 3,700 60 3.6 ± 0.1 ND1, ND6, NDUFS8, ND3 NDUFA8, NDUFA13, NDUFS5, NDUFA7, 
NDUFA12 
NDUFA2 5,500 1,400 25 4.2 ± 0.4 NDUFS1 - 
NDUFA3 8,100 3,300 41 4.1 ± 0.4 ND1, ND3, NDUFS8 NDUFA8, NDUFA13, NDUFS5, ND6, 
NDUFB5 
NDUFA5 8,500 2,900 34 3.9 ± 0.3 NDUFS3, NDUFS2, 
NDUFS8 
NDUFA7, NDUFA10, NDUFS4, NDUFA6 
NDUFA6 9,300 4,500 48 3.5 ± 0.1 NDUFS3, NDUFS1, ND3, 
NDUFS2, NDUFS7, ND6 
NDUFAB1a, NDUFS4, NDUFA9, NDUFA5 
NDUFA7 11,500 6,000 52 3.8 ± 0.3 NDUFS2, NDUFS3, 
NDUFS8, NDUFS1, 
NDUFV1, ND1, NDUFS7  
NDUFA12, NDUFA13, NDUFA5, NDUFA1 
NDUFA8 14,100 6,500 46 3.8 ± 0.2 ND2, ND4, ND1 NDUFA13, NDUFA3, NDUFA1, NDUFC2, 
NDUFB5, NDUFS5, NDUFC1, NDUFB1 
NDUFA9 17,000 4,100 24 3.5 ± 0.2 NDUFS7, NDUFS3, ND1, 
ND3, NDUFS1, ND6, 
NDUFS8 
NDUFS6, NDUFA6, NDUFS4, NDUFA12 
NDUFA10 17,000 3,900 23 3.8 ± 0.3 ND2, NDUFS2, ND4 NDUFC1, NDUFB11, NDUFC2, NDUFA5 
NDUFA11 9,300 1,600 17 3.6 ± 0.1 ND5, ND2, ND4, NDUFS2 NDUFB5, NDUFB4 
NDUFA12 11,800 4,600 37 3.5 ± 0.2 NDUFS8, NDUFS1, 
NDUFS7, ND1, NDUFS2 
NDUFS6, NDUFA7, NDUFS4, NDUFA9, 
NDUFA1 
NDUFA13 14,000 8,200 59 3.7 ± 0.2 ND3, NDUFS2, ND1, 
NDUFS8, ND6 
NDUFA1, NDUFA3, NDUFS5, NDUFB5, 
NDUFA7, NDUFA8 
NDUFAB1a 5,400 900 17 4.0 ± 0.2 - NDUFA6 
NDUFAB1b 6,300 3,300 53 3.9 ± 0.2 ND5 NDUFB9, NDUFB3, NDUFB6, NDUFB2, 
NDUFB8, NDUFB5 
NDUFB1 5,600 1,700 31 4.1 ± 0.4 ND4 NDUFB5, NDUFB10, NDUFA8, NDUFC2 
NDUFB2 6,700 3,200 48 4.1 ± 0.2 ND5 NDUFB3, NDUFB7, NDUFAB1b, NDUFB8, 
NDUFB6 
NDUFB3 7,000 2,800 39 4.1 ± 0.3 ND5 NDUFB2, NDUFB9, NDUFAB1b 
NDUFB4 12,600 5,900 47 3.6 ± 0.2 ND4, ND5 NDUFB8, NDUFB9, NDUFB10, NDUFB11, 
NDUFC2, NDUFA11 
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NDUFB5 13,700 7,700 56 3.9 ± 0.3 ND4, ND2, ND5 NDUFB10, NDUFS5, NDUFB11, NDUFC2, 
NDUFB1, NDUFA8, NDUFB9, NDUFB6, 
NDUFA11, NDUFA13, NDUFAB1b, NDUFA3 
NDUFB6 10,700 5,000 47 4.1 ± 0.3 ND5 NDUFB10, NDUFB9, NDUFB7, NDUFAB1b, 
NDUFB5, NDUFB2, NDUFB11 
NDUFB7 9,500 3,900 41 4.1 ± 0.3 ND5 NDUFB8, NDUFB6, NDUFB2, NDUFB10 
NDUFB8 13,200 5,500 42 3.6 ± 0.2 ND5, ND4 NDUFB4, NDUFB7, NDUFB9, NDUFB10, 
NDUFAB1b, NDUFB2 
NDUFB9 15,300 7,100 47 3.8 ± 0.3 ND5, ND4 NDUFAB1b, NDUFB4, NDUFB6, NDUFB3, 
NDUFB5, NDUFB8, NDUFB11 
NDUFB10 15,400 8,000 52 4.0 ± 0.4 ND5, ND4 NDUFB11, NDUFB6, NDUFB5, NDUFC2, 
NDUFB7, NDUFB4, NDUFB1, NDUFB8 
NDUFB11 10,500 5,300 51 3.8 ± 0.3 ND4, NDUFS2, ND5, ND2,  NDUFB10, NDUFB5, NDUFA10, NDUFC2, 
NDUFB9, NDUFB4, NDUFB6 
NDUFC1 5,100 1,500 29 4.3 ± 0.3 - NDUFC2, NDUFA10, NDUFA8 
NDUFC2 10,500 4,900 47 3.8 ± 0.2 ND2, ND4 NDUFC1, NDUFB5, NDUFB10, NDUFA8, 
NDUFA10, NDUFS5, NDUFB11, NDUFB4, 
NDUFB1 




Table 4.3: The interfaces between subunits in the 3.3 Å structure of mouse complex I. 
Surface areas of contacts between subunits were calculated using the PDBePISA server 
(http://www.ebi.ac.uk/pdbe/pisa/) and reported to 100 Å2 accuracy. Local resolutions were 
estimated using the Local Resolution function in RELION with default parameters, then UCSF 
Chimera was used to extract the resolution at each atomic coordinate in each subunit and the 
values were averaged. 
4.6 Assignment of the 3.3 Å resolution structure to the active state, 
and comparison with a de-active structure 
 
 
The 3.3 Å resolution structure of mouse complex I, determined from the protein as isolated, 
was assigned to the active state for the following reasons. First, the global RMSD values 
calculated in Pymol, which gives an indication of similarity between two atomic coordinate 
models, were much lower when the active mouse complex I model was compared with the 
active (class 2) bovine complex I model than the de-active (class 1) or broken (class 3) models 
(1.6, 3.2 and 4.2 Å, respectively). Second, the different orientations of the hydrophilic and 
membrane domains in the active and de-active states are captured visually by the different 
positions of NDUFA5 (hydrophilic domain) and NDUFA10 (membrane domain), showing 
clearly that the mouse structure matches the active bovine structure (Figure 4.13a). Third, 
densities for all the loops that become disordered in the de-active state are clearly visible in the 
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mouse map (Blaza et al., 2018; Zhu et al., 2016), and remained so even when its resolution was 
decreased to 4.3 Å, to match the resolution of the original bovine structures. 
 
Figure 4.13: Differences in structure between the active and de-active states of mouse 
complex I. (a) Left - NDUFA5, on the hydrophilic domain, and NDUFA10, on the membrane 
domain, form a second contact between the two domains. Right – the different arrangements 
of NDUFA5 and NDUFA10 are illustrated by superimposing the NDUFA10 subunit in the 
NDUFA5-NDUFA10 pairs from the bovine and mouse de-active and active states. NDUFA5 is 
present in markedly different positions in the active (red) and de-active (wheat/grey) states. 
(b) Structural elements that become disordered or change between the active and de-active 
states. The ubiquinone binding channel determined by CAVER 3.0 is shown for reference 
(Chovancova et al., 2012). (c) The different structures of ND6-TMH3 in the active (red) and de-
active (wheat) states, superimposed on the N-terminal section, and the positions of key 
sidechains. The p-bulge is present only in the de-active state. (d) Densities for key sidechains 
in the active state. (e) Rotation of the bulky sidechains of Phe67 and Tyr69 between the TMHs 
of ND3, ND4L and ND1. The structures were superimposed on ND4L with the active structure 
in different colors and the de-active in wheat. Only the TMHs are shown, plus the loops 
between ND3-TMHs 1 and 2 and ND6-TMHs 3 and 4. 
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To confirm that the active and de-active structural states observed for bovine complex I apply 
equally to the mouse enzyme, mouse complex I was prepared in the deactivate state using the 
method of Blaza et al., (Blaza et al., 2018), and its structure was determined to 3.9 Å resolution 
(Figure 4.11), following 3D particle classification into a major (69%) and a minor (25%) class 
(Figure 4.8b). Comparisons of the minor class with the three classes of bovine complex I  
suggested it represents the active state of the mouse enzyme (Zhu et al., 2016). The complex I 
model for the major class exhibited its lowest global RMSD value when compared with the de-
active bovine complex I, with values of 1.6, 2.4 and 2.7 Å for classes 1, 2 and 3, respectively. 
Moreover, Figure 4.13a reveals a close match in the relative positions of NDUFA5 and 
NDUFA10 between the de-active bovine and mouse enzyme. Consistent with de-active bovine 
complex I, there are no clear densities are observed for the loops of ND1 TMH5-6, ND3 TMH1-
2 and NDUFS2 b1-b2, or several loops in NDUFA9 (Table 4.1). However, key features which 
are absent in the inactive state (class 3) such as the transverse helix of ND5 are clearly visible, 
which means the deactivation of the enzyme has not denatured it (Zhu et al., 2016). Therefore, 
the structural changes accompanying deactivation are common to both the bovine and mouse 
enzyme, providing a clear understanding of the active-deactive transition seen in mammalian 
complex I. 
 
Figure 4.13a shows that NDUFA5 and NDUFA10 form an interface between the membrane 
arm and the hydrophilic arm of complex I, which is the only interface between the two domains 
other than the main domain contact between the core subunits. There are changes in the 
interface interaction between NDUFA5/NDUFA10 upon deactivation. In the active state, the 
buried interface between the two subunits is 400 Å2, including three salt-bridges and three 
hydrogen bonds. In contrast, in the de-active state, the interface is decreased to 200 Å2 and 
includes only one salt-bridge and one hydrogen bond. The implication that 
NDUFA5/NDUFA10 interactions stabilise the active state is supported by coarse-grained 
simulations that illustrated how NDUFA5 and NDUFA10 restrict global vibrational modes in 
the mammalian complex that resemble the changes required to interconvert the active and de-
active states (Di Luca and Kaila, 2018). 
 
In addition to the loops in ND1, ND3, NDUFS2 and NDUFA9, which are known to become 
disordered upon deactivation (Blaza et al., 2018; Zhu et al., 2016a), the higher-resolution active 
and de-active mouse structures reveal subtle differences in ND1, ND6 and NDUFS7, 
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illustrating better how the disorder propagates from the ubiquinone-binding site (Figure 4.13b). 
In ND6, the TMH3-4 loop is affected in the active-de-active transition (i.e. becomes more 
disordered), and in the de-active map, TMH4 is poorly resolved. Furthermore, a striking 
difference between the active and de-active states is revealed in ND6-TMH3. In all existing 
complex I structures, a p-bulge (a stretch of a p-helix) has been modelled in ND6-TMH3, 
following its identification in the high-resolution bacterial membrane domain of complex I 
(Efremov and Sazanov, 2011). The p-bulge is present in de-active mouse complex I, but not in 
the active mouse enzyme. Consequently, in the active state TMH3 is extended, and the residues 
in its C-terminal section are rotated around the helical axis (Figure 4.13c). Although ND6-
Tyr59, which may form a functionally-important interaction with ND4L-Glu34, is at the start 
of the p-bulge and so not affected, two aromatic residues, Phe67 and Tyr69, undergo large 
changes (Figure 4.13d). They rotate, respectively, from between ND4L-TMH2/3 and ND1-
TMH5/ND3-TMH2 in the de-active state to between ND1-TMH4/5 and ND3-TMH2/ND4L-
TMH3 in the active state (Figure 4.13e). The rotation locks the enzyme into different 
conformations, explaining why ND6 moves relative to ND1 and ND3 between the active and 
de-active states (Zhu et al., 2016), and thus confirming the importance of the ND6 p-bulge for 
catalysis. 
4.7 Phospholipid densities  
 
Densities for twenty phospholipids were identified in the map for active mouse complex I 
(Figure 4.14 and Table 4.4). Four of them are cardiolipins, 11 phosphatidylethanolamines and 
five phosphatidylcholines. Many of the headgroup phosphates are stabilized by arginines, 
histidines or tyrosines (Hunte, 2005). Eight phospholipids overlap with the 12 phospholipids 
that were previously modelled in ovine complex I (Fiedorczuk et al., 2016), and nine and 11 of 
phospholipids modelled in the mouse structure overlap with the 11 and 18 phospholipids 
modelled in the porcine and human respirasomes (Guo et al., 2017; Wu et al., 2016), 
respectively (Table 4.4). Altogether nine cardiolipins have been modelled, corresponding to the 
~10 cardiolipins that co-purify with bovine complex I, along with a similar number of 
interchangeable phosphatidylethanolamines and phosphatidylcholines.  
 
The locations of the phospholipids (Figure 4.14 and Table 4.4) suggest they stabilize intra-
protein and subunit interactions. Four stabilize the C-terminus of ND5, one at its interface with 
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NDUFA11 and ND2 and two ‘behind’ its transverse helix, and on the heel, they stabilize 
hydrophilic-domain amphipathic helices and supernumerary TMHs against ND1 (Figure 
4.14b). Many phospholipids are packed between the core membrane subunits. Notably, the 
contact areas between ND2, ND4 and ND5 are low, with less than 20% of the surface of ND4 
buried at interfaces with ND2 and ND5, suggesting loose contacts between the core subunits 
of the membrane domain. Therefore, along with the ‘cage’ of supernumerary subunits, 
phospholipids may also be crucial for the integrity of the membrane domain. Finally, two 
phospholipids (Figure 4.14c) interact with NDUFA9 residues relevant to the active to de-active 
transition. In particular, one of them extends from close to the NAD(P)H ribose-phosphate, 
along an interface between NDUFS7 and two regions (a loop in NDUFA9 and the start of the 
ND3-TMH1-2 loop) that become disordered in the de-active state. Therefore, protein-





Figure 4.14: Phospholipids in the 3.3 Å resolution structure of mouse complex I. a) 
Membrane-bound helices in the complex I viewed from the matrix side, with phospholipids in 
red and labelled with the nomenclature in Supplementary Table 4. b) Phospholipids stabilizing 
amphipathic helices on the matrix side of the heel of the complex. The structure shown in 
blue is from supernumerary subunits NDUFA1, NDUFA3, NDUFA7, NDUFA12 and NDUFA13 
and phosphorus atoms are marked with spheres. c) Two phospholipids that interact with 
NDUFA9 may stabilize loops in ND3 and NDUFA9 that become disordered in the de-active 
state (shown in darker colours than the rest of the two subunits). The arrows on the insets to 












1 IMS Interface of ND1, ND3-TMH1 and ND6 (also loops of 
NDUFA1 and NDUFA13 in IMS). 
PE PE PE 
H-402 
PC1 
2 Matrix Interface of ND1 and ND6 (also loops in C-terminal 
domain of NDUFA9). 
- - - 
A-201 
3PE 
2 Matrix Interface of ND4L and ND6 (also C-terminal TMH of 
ND5). 
- - - 
N-401 
3PE 
2 Matrix Interface of ND2, NDUFA11 and transverse and final 
TMH of ND5. 
CDL - CDL 
M-501 
3PE 
1 Matrix Interface of ND2, ND4 and ND5 transverse helix (also N-
terminus of NDUFS2). See also M-502. 
PE - PE 
M-502 
3PE 
2 IMS Interface of ND2, ND4 and NDUFA11. See also M501. PE - PE 
L-701 
3PE 
1 Matrix Interface of ND4 and ND5 and ND5 transverse helix (also 
loops and TMH of NDUFB8). 
PE - PE 
L-702 
CDL 
1 Matrix Interface of ND4, ND5 and NDUFB5 (also NDUFB11). 
See also L-703, M-503, L-704. 
CDL CDL CDL 
L-703 
CDL 
2 IMS Interface of ND4, ND5, NDUFB5, NDUFB6 and 
NDUFB11 (also NDUFB10 on IMS face). See also L-702, 
M-503, L-704. 
CDL CDL - 
M-503 
3PE 
1 IMS Interface of ND4, ND5 and NDUFB11. See also L-702, L-
703, L-704. 
PC (CDL) - 
L-704 
3PE 





2 IMS Interface of ND4, NDUFB1 and NDUFB11 (also NDUFB5 
on IMS face). 
- - - 
M-505 
3PE 
2 Matrix Interface of ND2, ND4 and NDUFC2 (also C-terminal 
helix of NDUFA10). See also M-506, M-507. 
CDL - CDL 
M-506 
3PE 
2 Matrix Interface of ND2, ND4 and NDUFC2 (also NDUFB1 and 




1 IMS Interface of ND2, ND4, NDUFB1 and NDUFC2 (also C-
terminus of NDUFA8 on IMS face). See also M-505, M-
506. 
CDL PC CDL 
H-403 
PC1 
1 Matrix Interface of ND1, NDUFA3 and NDUFA13 (also helix in 
NDUFS2 and N-terminus of NDUFS8). See also H-404. 
PC PE PC 
H-404 
PC1 
1 Matrix Interface of ND1 and NDUFA13 (also helices of NDUFS8 
N-terminus and NDUFA7). See also H-403. 
- - - 
H-405 
CDL 
1 Matrix Interface of NDUFA1 and helix of NDUFA12 (also ND1, 
NDUFS8 and NDUFA7). 
- CDL - 
H-406 
PC1 
2 Matrix Interface of helices on ND1, NDUFS7 and NDUFA12 (also 
NDUFS8). 
- - - 
P-401 
PC1 
2 Matrix Interface of ND3-TMH1, amphipathic helices on NDUFS7 
and loops in ND3, NDUFS7 and NDUFA9. 
- - - 
 
Table 4.4: Phospholipids modelled in the structure of active mouse complex I. The 
phospholipids were assigned on two confidence levels, where 1 is the highest, based on the 
quality of the density and interactions with nearby residues. Cases in which partial overlap 
between phospholipids are observed in different structures are indicated with brackets. 







4.8 Nucleotide binding to NDUFA10  
 
 
The improved resolution of the active mouse structure has allowed the tetrahedral coordination 
of the Zn in NDUFS6 and the acyl chains in NDUFAB1a and NDUFAB1b to be clearly 
visualized, revealed the coordination of the NAD(P)H in NDUFA9 by conserved charged 
residues, confirmed 11 disulfide bonds on the inter-membrane space side of the complex and 
showed that no disulfide is present in the thioredoxin-like subunit NDUFA2 (located in the 
reducing matrix environment). Most strikingly, however, it has revealed clear density for a 
bound nucleotide in subunit NDUFA10, a member of the nucleoside-kinase family (Figures 
4.15a and b) that transfer a phosphate from a nucleotide triphosphate to a nucleoside (Eriksson 
et al., 2002). The density has been tentatively modelled as ADP because it resembles a purine 
nucleoside plus two phosphates, and ADP is abundant in the matrix. The putative ADP is 
coordinated by the sidechains of widely conserved residues: the adenosine by Tyr83, Gln97, 
Arg104 (which interacts with Glu53 and Arg126), Phe134, Glu191 and Tyr198, and the 
phosphates by Lys35 (P-loop), Glu125 and Lys186. However, comparison with structural 
information from canonical nucleoside kinases, such as ADP-bound human deoxycytidine 
kinase (Sabini et al., 2008), showed that the ADP is bound with its adenosine in the nucleoside-
binding site and its two phosphates towards the P-loop nucleotide-phosphates binding site 
(Figure 4.15d). Therefore, it is bound in a configuration resembling the feedback-inhibition 
mode characterized for deoxythymidine triphosphate bound to Drosophila melanogaster 
deoxyribonucleoside kinase (Mikkelsen et al., 2003). 
 
Similar, less well-defined densities are present (but were not interpreted) in NDUFA10 in the 
maps for the human and porcine respirasomes (Guo et al., 2017; Wu et al., 2016a), but not in 
the maps for ovine or bovine complex I (Fiedorczuk et al., 2016; Zhu et al., 2016a). In the 
bovine maps increased density in the ADP phosphate-binding region can be attributed to 
phosphorylation of Ser36 (Schilling et al., 2005) (Figure 4.15c), which has now been confirmed 
in the structurally-characterized (bovine) preparation (Figure 4.16). Ser36 is conserved in ovine 
complex I, but substituted by Asn/Gly in the mouse, porcine and human homologs, suggesting 
phosphorylation blocks nucleotide binding. As the active site is accessible to the solution and 
key residues are present (Elurbe and Huynen, 2016), phosphorylation of Ser36 and inhibitory 
substrate binding may together explain why no nucleoside kinase activity has yet been reported 
for mammalian complex I. 
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Figure 4.15: Nucleotide/nucleoside binding to NDUFA10. (a) Density for the bound 
nucleotide/nucleoside (modelled as ADP) in NDUFA10 in active mouse complex I. The density 
has been carved around the modelled ADP and the phosphate in the overlaid model from 
panel c (2 Å carve radius, threshold level of 0.075). Key residues that interact with the 
nucleotide/nucleoside are indicated, and N36, the homolog of S36 is in green. (b) Overview 
of the typical nucleoside-kinase fold of NDUFA10 with nucleotide bound and the P-loop 
adjacent to the bound phosphates. (c) The nucleotide/nucleoside-binding site in the bovine 
complex (taken from 5O31.PDB (Blaza et al., 2018)) with a phosphate added to the side-chain 
of Ser36 (green) on the basis of mass spectrometry evidence. The density has been carved 
around the phosphate and the ADP in the overlaid model from panel a (2 Å carve radius, 
threshold level of 0.16). (d) Comparison of the binding mode of the ADP modelled in NDUFA10 
(red) with deoxythymidine triphosphate bound in the feedback inhibition mode in Drosophila 
melanogaster deoxyribonucleoside kinase (1OE0.PDB (Mikkelsen et al., 2003), blue) and with 
ADP (green) and a nucleoside analogue (wheat) in the substrate-binding site of human 
deoxycytidine kinase (2ZI4.PDB (Sabini et al., 2008)). The structures were overlaid using the 





Figure 4.16: Mass spectrometry evidence for the phosphorylation of bovine NDUFA10-
Ser36. (a) Intact mass measurements revealed two masses for NDUFA10, for the unmodified 
and singly phosphorylated versions (present at the point of measurement). (b) Spectrum of 
fragment ions produced by ETD of a doubly charged precursor ion 942.48 (m/z) with the 
precursor ion truncated to 10% relative intensity. The observed neutral peptide mass for the 
phosphorylated peptide is 1882.955 Da, relative to a calculated mass of 1882.959 Da. The 
observed peptides are mapped onto the amino acid sequence where the phosphorylation site 
is marked and c is carbamidomethylcysteine. The z7 and z8 fragments confirm Ser36, rather 




























































































































































































































4.9  The second coordination sphere of cluster N2 
 
 
The residues surrounding cluster N2, the final cluster in the FeS chain that donates electrons to 
ubiquinone (Figure 4.9), are clearly resolved in the active mouse complex I map (see, for 
example, Arg85 in Figure 4.10), defining its environment in the mammalian enzyme (Figure 
4.17a). Three basic residues, Arg85, Arg105 and His190 in NDUFS2, are close to N2 and their 
positive charges may explain its high reduction potential (Hirst and Roessler, 2016). Arg85 is 
widely conserved but absent from Thermus thermophilus, in which N2 has a lower reduction 
potential (Hirst and Roessler, 2016). Furthermore, it is symmetrically dimethylated in all 
species tested except E. coli (Carroll et al., 2013), in which the N2 reduction potential is also 
unusually low (Hirst and Roessler, 2016). Protonation of His190 upon N2 reduction explains 
why N2 has a weakly pH-dependent reduction potential (Le Breton et al., 2017; Zwicker et al., 
2006). Although the His190Met variant of Yarrowia lipolytica complex I remains catalytically 
competent  (Le Breton et al., 2017; Zwicker et al., 2006), molecular simulations have suggested 
His190 deprotonation is required for electron transfer from N2 to semiquinone, and that both 
His190 and Arg105 (which form a cation π-stacking arrangement) contribute to the pH 
dependence (Gamiz-Hernandez et al., 2017). Notably, no channels from the His190 sidechain 
to the outside could be detected in Caver analyses (even with a 0.9 Å probe radius). Conversely, 
similar analyses revealed channels from both NDUFS2-Asp104 (within hydrogen-bonding 
distance of His190) and Glu115 (hydrogen bonded to Asp104). Unusually for cryoEM-density 
maps, Asp104 and Glu115 both have well-resolved sidechains, so their negative charges may 
be neutralized by protonation (Hryc et al., 2017). Therefore, they may act as a proton reservoir, 





Figure 4.17: The environment of cluster N2, the ubiquinone-binding channel and the E-
channel in active mouse complex I. (a) Cluster N2 and nearby key residues in NDUFS2. 
Dimethyl-Arg85 and Arg105 are positively charged, His190 is the redox-Bohr group that 
changes protonation state upon N2 reduction  (Le Breton et al., 2017; Zwicker et al., 2006), 
and Asp104 and Glu115 may transfer protons to/from His190. (b) The structure around the 
ubiquinone-headgroup binding site with key residues in NDUFS2. The structure of active 
mouse complex I (teal) is overlaid on the modelled structure of bovine complex I with 
ubiquinone-10 bound (wheat) in which its  headgroup is hydrogen bonded to the Tyr108 and 
His59 residues, and His59 in turn is hydrogen bonded to Asp160 (Fedor et al., 2017). Distances 
in brackets are for the active mouse structure. (c) The ubiquinone-binding channel (mesh) in 
active mouse complex I was predicted using CAVER 3.0 with a 1.4 Å probe radius. The key 
residues from panel b are shown with charged residues in the vicinity of the site (inset, 
charged residues around the centre of the channel and their interactions). The main figure 
highlights the carboxylate-rich ND1 TMH 5-6 loop and the E channel residues (blue) that 
connect the ubiquinone-binding site to the p-helix present in ND6 in the de-active enzyme, 
and to charged residues in the central membrane plane (Baradaran et al., 2013). Long 
distances of interest are in red, and all residues are in ND1 unless otherwise indicated (B - 
NDUFS7, D - NDUFS2, J - ND6 and K - ND4L). All distances are in Å. 
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Figure 4.18: Densities around the N2 cluster and the ubiquinone site. Densities (green) were 
carved at 3 Å at a threshold of 0.067. The ubiquinone binding cavity is shown in grey mesh 












4.10 The ubiquinone binding site and E-channel 
 
Tyr108 and His59 in NDUFS2 are generally considered to bind the ubiquinone headgroup in 
complex I by forming hydrogen bonds to its redox-active C=O groups. Both residues are well 
resolved in the mouse map but positioned too close for ubiquinone to fit between them (5.9 Å 
O-to-N distance). Figure 4.17b compares the structure with a modelled structure for ubiquinone 
bound to bovine complex I (7.8 Å O-to-N distance) (Fedor et al., 2017), showing a substantial 
change in the His59 loop required for binding. Compared to previous structures, the mouse and 
porcine ubiquinone-binding sites match closely (Wu et al., 2016), but differ from the ovine and 
Y. lipolytica structures (Fiedorczuk et al., 2016; Zickermann et al., 2015), which have markedly 
different His59-loop conformations. The variation confirms the flexibility of the site, 
suggesting it is configured by the substrate or inhibitor binding. Finally, in the mouse structure, 
the His59 to NDUFS2-Asp160 (O-to-N) distance is 5.0 Å, whereas in the modelled ubiquinone-
bound bovine and T. thermophilus structures the two are within hydrogen-bonding distance 
(Baradaran et al., 2013; Fedor et al., 2017). Although Asp160 has been proposed to undergo 
large movements upon ubiquinone reduction to initiate proton translocation (Sharma et al., 
2015), its position on a nearby helix is conserved in all structures reported so far. 
 
Figure 4.17c and 4.18 shows how networks of charged residues surround the central section 
(isoprenoids ~4-7) of the predicted ubiquinone-binding channel, with the regions before and 
after dominated by hydrophobic residues (Fedor et al., 2017). As expected for cryo-EM maps, 
the Arginine sidechains in Figure 4.17c are better defined than the (negatively-charged) 
carboxylates (Hryc et al., 2017). Nevertheless, tight interactions are observed within the 
networks (Figure 4.17c, inset) that, by neutralizing individual charges and restricting hydration, 
may assist the hydrophobic isoprenoids to bind. The charged networks may also be involved in 
coupling ubiquinone reduction to proton translocation. Carboxylate residues on the ND1-
TMH5-6 loop (that becomes disordered in the de-active state, but exhibits similar 
conformations in the active mouse and bovine, porcine, human and T. thermophilus structures) 
contribute to the ‘E-channel’ (Baradaran et al., 2013; Guo et al., 2017; Wu et al., 2016; Zhu et 
al., 2016) (Figure 4.17c), which connects them (and thus the ubiquinone-binding site) to the p-
bulge in ND6-TMH3 and two glutamates in ND4L, presenting a route for energy transfer to the 
chain of charged residues through ND2, ND4 and ND5. 
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4.11 p-helices in ND2, ND4 and ND5 
 
The antiporter-like subunits ND2, ND4 and ND5 contain a common core structure of ten 
TMHs, TMHs 4–13 in ND4/ND5 and 1–10 in mammalian ND2, which lacks three N-terminal 
TMHs (Birrell and Hirst, 2010). For simplicity, the numbering system for ND4/ND5 is used 
throughout. TMHs 4–8 and 9–13 comprise two symmetry-related domains that face opposite 
sides of the membrane in a front-to-back arrangement related by rotation in an axis along the 
membrane domain (Efremov and Sazanov, 2011). As first observed in E. coli complex I 
(Efremov and Sazanov, 2011), symmetry-related TMHs 7 and 12 are discontinuous (interrupted 
in the center by substantial loops), and TMH 8, but not its symmetry-related TMH13, is 
distorted. The six domains of ND2, ND4 and ND5 thus form alternating ‘layers’ of 
interrupted/distorted (7-8 and 12) and continuous-a-helical (4-6 and 9-11) TMHs, along the 
membrane domain (Figure 4.19a). 
 
The distortions in TMH8 of ND2, ND4 and ND5 have been described as p-bulges, although 
the formal (i + 5 ® i) hydrogen-bonding pattern is not always fulfilled in current structures, 
and they are clearly distorted outside the p-bulges also (Figure 4.21a and 4.22 for densities of 
p helices). Formal p-bulges are present in ND2-TMH8 only in the T. thermophilus and human 
respirasome structures (Baradaran et al., 2013; Guo et al., 2017), although the mouse and 
human structures match closely. The p-bulge is centred on Leu131, close to Lys135, a 
conserved charged residue in the central membrane plane (Figures 4.18c and 4.19a). 
Comparison of all available structures, particularly the higher-resolution (£3.3 Å) structures 
from mouse, T. thermophilus and E. coli (Baradaran et al., 2013; Efremov and Sazanov, 2011), 
revealed no substantial differences in ND2-TMH8 or Lys135. In contrast, in ND4-TMH8, 
formal p-bulges are present in a common position in the E. coli, human and ovine structures 
(Efremov and Sazanov, 2011; Fiedorczuk et al., 2016; Guo et al., 2017), with the mouse 
structure matching its human counterpart closely, but differing in the T. thermophilus complex 
I (Baradaran et al., 2013) (Figure 4.21a). Strikingly, the two p-bulges border a central unwound 
region that contains conserved Lys237 in different positions, rotated around the helical axis 
(Figure 4.21a). In ND5-TMH8, formal p-bulges were detected centred on His248, a further 
conserved residue, in the mouse, porcine, E. coli and T. thermophilus structures (Baradaran et 
al., 2013; Efremov and Sazanov, 2011; Wu et al., 2016a) (Figure 4.21a). The position of His248 
varies, although the positions of Pro242 and Phe258 are conserved to each side.  
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Figure 4.21b compares the positions of the conserved charged residues in ND2, ND4 and ND5, 
and Figure 4.19c and 4.20 shows how they form a chain along the membrane domain. In each 
subunit a His residue on the loop in interrupted-TMH7 points outside the subunit (Figure 4.19c, 
grey labels) [ND4-His213 interacts with ND5-Asp554 on the transverse helix, clasping it 
against ND4]. Glutamate residues on TMH5 may be stabilized electrostatically by charged 
residues on interrupted-TMH7 and -TMH12 (Figure 4.19c, red labels). ND2-Lys135 and ND4-
Lys237 (Figure 4.19c, blue labels) are on TMH8 but not conserved in ND5. Instead, ND5-
His248 on TMH8 is positioned, like ND4-His220, closer to the matrix side of the membrane, 
suggesting a role in proton uptake. Further residues, not conserved in all three subunits, 
contribute additional stepping stones along the domain (Figure 4.19c, black labels).  
 
Finally, the ND5 transverse helix, which runs alongside ND5, ND4 and ND2 (Figure 4.9), has 
been suggested to form an important coupling element for energy transfer (Efremov and 
Sazanov, 2011). It contains a substantial stretch of p-helix in the mouse structure (Figure 
4.21b), and also in the porcine and E. coli structures (in which the C-termini of ND5 are clearly 
resolved) (Efremov and Sazanov, 2011; Wu et al., 2016). However, in T. thermophilus complex 
I (Baradaran et al., 2013), except for a short distortion at the start, the transverse helix is a-
helical throughout. Despite these differences, the position of Asp554 is conserved and the 
whole transverse helix extends the same distance in each case — due to its different structures 
















Figure 4.19: Charged residues and discontinuous and p-helices in subunits ND2, ND4 and 
ND5. (a) Overview of subunits ND2, ND4 and ND5 showing the layered arrangement of core 
TMHs 4 to 13.  TMHs 4 to 6 (red) and 9 to 11 (magenta) are a helical whereas TMH7 is 
discontinuous and TMH8 contains p-helical structure (cyan) and TMH12 (blue) is also 
discontinuous. The transverse helix from ND5 is also shown. (b) Overlay of conserved charged 
residues in the central membrane plane in ND2, ND4 and ND5. A cartoon representation of 
ND4 is shown for reference, and conserved residues are coloured cyan for ND2, green for ND4 
and pink for ND5. Numbers refer to ND4, except for residues only in ND5 numbered in grey. 
(c) The distribution of charged residues and helical elements along the membrane arm with 
key residues labelled and the distances between ionizable groups shown in Å. TMH7 and 12 




Figure 4.20: Densities of discontinuous and p-helices in subunits ND2, ND4 and ND5. 
Densities were carved at 3 Å at a threshold of 0.067. key residues are labelled. TMH7 and 









Figure 4.21 Comparison of p-helices in subunits ND2, ND4 and ND5 in mammalian and 
bacterial complex I structures. (a) TMH8 in ND2, ND4 and ND5 orientated with the 
mitochondrial matrix at the top. (b) Comparison of structures of the transverse helix in ND5 
with TMH16 (the C-terminus) on the right and the conserved aspartate residue indicated. 
Groups of structures have been aligned using the whole subunits structure. The ribbons join 
the Ca atoms together, and each fifth residue is numbered. The approximate positions of 
stretches of p-helix are indicated. The mouse structure is for the active state, the structure of 
T. thermophilus complex I is from 4HEA.PDB (Baradaran et al., 2013) and the structure of the 
membrane domain of complex I from E. coli is from 3RKO.PDB (Efremov and Sazanov, 2011). 
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Figure 4.22: Densities of TMH8 in the active mouse complex I structure. Densities were 



















4.12.1 Resolution-based limitation of previous mammalian structures 
 
 
The architecture of mammalian complex I was first resolved in bovine, and it proved crucial in 
determining the arrangement of some of the supernumerary subunits (Vinothkumar et al., 
2014). The rest of the supernumerary subunits were later assigned when the structures of the 
bovine and ovine complex were resolved (Fiedorczuk et al., 2016; Zhu et al., 2016). In addition, 
the structure of the respiratory supercomplexes (the higher-order organisation of respiratory 
enzymes) were also resolved (Gu et al., 2016; Guo et al., 2017; Letts et al., 2016a; Wu et al., 
2016). 
 
However, with the exception of T. thermophilus and E. coli complex I (Baradaran et al., 2013; 
Efremov and Sazanov, 2011), the medium resolution structures of mammalian complex I have 
hampered structural analysis into key elements that may be involved in catalytic turnover 
(Fiedorczuk et al., 2016; Guo et al., 2017; Letts et al., 2016a; Wu et al., 2016; Zhu et al., 2016), 




The structure of mouse complex I at 3.3 Å resolution, now matching the T. thermophilus 
structure in terms of resolution, has many identifiable features that was only previously inferred 
from mass spectrometry (Carroll et al., 2009), such as the symmetrically demethylated 
modification of Arg85  (see Figure 4.10). This arginine modification is important as it is 
suggested to modulate the midpoint potential of the terminal iron-sulphur cluster of complex I, 
N2 (Hirst and Roessler, 2016). 
 
In addition, a novel density detected in the active site of the nucleoside kinase subunit of 
complex I, NDUFA10, has been modelled as ADP. Comparison with bovine complex I show 
that the nucleotide binding site is precluded by a phosphorylated serine not conserved in the 
mouse enzyme. Despite the nucleotide being bound to the catalytic site of NDUFA10, its bound 
in an inhibitive state, resembling the feedback inhibition state exhibited in the 




Finally, this study has shown that transmembrane helices (TMH) of the mitochondrially 
encoded subunits are able to adopt different confirmations/distortions within the same species 
and between species. For example, TMH3 of ND6 can forms a π-helix from an α-helix upon 
induced de-activation of the mouse enzyme. The π-helix forming TMH3 of ND6 connects the 
ubiquinone binding cavity to the charged residues lining the membrane domain, and therefore 
under catalysis, this may potentially be important in coupling redox reaction at the Q-site to 
proton translocation in the membrane domain. TMH8 in ND2, ND5 and ND4 also form π-
helices, in particular, the ND4 π-helix adopts a different conformation in mouse complex I 
compared to the T. thermophilus enzyme, which may be crucial for proton uptake, as this helix 
is closer to the matrix/cytoplasmic side. 
 
4.12.2 Future prospects  
 
Even at 3.3 Å, the resolution is still limited as water molecules are not clearly resolved and 
therefore cannot be assigned in the structure. Water molecules are essential in proton 
conductance in complex I; however, their presence has only been predicted but never visualised 
(Sharma et al., 2015). Therefore in order to improve the resolution of complex I, the purified 
mouse enzyme must be imaged at an even higher magnification than what is used in this study, 
and using the K2 summit camera, as this would improve the detective quantum efficiency at 
higher special frequency (higher resolution) (McMullan et al., 2016). 
 
As all the structures of complex I are in the oxidised state, resolving the structure in the reduced 
state would prove crucial in understanding the catalytic cycle of the enzyme and how key 













Chapter 5: Molecular characterisation of complex I from the 




5.1.1 The NDUFS4 subunit of complex I 
 
NDUFS4 (18 kDa in bovine nomenclature) is a nuclear-encoded supernumerary subunit of 
complex I located in the matrix arm of the enzyme (Figure 5.1). The Ndufs4 gene in mouse is 
made up of 5 exons, encoding a protein of 133 amino acids. NDUFS4 is a highly conserved 
protein and one of three supernumerary subunits (along with NDUFA12 and NDUFS6), that 
are conserved between mammals and the mitochondria-related alphaproteobacterium 
Paracoccus denitrificans (Yip et al., 2011).  
 
 
Figure 5.1: Position of NDUFS4 on complex I. Surface representation of NDUFS4 (green) on 
complex I (wheat). The structure is of the active mouse complex I presented in Chapter 4.  
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Early reports of NDUFS4 in bovine heart mitochondria suggested that it was phosphorylated 
at serine 131 by cAMP-dependent protein kinase (Papa et al., 1996). Others further reported 
that phosphorylation of NDUFS4 in mouse fibroblasts increased rotenone-sensitive oxygen 
consumption (Scacco et al., 2000), thus proposing NDUFS4 phosphorylation has a regulatory 
role for the catalysis of complex I. However, in-depth proteomic analyses of cAMP 
phosphorylation of complex I showed that the phosphorylation site was in NDUFB11 and not 
NDUFS4. The confusion arose because of their similar masses, leading to miss-identification 
of the phosphorylated protein. In spite of this, loss of regulation of NDUFS4 by 
phosphorylation is still mistaken as the cause of complex I deficiencies when the said subunit 
is deleted (Anderson et al., 2008; van den Heuvel et al., 1998). 
 
5.1.2 Mutations in Ndufs4 and associated clinical phenotypes  
 
Pathological mutations in Ndufs4 result in complex I deficiency in humans, and animal models 
(Anderson et al., 2008; Kruse et al., 2008; Petruzzella et al., 2001; Scacco et al., 2003). 
Pathological Ndufs4 mutations result in the loss of protein but are always autosomal recessive, 
meaning both genes have to be affected by a severe phenotype to manifest, resulting in a 
functional knockout of the protein. Patients with these mutations display Leigh syndrome, 
which is an early onset neurodegenerative encephalopathy. Presentation of this disease includes 
symmetrical bilateral lesions in the basal ganglia and other parts of the brain, visible by 
magnetic resonance imaging (Figure 5.2) (Ortigoza-Escobar et al., 2016). Clinical symptoms 
include, but are not limited to, lactic acid accumulation in blood plasma, lethargy, ataxia, loss 
of motor skills, and as the disease progresses, death (Budde et al., 2003; Ortigoza-Escobar et 
al., 2016). 22 reported clinical cases of Ndufs4 mutations have been reviewed in Ortigoza et al, 







Figure 5.2: Magnetic resonance imaging of a cross-section of the brain of a patient with a 
premature stop codon in the Ndufs4 gene (Trp97Ter) display white lesions in the basal ganglia. 
This figure was taken from Ortigoza et al, 2016 (Ortigoza-Escobar et al., 2016). 
 
5.1.3 The Y. lipolytica Ndufs4 deletion strain  
 
The NDUFS4 (NUYM) subunit in the aerobic yeast, Y. lipolytica was removed by deleting the 
entire open reading frame encoding the protein, using homologous recombination (Kahlhöfer 
et al., 2017). As a result of the mutation, complex I content and catalytic activity (NADH:DQ 
oxidoreduction) in mitochondrial membranes is significantly diminished when compared to its 
wild type counterpart. Interestingly, complex I from the knockout strain appears intact on BN-
PAGE. This is in contrast to human and mouse models that lack NDUFS4, in which 
subassemblies of complex I are observed alongside the intact enzyme (Calvaruso et al., 2012; 
Ugalde et al., 2004). Electrophoretic analyses of purified complex I from the mutant strain 
revealed the presence of NDUFAF2 (N7BML), which is a putative assembly factor of complex 
I (Kahlhöfer et al., 2017).  However, this assembly factor was detected at a substoichiometric 
level in the purified sample, making its role unclear in the mutant strain. Comparison of the 
EPR spectra of the iron-sulphur clusters between the wild type and knockout strain, showed 
that the absence of NDUFS4 results in their decreased signal, in particular, N1b. This means 
that the clusters of complex I are not as readily reduced in the knockout strain when compared 
to its wild type counterpart. Surprisingly, the flavin site activity (using HAR) of both strains 
were essentially indistinguishable despite a reduction in NADH:DQ activity, suggesting a 
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problem with intramolecular electron transfer. Although the study provided plenty of 
information regarding how NDUFS4 deletion affects complex I content and activity, the yeast 
model system is limited and cannot fully recapitulate the effects seen in mammals (Kruse et al., 
2008). 
 
5.1.4 A mouse model with an Ndufs4 deletion 
 
In order to generate a mouse model based on the human mutations of Ndufs4, the second exon 
of Ndufs4 was removed by Cre Recombinase-mediated  homologous recombination (using 
exon 2 flanking loxP sites), resulting in a gene only coding for the first 14 amino acid residues 
of the mitochondrial targeting sequence (Kruse et al., 2008). NDUFS4 could not be detected 
by Western blotting when both copies of the gene were affected, therefore the mouse model is 
essentially an NDUFS4 knockout or an Ndufs4 (-/-), (which is similar to humans with mutations 
in NDUFS4). Mice with the mutation presented signs of neurodegeneration, including lethargy, 
ataxia, and loss of motor skills. Similar to humans, the progression of the disease resulted in 
early death compared to wild type mice (~50 days). The Ndufs4 (-/-) mice model is able to 
broadly recapitulate the effects seen in humans with mutations in Ndufs4.  
 
Complex I from mice with NDUFS4 absent had a reduced NADH:DQ activity and content in 
mitochondria, as with human patients with mutations in the gene (Antonicka et al., 2003; Kruse 
et al., 2008; Ugalde et al., 2004). Moreover, there have been some reports of the visualisation 
of a stalled complex I assembly intermediate (~830 kDa) by BN-PAGE in the Ndufs4 (-/-) 
mouse model (Calvaruso et al., 2012; Valsecchi et al., 2012), also observed in humans (Ugalde 
et al., 2004). As this observed putative assembly intermediate did not contain the flavoprotein 
domain (site of NADH oxidation). It was reasoned that NDUFS4 may be required for the 
assembly of the enzyme (Calvaruso et al., 2012).  
 
5.1.5 Deletion of Ndufs4 in Arabidopsis thaliana 
 
As with mice and aerobic fungi, the Ndufs4 gene was also deleted in A. thaliana to observe the 
effect it would have on complex I assembly (Meyer et al., 2011). In the Ndufs4-deleted plant 
strain, there was no detectable flavin-sensitive NBT staining by BN-PAGE analysis, meaning 
no mature complex I was present for that strain. This is dissimilar to the Ndufs4 (-/-) fungus and 
mice strain where although complex I content is reduced, the intact enzyme could still be 
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detected by BN-PAGE analysis (Calvaruso et al., 2012; Kahlhöfer et al., 2017). Moreover the 
sub-assembly of complex I contained mostly proteins from the membrane arm, indicating that 
its assembly may differ from that of the mouse enzyme, where the corresponding deletion 
results in the detection of a larger subcomplex containing both the membrane arm and lower 
half of the matrix arm (Calvaruso et al., 2012). 
 
 
5.1.6 Potential therapies  
 
Ndufs4 (-/-) mice treated with rapamycin, an inhibitor of the mechanistic target of rapamycin 
(mTOR), showed improved longevity, and an ameliorated neurological disorder compared to 
the untreated Ndufs4 (-/-) mice (Johnson et al., 2013). It was suggested that a rewiring of 
metabolism resulted in a decrease in glycolysis and catabolism, preventing the build of excess 
glycolytic intermediates in mice. However, treatment with rapamycin retarded the growth of 
the mice and in addition, because of the short half-life of rapamycin in the blood meant that 
daily treatment with the drug was required. 
 
A genome-wide editing study (Cas9 mediated) on cell lines treated with antimycin A (an 
inhibitor of complex III) showed that deletion of von Hippel-Lindau (VHL), a ubiquitin ligase, 
is protective against defects in the respiratory chain by an increase in cell growth compared to 
control cells (Jain et al., 2016). Under normoxia (~20% oxygen), the hypoxia-inducible 
transcription factors (HIFs), which are responsible for the hypoxic response, are constitutively 
made and marked for degradation by VHL, but under hypoxia, HIFs are stabilised and are 
transcriptionally active resulting in the up-regulation of hypoxia-dependent changes (Choudhry 
and Harris, 2018). To investigate whether there was a link between hypoxia and protection 
against respiratory defects, Ndufs4 (-/-) mice were subjected to chronic hypoxia (~11% oxygen) 
and as a result, mice survived for longer, displayed normal growth and showed few neurological 
symptoms, making it phenotypically indistinguishable from wild type mice (Jain et al., 2016). 
Later work even showed a reversal of brain lesions after hypoxic exposure (Ferrari et al., 2017). 
Attempts to inhibit VHL in mice in order to initiate the hypoxic response (to alleviate some of 
the symptoms of the Leigh-like syndrome) were unsuccessful because of obstruction of drug 
delivery to the central nervous system by the blood-brain barrier (Jain et al., 2016). Although 
hypoxia therapy appears effective in alleviating neurological symptoms for this mouse model, 
 148 
application of this treatment must be tried in other mitochondrial disease models that affect 
respiration before trials on humans can begin. 
 
Logically, the most reasonable treatment for the Ndufs4 deletion is to re-introduce the missing 
subunit to all tissues. Introducing a viral vector carrying the human version of Ndufs4 gene into 
Ndufs4 (-/-) mice, restored complex I in liver mitochondria and partially alleviated the clinical 
phenotype (Di Meo et al., 2017). The main problem encountered in this study was the uniform 
delivery of the viral vectors to all tissues. In particular, the blood-brain barrier obstructs the 



















5.2 Aims of this chapter 
 
The work in this chapter aimed to: 
 
• Using a proteomic approach, establish whether the absence of NDUFS4 affects the 
maturation of complex I. 
• Characterise complex I from the Ndufs4 (-/-) mice, in order to understand the underlying 





















5.3 Genotyping Ndufs4 mice 
 
The severity of Ndufs4 (-/-) mice phenotype makes breeding from (-/-) breeding pairs unfeasible, 
therefore, in order to maintain a progeny with the Ndufs4 disruption, a heterozygous breeding 
pair is required Ndufs4 (+/-). This theoretically results in a progeny that is 50% (+/-), 25% (+/+) 
and 25% (-/-) for NDUFS4, according to Mendelian genetics. Prior to any characterisation of 
complex I from mice, the status of disruption of Ndufs4 from the genome of mouse pups had 
to be confirmed. Genomic DNA was extracted from mouse ear biopsy tissue using a Maxwell® 
16 DNA Purification Kit according to the manufacturer’s protocol. Thereafter, DNA regions 
were amplified using PCR, with the DNA primers used and the conditions for the reaction 
described in detail in Chapter 2.2. The resulting products were analysed by agarose gel 
electrophoresis (Figure 5.3). The presence of Ndufs4 exon 2 was confirmed by amplification of 
a genomic region, resulting in a single band ~150 base pairs in size (Figure 5.3a). Similarly, 
disruption of Ndufs4 exon 2 was confirmed by amplification of a product that is ~200-300 base 
pairs in size (Figure 5.3b). A simplified scheme of both reactions is shown in figure 5.3c. Based 
on complementary information from both reactions, mice were genotyped heterozygous Ndufs4 
(+/-), homozygous Ndufs4 (-/-) or wild type Ndufs4 (+/+). Furthermore, the genotyping was 
confirmed for Ndufs4 (-/-) mice, as they display a severe phenotype (growth and mobility 
defects) compared to wild type Ndufs4 (+/+) and heterozygous Ndufs4 (+/-) mice, which 




Figure 5.3: Genotyping mice (ear biopsy) for Ndufs4 deletion. PCR and electrophoresis were 
carried out as described in Chapter 2.2. PCR products (5 µl) were separated by agarose gel 
electrophoresis, then DNA products were stained with ethidium bromide and visualised using 
a Biorad imaging system. Known DNA markers (in base pairs) were loaded for reference. The 
same genomic DNA was used for both PCR, to confirm the presence (a) or absence (b) of 
Ndufs4 exon 2. (c) A scheme of both reactions resulting in the genotyping mice as 
heterozygous Ndufs4 (+/-), homozygous Ndufs4 (-/-) or homozygous Ndufs4 (+/+). Exons, LoxP 
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5.4 Analyses of Ndufs4 (-/-) membranes 
 
First mitochondria and then membranes were prepared from Ndufs4 (-/-) heart as described for 
Ndufs4 (+/+) in Chapter 2.4. As Ndufs4 (-/-) mice suffer from complex I deficiency, with an 
associated decrease in mitochondrial quality compared to Ndufs4 (+/+) (Kruse et al., 2008), 
solubilised membrane protein (1% DDM) from both strains were compared by BN-PAGE 
(Figure 5.4). In agreement with previous studies, intact complex I was significantly reduced in 
Ndufs4 (-/-) membranes compared to the Ndufs4 (+/+) membranes, while the amount of the other 




Figure 5.4: Comparative BN-PAGE of Ndufs4 (-/-) and Ndufs4 (+/+) membranes. Membranes 


















Catalytic activities were also measured for Ndufs4 (-/-) mouse membranes and compared to 
Ndufs4 (+/+) mouse membranes (as described in Chapter 2.6). Complex I-dependent NADH:O2 
measurements (catalysis by complexes I, III and IV) of Ndufs4 (-/-) membranes showed only 
10% of the catalytic activity of Ndufs4 (+/+) membranes, as expected for a complex I-deficient 
strain. This result is consistent with the decrease in complex I observed by BN-PAGE (Figure 
5.4). Complex I-independent succinate:O2 rates (catalysis by complexes II, III and IV) were 
essentially the same for Ndufs4 (-/-)  membranes and Ndufs4 (+/+) membranes, confirming that, 
for the knockout, complex I is rate limiting for catalysis (Table 5.1). However, relative NADH 
oxidation activities that measure the rate of flavin-site reactions of Ndufs4 (-/-) membranes 
compared to Ndufs4 (+/+) membranes varied substantially with the oxidising substrate used 
(FeCN, HAR and APAD).  The relative activities of Ndufs4 (-/-) membranes to Ndufs4 (+/+) 
were 6% with HAR, 16% with FeCN and 25% with APAD (Table 5.1). Although the flavin-
site assays are in agreement with the result from BN-PAGE (Figure 5.4), in which complex I 
is markedly reduced in Ndufs4 (-/-)  membranes, the inconsistency in the relative activities, 
coupled with the different mode of action by the artificial substrates used (Birrell et al., 2011, 
2009), suggests that in addition to reduced abundance, there is a change in the flavin-site 
characteristics of the enzyme as a result of the subunit deletion.  
 
As complex I is the main source of reactive oxygen species in mitochondrial membranes (Pryde 
and Hirst, 2011), mutations in complex I are often correlated with increased superoxide 
production. H2O2 production in membranes, which is a product of the rapid dismutation of 
superoxide, was measured by monitoring the oxidation of Amplex Red to resorufin (Table 5.1). 
Interestingly, H2O2 production by Ndufs4 (-/-) membranes was 65% of that of Ndufs4 (+/+) 
membranes. H2O2 is also produced by the flavin-site, so this is inconsistent with the range of 
relative activities (6-25%) observed in the other flavin-site reactions (Table 5.1). Considering 
membranes contain a complicated mixture of proteins, not all of the reactive oxygen species 
produced may be attributed to complex I, particularly in the case of Ndufs4 (-/-) membranes, 
with reduced complex I content.  Alternatively, there could also be a change in the flavin-site 
characteristics as a result of the subunit deletion. 
 
Finally, hydrolysis of ATP by F1FO-ATPase was measured in membranes, and it was observed 
that the activity of Ndufs4 (-/-) membranes is noticeably lower than Ndufs4 (+/+) membranes 




(µmol min-1 mg-1) Ndufs4 (




NADH:O2 0.15 ± 0.002 1.47 ± 0.08 10 
Succinate:O2 1.18 ± 0.04 1.22 ± 0.02 97 
ATP hydrolysis 2.58 ± 0.02 3.82 ± 0.07 68 
H2O2 2.28×10-3 ± 0.06×10-3 3.53×10-3 ± 0.12×10-3 65 
FeCN 0.83 ± 0.03 5.13 ± 0.07 16 
HAR 0.35 ± 0.02 5.71 ± 0.06 6 
APAD 0.19 ± 0.006 0.75 ± 0.02 25 
Table 5.1: Enzymatic activity measurements on Ndufs4 (-/-) and Ndufs4 (+/+) mouse 
membranes. Enzymatic activity measurements were carried as described in chapter 2.6. The 
rates presented for Ndufs4 (+/+) membranes are taken from Table 3.2. The data are presented 
as mean values with standard error of the mean (n ≥ 3). 
 
The catalytic activities measured in Table 5.1 in conjunction with BN-PAGE evidence suggest 
that both complex I amount and catalytic function is severely affected as a result of the subunit 
deletion. To investigate whether the altered flavin-site reactions in Ndufs4 (-/-) membranes 
result from a structural rearrangement of the enzyme (for example stalled assembly 
intermediates), membranes from both strains were analysed and compared using the proteomic 
BN-PAGE complexome profiling technique as described in detail in Chapter 2.9.6 (Figure 5.5) 
(Heide et al., 2012). In brief, membranes were solubilised by 1% DDM, then the solubilised 
proteins were separated by BN-PAGE and stained with Coomassie Blue. Thereafter, the gel 
was excised into 64 equal-sized slices for tryptic digestion, and the resulting peptides were 
sequentially analysed by LC-MS.  
 
In agreement with previous analysis (Figure 5.4), the BN-PAGE showed a reduced complex I 
content in Ndufs4 (-/-) membranes compared to Ndufs4 (+/+) membranes, but similar amounts 
for the other oxidative phosphorylation enzymes (Figure 5.5a, b).  
 
To gain insight into new interactions between complex I and other proteins as a result of the 
knockout, hierarchical clustering of proteins was carried out, based on migration pattern on the 
gel (Heide et al., 2012). In essence, the three top scoring peptides for each protein from the LC-
MS analyses were chosen as representative peptides for the same protein. For proteins detected 
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in the gel slices, normalised scores were assigned based on their maximum scores along the 
gel, visualised with the corresponding heatmap (Figure 5.5a, b). The heatmap was filtered to 
highlight credible protein interactions with complex I (i.e. known assembly factors) in Ndufs4 
(-/-) membranes, using the following criteria:  
 
• A similar migration pattern of proteins to known complex I subunits.  
• A change in the migration pattern of proteins along the gel in Ndufs4 (-/-) membranes 
compared to Ndufs4 (+/+) membranes, signifying a functional change in proteins not 
affected by gel electrophoresis. 
• An apparent increase in the amount of proteins in Ndufs4 (-/-) membranes compared to 
Ndufs4 (+/+) membranes, indicating their importance in the knockout. 
 
As observed in the heatmaps, 41 out of 44, and 39 out of 43 (minus NDUFS4) unique subunits 
of complex I were detected in the analyses of Ndufs4 (+/+) membranes and Ndufs4 (-/-) 
membranes, respectively (Figure 5.5a, b). ND6, ND3 and ND4L were not detected in either 
membranes (evident by their absence in both heatmaps), owing to the few tryptic cleavage sites 
present in those subunits. In the heatmaps, NDUFB5 shows aberrant migration patterns from 
the rest of the complex I subunits by appearing at a higher molecular position on the gel, in 
both Ndufs4 (-/-) and Ndufs4 (+/+) membranes, suggestive of a BN-PAGE artefact. ND1 appears 
to only migrate with the complex I cluster (slice 23 in heatmap) in Ndufs4 (-/-) membranes, but 
not with complex I (slice 21 in heatmap) in Ndufs4 (+/+) membranes (Figure 5.5a, b). However, 
because of the poor tryptic peptides produced from ND1, its detection is likely masked by 
complex I subunits rich in tryptic peptides (especially in Ndufs4 (+/+) membranes where 
complex I content is high). NDUFC1 was not detected in Ndufs4 (-/-) membranes, unlike in 
Ndufs4 (+/+) membranes. NDUFC1 has few tryptic peptides, making it difficult to detect, 
particularly if the complex I content is reduced.  
 
As observed on the heatmaps, there are three significant complex I clusters in Ndufs4 (+/+) 
membranes and Ndufs4 (-/-) membranes, respectively (Figure 5.5). The highest of those 
complex I clusters on the gel correspond to intact complex I for both samples. The intact 
complex I cluster is the least abundant in Ndufs4 (-/-) membranes, as observed by its weak 
intensity on the heatmap (Figure 5.5b). For Ndufs4 (-/-) membranes the second cluster (main 
cluster) appears in the same position as complex V on the gel (slice 24 on the heatmap); it is 
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termed the 830 kDa complex following previous nomenclature (Ogilvie et al., 2005), and 
contains 30 of the 44 unique subunits of complex I. The 830 kDa complex comprises the 
membrane domain and most of the quinone domain (Q-domain), with the exception of 
NDUFA7, which is mostly detected in slice 58 on the heatmap (Figure 5.5b). According to the 
heatmap, the 830 kDa complex also lacks the flavin domain (N-domain), therefore it cannot 
carry out NADH oxidation, making it undetectable with NBT staining (see Figure 5.9). Lastly, 
the smallest complex I cluster of Ndufs4 (-/-) membranes, which happens to co-migrate with 
complex IV on the gel (slice 37) is termed the flavin complex. It contains 5 of the 44 unique 
subunits of complex I, and 5 of the 7 flavin domain proteins (NDUFV3, NDUFV2, NDUFV1, 
NDUFS1 and NDUFA2), with NDFS6 and NDUFA12 migrating on the gel at slice 55 and 41 
respectively.  
 
Of the known complex I assembly factors considered (NDUFAF1, NDUFAF2, NDUFAF3, 
NDUFAF4, NDUFAF5, NDUFAF6, FOXRED1, NUBPL, ACAD9, ECSIT, TMEM70, 
TMEM126A, TMEM126B and TIMMDC1), none were found to cluster with complex I in 
Ndufs4 (+/+) membranes (5.5a). For Ndufs4 (-/-) membranes, only NDUFAF2 and ACAD9 
appear to co-migrate with the 830 kDa complex on the gel (5.5b). ACAD9 and NDUFAF2 are 
early and mid-late stage assembly factors, respectively (Andrews et al., 2013; Guerrero-Castillo 
et al., 2016): they are considered to dissociate from the complex I during attachment of the N-
domain, consistent with their absence from both the full complex I and the flavin complex. A 
summary of peptide scores and coverages for the LC-MS analyses are given in (Table 5.2).  
 
Ndufs4 (-/-) complex I appears as three separate assemblies on BN-PAGE, an intact complex, 
an 830 kDa complex (without the flavin domain) and a flavin domain complex. In addition, 
two known complex I assembly factors, NDUFAF2 and ACAD9, were found to co-migrate 
with complex I. Therefore, in order to determine whether these observations are substantial or 




Figure 5.5: Complexome profiles of Ndufs4 (-/-) and (+/+) solubilised membranes. 20 µg of 
solubilised Ndufs4 (+/+) membranes (a) and Ndufs4 (-/-) membranes (b) were separated by BN-






































































































































































































































NDUFV3 NDUFV2 NDUFV1 
NDUFS1 NDUFA2 NDUFS6 
NDUFS4 NDUFA12 NDUFA7 
NDUFA6 NDUFA9 NDUFA5 
NDUFS2 NDUFS3 NDUFS8 
NDUFS7 NDUFS5 NDUFC2 
NDUFC1 NDUFB9 NDUFB8 
NDUFB7 NDUFB6 NDUFB5 
NDUFB4 NDUFB3 NDUFB2 
NDUFB11 NDUFB10 NDUFB1 
NDUFA8 NDUFA3 NDUFA13 
NDUFA11 NDUFA10 NDUFA1 
ND5 ND4 ND2 
ND1 NDUFAB1  
Intact complex I 
Intact complex I 
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Figure 5.5: continued. The gel lanes were then cut into 64 equal-sized slices, followed by 
tryptic digestion and analyses by LC-MS.  Hierarchal clustering of proteins was carried out 
according to previous work by Dr Mike Harbour (Heide et al., 2012). The heat map indicates 
the migration pattern of proteins and their relative abundance in the gel.  Different domains 
of complex I detected in the analyses are coloured to correspond with the mouse active 
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NDUFA1 1 14% 136 1 14% 108 
NDUFA2 7 55% 293 6 42% 274 
NDUFA3 4 51% 241 4 51% 143 
NDUFA5 6 44% 668 9 62% 772 
NDUFA6 9 61% 635 8 56% 492 
NDUFA7 7 55% 435 11 57% 513 
NDUFA8 7 40% 395 8 40% 419 
NDUFA9 21 74% 1420 22 77% 1530 
NDUFA10 13 46% 972 16 53% 1845 
NDUFA11 3 10% 256 2 9% 222 
NDUFA12 10 57% 804 5 30% 260 
NDUFA13 11 63% 1244 15 87% 817 
NDUFAB1 5 46% 106 2 20% 115 
NDUFB1 3 34% 122 2 32% 96 
NDUFB2 2 12% 28 2 12% 46 
NDUFB3 3 34% 244 4 34% 320 
NDUFB4 8 54% 303 9 73% 308 
NDUFB5 9 44% 462 8 44% 389 
NDUFB6 11 65% 488 9 73% 370 
NDUFB7 5 34% 947 6 45% 893 
NDUFB8 6 51% 392 6 51% 586 
NDUFB9 7 53% 447 7 45% 431 
NDUFB10 8 45% 677 8 45% 549 
NDUFB11 7 59% 838 7 48% 680 
NDUFC1 1 78% 134 - - - 
NDUFC2 8 54% 269 9 51% 269 
NDUFS1 29 43% 2343 35 54% 2868 
NDUFS2 19 61% 1573 19 64% 1766 
NDUFS3 14 50% 814 13 48% 740 
NDUFS4 8 65% 400 - - - 
NDUFS5 4 39% 266 5 39% 277 
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NDUFS6 4 39% 479 5 46% 318 
NDUFS7 9 36% 390 7 21% 512 
NDUFS8 7 32% 278 9 46% 448 
NDUFV1 14 33% 731 20 40% 796 
NDUFV2 11 53% 1165 10 48% 912 
NDUFV3 4 36% 182 4 38% 204 
ND1 4 11% 367 3 11% 289 
ND2 3 15% 279 3 14% 261 
ND3 - - - - - - 
ND4 7 22% 663 5 13% 512 
ND4L - - - - - - 
ND5 6 12% 880 7 14% 422 
ND6 - - - - - - 
ACAD9 7 13% 330 9 16% 428 
NDUFAF2 2 13% 56 13 72% 425 
Table 5.2: LC-MS peptide-based protein identifications for complexome profiling (Figure 
5.5). The number of peptides detected from each subunit is given together with the sequence 
coverage of the mature protein. The score given for each subunit is the sum of the peptide 
















5.5 Purification of complex I from Ndufs4 (-/-) mouse membranes 
 
Complex I from Ndufs4 (-/-) membranes was enriched using an anion exchange column 
according to the protocol described for Ndufs4 (+/+) complex I in Chapter 2.7 First, membranes 
were solubilised in 1% DDM, centrifuged, then the supernatant was loaded onto a HiTrapTM Q 
HP column. The complexes were eluted by increasing the salt concentration and complex I-
containing fractions (Anion-exchange elution profile of Ndufs4 (-/-) complex I was initially 
determined by Western blotting: data not shown) were collected and concentrated for further 
purification (Figure 5.6). Interestingly, the Ndufs4 (-/-) complex I elutes in 350 mM NaCl, 
similar to Ndufs4 (+/+) complex I, so the subunit deletion has little effect on the anion-exchange 
elution profile of the enzyme. 
 
 
Figure 5.6: Purification of Ndufs4 (-/-) mouse complex I using anion-exchange 
chromatography. The Äkta micro system and the attached 1 mL HiTrapTM Q HP column were 
washed and equilibrated at a flow rate of 0.3 mL min-1 with buffer A (20 mM Tris-HCl pH 7.14 
at 23 °C, 1 mM EDTA, 0.1% DDM, 10% ethylene glycol, 0.005% asolectin and 0.005% CHAPS), 
and proteins were eluted by increasing the proportion of buffer B (buffer A + 1 M NaCl). 
 






























In order to purify complex I further, size-exclusion chromatography was carried out, by 
injecting the pooled and concentrated complex I-containing fractions onto a Superose 6TM 
Increase 3.2/300 column (Figure 5.7a). Complex I elutes at ~1.39 mL, with the tail of the peak 
overlapping with complex IV (main peak at ~1.64 mL). A significant portion of complex IV 
also appears on the shoulder of the main peak (~1.52 mL), presumably a dimer of the complex. 
The relative magnitude of the complex I peak compared to the complex IV peak is reduced 
two-fold for Ndufs4 (-/-) enzyme compared to Ndufs4 (+/+) enzyme. This is suggestive of a 
decrease in complex I content in the knockout, in agreement with BN-PAGE analyses (Figure 
5.7). Moreover, there is a slight shift in the elution volume between Ndufs4 (+/+) complex I 
(1.36 mL) and Ndufs4 (-/-) complex I (1.39 mL), which may be cautiously attributed to a change 
in the hydrodynamic radius of the enzyme as a result of the subunit deletion. Otherwise, the 
purification of Ndufs4 (-/-) complex I is identical to that of Ndufs4 (+/+) complex I, indicating 
Ndufs4 (-/-) complex I is intact. This is in contradiction to the complexome analysis, with three 
complex I assemblies detected in Ndufs4 (-/-) complex I membranes (Figure 5.5b). To assess 
this further, purified Ndufs4 (-/-) complex I was analysed by BN-PAGE (5.7b), and it was found 
that the complex fragments under those conditions. The most prominent complex I band in the 
native gel corresponds in mass to the 830 kDa complex detected during the complexome 




Figure 5.7: Purification of Ndufs4 (-/-) mouse complex I using size-exclusion 
chromatography. (a) The Äkta micro system was operated at a flow rate of 0.03 mL min-1 with 
buffer C (20 mM Tris-HCl pH 7.14 at 23 °C, 10% ethylene glycol, 150 mM NaCl and 0.02% DDM), 
using a Superose 6TM Increase 3.2/300 column. The purification trace for Ndufs4 (-/-) complex 
I is compared to Ndufs4 (+/+) complex I from Figure 3.3 (b Ndufs4 (-/-) complex I (5 µg) and 
bovine membranes were analysed by BN-PAGE (see Chapter 2.5.1).  The asterisk corresponds 
to the 830 kDa complex detected in the complexome analyses (5.5b) 
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5.6 Cross-linking Ndufs4 (-/-) mouse complex I in membranes 
 
Due to the contradictory results obtained, where Ndufs4 (-/-) complex I behaves as an intact 
complex during size-exclusion chromatography (Figure 5.7) but not in BN-PAGE analyses 
(Figure 5.5b), it was proposed that complex I is disassembling during BN-PAGE. To 
investigate the proposal, a water-soluble cross-linker (BS3) that reacts with primary amines 
(lysines and N-terminal amines) using both ends of its structure, releasing an N-
hydroxysulphosuccinimide leaving group (Figure 5.8) (Shi et al., 2017). The BS3 cross-linker 
was chosen because it is specific and the cross-linking distance (~11 Å) is ideal for intra-
complex stabilisation, but not inter-complex cross-linking. Membranes were solubilised as 
usual with DDM detergent at 1%, then BS3 was added and then the complexes analysed by BN-





Figure 5.8: Mechanism of BS3 cross-linker.  Reaction scheme of BS3 with Lysine. This figure 
was taken from Shi et al., (Shi et al., 2017). 
 
Alongside Ndufs4 (-/-) membranes, Ndufs4 (+/+) membranes were also cross-linked to confirm 
that the effects observed are not due to a native gel artefact (Figure 5.9). For Ndufs4 (-/-) 
membranes the amount of intact complex I detected by NADH-sensitive in-gel activity assay 
increases with higher concentrations of cross-linker used. Conversely, Ndufs4 (+/+) complex I 
remains the same with increasing concentration of cross-linker. However, there is an increase 
in the appearance of an NADH:NBT reactive band above complex I with increasing cross-
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linker concentration (Figure 5.9). The identity of this protein is not known. Interestingly, with 
increasing cross-linker concentration, there follows the disappearance of a relatively low 
molecular weight band with in-gel activity (marked with an asterisk), concurrent with the 
increased detection of complex I. This lower molecular weight band corresponds to the flavin 
complex detected in the complexome analysis (Figure 5.5b). In opposition to previous results 
(Antonicka et al., 2003; Calvaruso et al., 2012; Ugalde et al., 2004; Valsecchi et al., 2012), the 
data presented here show that the 830 kDa complex is a result of destabilisation of Ndufs4 (-/-) 
complex I during BN-PAGE, and not a late-stage complex I assembly intermediate. The Ndufs4 




Figure 5.9: BN-PAGE in-gel complex I activity assay of cross-linked solubilised mouse 
membranes. Solubilised membranes (30 µg) incubated in various concentrations of BS3 cross-
linker were separated by BN-PAGE, and complex I was stained with 0.5 mg mL-1 and 100 µM 
NADH in 20 mM Tris-HCl pH 7.55 at 32 °C. Ndufs4 (+/+) and Ndufs4 (-/-) solubilised membranes 
are indicated by WT and KO, respectively. The asterisk indicates the position of the flavin 




0.1 mM BS3 0.2 mM BS3 0.5 mM BS3 1 mM BS3
*
WT KO WT KO WT KO WT KO WT KO
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5.7 Protein analyses of purified Ndufs4 (-/-) mouse complex I 
 
To determine whether Ndufs4 (-/-) complex I has any assembly factors bound, or whether any 
subunits were dissociated during purification, as is the case for BN-PAGE, the protein content 
was analysed by mass spectrometry (the methods of which are described in Chapter 2.9). 
 
Purified Ndufs4 (-/-) complex I was separated by SDS-PAGE, and then stained with Coomassie 
R-250 to visualise the proteins (Figure 5.10). The gel lane was cut into equal-size slices and 
then digested with trypsin. The resulting peptides were used to identify proteins by peptide 
mass fingerprinting using a MALDI TOF/TOF mass spectrometer (Figure 5.10 and Table 5.3). 
26/43 unique subunits of Ndufs4 (-/-) complex I were identified using this method, with 8 and 
18 being core and supernumerary subunits respectively. This is in contrast to Ndufs4 (+/+), 
where 33 subunits of complex I were identified (Figure 3.6 and Table 3.5). The subunits that 
are detected in Ndufs4 (+/+) complex I, but not in Ndufs4 (-/-) complex I, are NDUFAB1, 
NDUFB5, NDUFB6, NDUFB7, NDUFS5, NDUFS8, NDUFV2 and NDUFV3 (Table 5.3). 
These subunits are distributed in both the membrane and peripheral domains. Therefore, a lack 
of detection of those subunits probably reflects a general destabilisation of the enzyme. The 
assembly factors ACAD9 and NDUFAF2 were both identified, however, the sequence 
coverage of the former is low. Taking into account that ACAD9 is rich in suitable tryptic 
peptides, its low sequence coverage suggests it is a minor component in this preparation. 
Further protein contaminants in the preparation were also detected by MALDI TOF/TOF mass 
spectrometry, (Table 5.4), but are not considered relevant because they are not complex I-
associated proteins. 
 
To confirm the results obtained from the MALDI TOF/TOF analyses, the purified sample was 
subjected to tryptic digestion followed by analyses using LC-MS.  38 complex I subunits were 
detected, of which 10 were core subunits and 28 were supernumerary subunits (Table 5.3). The 
absence of particular subunits (NDUFAB1, NDUFB5, NDUFB6, NDUFB7, NDUFS5, 
NDUFS8, NDUFV2 and NDUFV3) in the MALDI TOF/TOF analyses but their detection by 
LC-MS suggests that they may be substoichiometric components, consistent with the Ndufs4 (-
/-) complex I being destabilised. Assembly factors ACAD9 and NDUFAF2 were also detected, 
with low and high sequence coverage respectively. However, it is possible that the detected 
assembly factors are contaminants and not complex I-associated proteins.  
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Finally, in order to observe whether any complex I subunit modifications have changed as a 
result of the subunit deletion, subunit masses were measured by ESI-MS.  Assignment of the 
masses to subunits of complex I were aided by previous bovine work (Carroll et al., 2009) and 
Ndufs4 (+/+) complex I measurements (Figure 3.7 and Table 3.7). 34 complex I subunits Ndufs4 
(-/-) were assigned to their respective masses (Figure 5.11 and Table 5.5). There are no 
differences in the post-translation modifications between complex I from both strains. Masses 
corresponding to ACAD9 and NDUFAF2 were not measured, suggestive that these are either 
minor components in the preparation or they are more difficult to detect.  
 
Using mass spectrometry, 41/43 unique subunits of Ndufs4 (-/-) complex I were identified, 
consistent with complex I being intact. However, the lower detection of several subunits 
suggests the enzyme is unstable and loses some of its subunits during purification. Although 
NDUFAF2 was detected in the purified complex I in ΔNdufs4 Y. lipolytica (Kahlhöfer et al., 






Figure 5.10: SDS-PAGE analysis of purified Ndufs4 (-/-) mouse complex I. Complex I subunits 
(5 µg) were separated by SDS-PAGE and then stained by Coomassie Blue. Subunits were 
identified by peptide mass fingerprinting using a MALDI-TOF/TOF mass spectrometer. 
Assembly factors are displayed in red text. * Indicates proteins not considered to be 















































Subunit Number of residues 









NDUFA1 70 2 18% 52/33 6 42% 140 
NDUFA2 98 5 38% 243/32 9 71% 212 
NDUFA3 83 3 32% 40/33 4 51% 97 
NDUFA5 115 3 31% 109/33 10 64% 433 
NDUFA6 130 3 26% 148 19 88% 710 
NDUFA7 112 - - - 18 86% 756 
NDUFA8 171 4 26% 127/32 12 52% 423 
NDUFA9 342 11 39% 596/34 25 71% 1331 
NDUFA10 320 11 46% 600/33 20 45% 896 
NDUFA11 140 - - - 2 10% 194 
NDUFA12 145 - - - 14 83% 615 
NDUFA13 143 5 30% 230/33 20 82% 1426 
NDUFAB1 88 - - - 1 20% 71 
NDUFB1 56 4 62% 123/33 5 51% 82 
NDUFB2 72 2 12% 70/32 1 12% 41 
NDUFB3 103 2 14% 39/33 5 33% 115 
NDUFB4 128 7 53% 302/32 17 70% 601 
NDUFB5 143 - - - 9 46% 412 
NDUFB6 127 - - - 15 76% 404 
NDUFB7 136 - - - 5 45% 479 
NDUFB8 157 5 45% 273/32 9 51% 550 
NDUFB9 178 3 24% 74/32 16 66% 467 
NDUFB10 175 1 8% 54/32 11 55% 520 
NDUFB11 122 - - - 11 69% 521 
NDUFC1 49 - - - - - - 
NDUFC2 120 3 17% 126/32 12 60% 359 
NDUFS1 704 9 13% 227/33 44 48% 2754 
NDUFS2 430 11 33% 479/34 23 52% 1063 
NDUFS3 228 6 30% 336/33 18 53% 978 
NDUFS4 133 - - - - - - 
NDUFS5 105 - - - 10 46% 244 
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NDUFS6 96 4 39% 189/33 6 60% 518 
NDUFS7 189 5 17% 199/33 10 36% 441 
NDUFS8 178 - - - 9 40% 228 
NDUFV1 444 10 27% 475/34 24 43% 1039 
NDUFV2 217 - - - 13 51% 955 
NDUFV3 69 - - - 6 68% 142 
ND1 318 - - - 3 8% 140 
ND2 345 1 4% 61/32 - - - 
ND3 115 - - - - - - 
ND4 459 3 7% 112/34 3 7% 118 
ND4L 98 - - - - - - 
ND5 607 1 2% 50/32 5 8% 253 
ND6 172 - - - - - - 
ACAD9 625 2 4% 54/33 4 8% 196 
NDUFAF2 168 4 23% 157/34 11 71% 342 
Table 5.3: Peptide-based protein identification of the composition of Ndufs4 (-/-) complex I. 
The number of peptides detected from each subunit is given together with the sequence 
coverage of the mature protein (number of residues column). For the two analytical methods, 
the score given for each of the subunits is the sum of the peptide score with denominator 















Protein Number of residues 
MALDI TOF/TOF MS/MS 
Number of 
peptides Sequence coverage Score 
OGDH 1019 7 9% 265/33 
SLC4A1 929 4 5% 193/33 
HSPA9 679 3 6% 98/32 
ACADVL 634 10 22% 407/33 
ATP5A1 503 8 24% 379/33 
DLD 509 3 4% 168/32 
ATP5B 529 6 17% 221/32 
DLST 454 3 4% 62/32 
COX1 514 1 1% 49/33 
VDAC1 283 3 20% 83/34 
PHB 272 6 28% 135/32 
COX4I1 169 6 30% 208/34 
GM11273 129 2 14% 88/33 
COX6C 76 4 36% 135/34 
COX6B1 86 2 20% 86/32 
COX7A1 80 2 28% 113/33 
COX7C 63 2 28% 96/33 
Table 5.4: Identification of contaminants in Ndufs4 (-/-) preparation. The number of peptides 
detected from each subunit is given together with the sequence coverage of the protein. The 
score given for each of the subunits is the sum of the peptide score with denominator 





Figure 5.11: Analysis of Ndufs4 (-/-) mouse mitochondrial complex I by LC-MS. Complex I (30 
µg) subunits were separated by reverse-phase HPLC and detected by ESI-MS. The ion 
intensities of the eluents are indicated, and complex I subunits are identified and numbered 
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1. NDUFA1 8138.5 8139.6 1.1 - 
2. NDUFA2 10826.5 10826.2 -0.3 -Met, +N-acetyl 
3. NDUFA3 9241.7 9242.5 0.8 -Met, +N-acetyl 
4. NDUFA5 13270.5 13270.7 0.2 -Met, +N-acetyl 
5. NDUFA6 15193.6 15193.8 0.2 -Met, +N-acetyl 
6. NDUFA7 12486.4 12486.4 0.0 -Met, +N-acetyl 
7. NDUFA8 19852.9 19854.8 1.9 -Met, +4×Cys-Cys 
8. NDUFA9 38825.8 38841.0 15.2 -∆Import (1-35) 
9. NDUFA10 36943.0 36948.0 5.0 -∆Import (1-35) 
10. NDUFA11 14851.1 - - - 
11. NDUFA12 17128.4 17127.7 -0.7 +N-acetyl 
12. NDUFA13 16770.4 16770.8 0.4 -Met, +N-acetyl 
13. NDUFAB1 10662.1 10661.9 -0.2 -∆Import (1-68), +4PP-acyl 
chain 
14. NDUFB1 6822.9 6823.3 0.4 -Met 
15. NDUFB2 8491.4 8491.2 -0.2 -∆Import (1-33) 
16. NDUFB3 11561.0 - - - 
17. NDUFB4 14992.1 14992.0 -0.1 -Met, +N-acetyl 
18. NDUFB5 16858.4 16858.6 0.2 -∆Import (1-46) 
19. NDUFB6 15425.9 15426.5 0.6 -Met, +N-acetyl 
20. NDUFB7 16405.8 16407.2 1.4 -Met, +N-myristoyl, +2×Cys-
Cys 
21. NDUFB8 18745.1 18746.4 1.3 -∆Import (1-29) 
22. NDUFB9 21894.9 21895.7 0.8 -Met, +N-acetyl 
23. NDUFB10 20888.6 20890.7 2.1 -Met, +2×Cys-Cys 
24. NDUFB11 14343.0 14343.6 0.6 -∆Import (1-29) 
25. NDUFC1 5752.6 5753.8 1.2 -∆Import (1-27) 
26. NDUFC2 14205.7 14207.2 1.5 +N-acetyl 
27. NDUFS1 77210.6 - - - 
28. NDUFS2 49257.6 49276.4 18.8 ∆Import (1-27), +dimethyl-R85 
29. NDUFS3 26479.0 26479.6 0.6 -∆Import (1-35) 
30. NDUFS4 15325.3 - - -∆Import (1-42) 
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31. NDUFS5 12512.5 12513.3 0.8 -Met, +2×Cys-Cys 
32. NDUFS6 10777.0 10775.6 -1.4 -∆Import (1-20) 
33. NDUFS7 21032.5 21036.3 3.8 -∆Import (1-35), +Hydroxyl-
R87 
34. NDUFS8 20442.2 20438.6 -3.6 -∆Import (1-35) 
35. NDUFV1 48626.5 48646.3 19.8 -∆Import (1-20) 
36. NDUFV2 23847.4 23846.5 -0.9 -∆Import (1-31) 
37. NDUFV3 8027.8 8028.5 0.7 -∆Import (1-35) 
38. ND1 36087.3 - - - 
39. ND2 38780.4 - - - 
40. ND3 13246.9 - - - 
41. ND4 51909.8 - - - 
42. ND4L 10634.7 10634.3 -0.4 +N-formyl 
43. ND5 68502.8 - - - 
44. ND6 18654.2 - - - 
Table 5.5: Molecular mass measurement of complex I subunits. Measured masses were 
assigned to complex I subunits according to the mass discrepancy between the observed 
masses and calculated masses (mature protein with known modifications), as shown in 
previous work (Carroll et al., 2009) and in Chapter 3. Modification of the observed masses 
include (-) cleavage of import sequences or residues, or (+) or addition of post-translation 




5.8 Association of FMN to Ndufs4 (-/-) mouse complex I 
 
It was previously established in this thesis that Ndufs4 (-/-) complex I was intact but unstable, 
and a loss of subunits may occur during purification, therefore the FMN content of the enzyme 
was investigated. Flavin contents of both Ndufs4 (+/+) complex I and Ndufs4 (-/-) complex I 
were measured, using known FMN standards as a reference (described in chapter 2.10). 
Purified Ndufs4 (-/-) complex I contains noticeably less FMN than its wild type counterpart 
enzyme (Table 5.6). However, the amount of FMN in Ndufs4 (+/+) complex I is not 
stoichiometric, due to the lack of sensitivity in this method, therefore it is not clear whether the 
lower amount of detected FMN in Ndufs4 (-/-) complex I is relevant.  
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FMN concentration (µM) in complex I 
Ndufs4 (-/-) Ndufs4 (+/+) 
0.93 ± 0.02 1.30 ± 0.02 
 
Table 5.6: Flavin content of mouse complex I.  Details of the methods employed are described 
in chapter 2. The flavin concentration in complex I (1 µM) was measured by reference to a set 
of prepared standards ranging from 0.2 – 10 µg mL-1. The data are presented as mean values 
with error bars for the standard error of the mean (n ≥ 3). 
 
The association of FMN to complex I was then probed. Complex I was exposed to gradually 
increasing temperature, which leads to the dissociation of FMN (Figure 5.12). The temperature 
at which 50% of the FMN has dissociated can then be calculated (Tm50). The Tm50 for the 
purified knockout enzyme is 52.3 °C, which is essentially the same as that of the purified 
enzyme (51.2 °C, Figure 3.4). This suggests that there is no difference between the strength of 
association of FMN with complex I between Ndufs4 (-/-) complex I and Ndufs4 (+/+). Therefore, 
instability of Ndufs4 (-/-) complex I is the issue and not loss of FMN.  
 
 
Figure 5.12: Thermal-based assay for flavin association with purified Ndufs4 (-/-) mouse 
complex I.  Details of this assay are described in chapter 2. Purified complex I (6 µg) was 
exposed to increasing temperature from 20 – 80 °C, and the fluorescence signal of FMN was 



























5.9 EPR measurements on the iron-sulphur clusters in Ndufs4 (-/-) 
mouse complex I 
 
To characterise the iron-sulphur clusters and establish whether the subunit deletion in complex 
I has affected its ability to transfer electrons, X-band continuous wave EPR spectroscopy was 
carried out on Ndufs4 (-/-) complex I and compared to Ndufs4 (+/+) complex I (Figure 5.13a). 
Purified Ndufs4 (-/-) complex I was reduced with NADH and then plunge frozen. Assignment 
of signals in the EPR spectra to particular iron-sulphur clusters were aided by comparison to 
the previous bovine enzyme (Reda et al., 2008) and the mouse enzyme (Figure 3.5a). The 
positions of assigned iron-sulphur clusters are shown in the structure for reference (Figure 
5.13b).  Although the signal to noise for the spectra was poor, 4 out of 8 iron-sulphur clusters 
were detected for Ndufs4 (-/-) complex I (N1b, N2, N3 and N4), consistent with the EPR spectra 
of Ndufs4 (+/+) complex I (Figure 5.13a). Cluster N5, which was not detected, is fast-relaxing 
when reduced, therefore it is difficult to obtain a signal from it (Reda et al., 2008a). However, 
the overall signal amplitude of the spectra is significantly diminished in Ndufs4 (-/-) complex I 
compared to Ndufs4 (+/+) complex I. This is because of difficulty encountered in obtaining 
sufficient Ndufs4 (-/-) complex I to give good EPR spectra. Interestingly, EPR spectra on the 
clusters of purified complex I from ΔNdufs4 Y. lipolytica show broadening of the signals 
(Kahlhöfer et al., 2017), in particular N1b, which is in close proximity to Ndufs4 in the wild 
type strain, suggesting a perturbation of the clusters as a result of subunit loss in complex I. In 
the case of mouse Ndufs4 (-/-) complex I, perturbation of the clusters is not clear because of 
poor signal to noise in the EPR spectra. Despite this, it can be inferred that Ndufs4 (-/-) complex 
I has all of its iron-sulphur clusters, although it is unclear whether their midpoint potentials 






Figure 5.13: X-band continuous wave EPR spectra of Ndufs4 (-/-) mouse complex I.  (a) Details 
of the conditions of the EPR measurements are described in Chapter 2.11. 9 µl of purified 
Ndufs4 (-/-) complex I (100 µg) and Ndufs4 (+/+) complex I (180 µg) were reduced by 2 mM 
NADH and the first derivative of the absorbance of reduced iron-sulphur clusters (labelled) 
were detected by varying the temperature (15 K and 18 K) and magnetic field, but the 
microwave frequency was constant (~9 GHz). The Ndufs4 (-/-) complex I spectra was scaled by 
~2× to adjust for the concentration difference between the complexes (b) The structure of 
the bovine complex I (brown: core subunits and grey: supernumerary subunits) is depicted 
with the iron-sulphur clusters (yellow-orange spheres). This figure taken from Wright et al 
(Wright et al., 2016).  
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5.10 Activity measurements on purified Ndufs4 (-/-) mouse 
complex I 
 
It has been established that loss of NDUFS4 from complex I leads to multiple issues, such as 
low catalytic activity and instability of the enzyme. To further confirm this, activity 
measurements were carried out on isolated Ndufs4 (-/-) complex I, and compared to the 
previously characterised Ndufs4 (+/+) complex I (Table 5.7). The piericidin-sensitive 
NADH:DQ oxidoreduction rate of Ndufs4 (-/-) complex I (representative of the enzyme’s 
catalytic turnover) was 7% the value of Ndufs4 (+/+) complex I. This is consistent with the 
results from other groups for Ndufs4 (-/-) complex I in mitochondria (Kruse et al., 2008; 
Petruzzella et al., 2001; Quintana et al., 2010), confirming its catalytic dysfunction.  
 
To probe the source of the catalytic dysfunction, the flavin based oxidation of NADH was 
probed using artificial NADH oxidising substrates (HAR, APAD and FeCN). All the flavin 
activities were lower in Ndufs4 (-/-) complex I compared to Ndufs4 (+/+) complex I (Table 5.7). 
However, as previously observed in membranes, the relative activities of Ndufs4 (-/-) complex 
I compared to Ndufs4 (+/+) complex I differed substantially, with 7% for APAD, 16% for FeCN 
and 44% for HAR. Further biochemical characterisation of the flavin-site is required to 
understand the underlying reason for these rate differences in NADH oxidation, but it may be 
due to instability, change in the mechanism of NADH oxidation or possibly perturbation in the 





(µmol min-1 mg-1) 
Ndufs4 (+/+) 
(µmol min-1 mg-1) 
Relative activities 
(%) 
NADH:DQ 0.81 ± 0.03 11.99 ± 0.11 7 
H2O2 8.77 ×10-3 ± 0.26 ×10-3 15.30 ×10-3 ± 0.19 ×10-3 57 
FeCN 5.10 ± 0.06 32.87 ± 1.74 16 
HAR 21.06 ± 0.16 47.38 ± 1.49 44 
APAD 0.29 ± 0.01 4.46 ± 0.09 7 
Table 5.7 Kinetic characterisation of purified Ndufs4 (-/-) and Ndufs4 (+/+) mouse complex I.  
Rates for the purified enzyme were measured according to the protocols in chapter 2. Values 
for rates of Ndufs4 (+/+) were taken from Table 3.4.  The data are presented as mean values 




It has been previously reported that NDUFS4 deletion is linked with an increase in the level of 
reactive oxygen species produced (Valsecchi et al., 2013), therefore H2O2 production was 
measured from both strains. However, H2O2 production by Ndufs4 (-/-) complex I is 57% of 
that of Ndufs4 (+/+) complex I. It is not clear whether the results are pathophysiologically 
relevant or is a consequence of Ndufs4 (-/-) complex I destabilisation during purification. 
 
5.11 HAR titration on Ndufs4 (-/-) mouse membranes  
 
To further probe the unusual kinetics of the flavin-mediated reactions of Ndufs4 (-/-) complex 
I, HAR was chosen for further investigation because of its comparatively high activity (Table 
5.7). The rates of NADH oxidation by membranes from both strains were measured with 
various concentrations of HAR in the assay (Figure 5.14). The maximal rates (Vmax) of NADH 
oxidation were comparable between Ndufs4 (-/-) and Ndufs4 (+/+) complex I (Figure 5.14a, b, 
Table 5.8). However, considering that the complex I content is less in NDUFS4 (-/-) compared 
to Ndufs4 (+/+) membranes (diminished by at least half as observed by BN-PAGE in Figure 
5.4), the rate of NADH oxidation per complex I in membranes is much greater for the Ndufs4 
(-/-). Further analyses showed a striking 120-fold decrease in the KM value for Ndufs4 (-/-) 
compared to Ndufs4 (+/+) membranes. KM, a value describing substrate concentration at half-
maximal turnover, is dependent on the maximal velocity of the enzyme and its binding affinity 
with the substrate(s). Since the Vmax is increased in Ndufs4 (-/-) membranes compared to Ndufs4 
(+/+) membranes, the decrease in KM of Ndufs4 (-/-) membranes relative to Ndufs4 (+/+) 
membranes is attributable to an increased binding affinity of the substrate HAR to complex I. 
As HAR is thought to bind to the nucleotide phosphate in NADH (Birrell et al., 2011), it may 
be posited that binding of NADH may change as a result of structural changes in Ndufs4 (-/-) 
complex I, and consequently the binding of HAR to the enzyme, but to confirm this requires 





Figure 5.14: NADH:HAR activity measurements. Details of the protocol are described in 
Chapter 2. 4 µg mL-1 of membranes (a,b) were incubated with various concentrations of HAR. 
The reactions were initiated with 100 µM NADH. The data are presented as mean values with 




Ndufs4 (-/-) Ndufs4 (+/+) 
Vmax (µmol min-1 
mg-1) Km (mM) 
Vmax (µmol min-1 
mg-1) Km (mM) 
Membranes 4.52 ± 0.09 3.2 ×10-3 ± 0.32 ×10-4 3.67 ± 0.06 0.38 ± 0.03 
Table 5.8: Michaelis–Menten parameters for NADH:HAR activity measurements. Values are 
from the experiments of figure 5.14, with the experimental protocols discussed in chapter 2. 
The data are presented as mean values with error bars for the standard error of the mean (n 
≥ 3). 
 
5.12 Purification of cross-linked Ndufs4 (-/-) mouse complex I 
 
In order to stabilise Ndufs4 (-/-) complex I to prevent the loss of its components, solubilised 
membranes were cross-linked with 1 mM BS3 as described in chapter 2.8 Otherwise, the 
purification procedure was identical to that used previously. 
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First, complex I-containing fractions were enriched by anion-exchange chromatography 
(Figure 5.15). Similar to the previous complex I purifications, cross-linked Ndufs4 (-/-) complex 
I eluted in 350 mM NaCl. There is a large peak at 200 mM NaCl, which is not detected in the 
non-cross-linked preparation (Figure 5.15), which is assumed to arise from unreacted BS3. 
Complex I-containing fractions were pooled and concentrated for further separation as usual. 
 
 
Figure 5.15: Purification of cross-linked Ndufs4 (-/-) mouse complex I using anion-exchange 
chromatography. The Äkta micro system and the attached 1 mL HiTrapTM Q HP column were 
washed and equilibrated at a flow rate of 0.3 mL min-1 with buffer A (20 mM Tris-HCl pH 7.14 
at 23 °C, 1 mM EDTA, 0.1% DDM, 10% ethylene glycol, 0.005% asolectin and 0.005% CHAPS), 
and proteins were eluted in buffer B (buffer A + 1 M NaCl). Elution of BS3 and complex I-
containing fractions are shown. 
 
To further resolve complex I, size-exclusion chromatography was used to separate complexes 
IV and I (Figure 5.16). In the size-exclusion trace, both complexes I and IV elution volume 
have shifted to higher elution volumes for the Ndufs4 (-/-) preparation compared to the non-
cross-linked Ndufs4 (+/+) preparation (Figure 5.16), appearing smaller. It is plausible that cross-
linking has affected the migration of both enzymes in the size-exclusion column, as evident by 
the equal shift in their elution. Complex I from this preparation displayed an NADH:DQ 
activity of 0.86 µmol min-1 mg-1, meaning the enzyme is essentially catalytically inactive. 































Figure 5.16: Purification of cross-linked Ndufs4 (-/-) mouse complex I using size-exclusion 
chromatography. The Äkta micro system was operated at a flow rate of 0.03 mL min-1 with 
buffer C (20 mM Tris-HCl pH 7.14 at 23 °C, 10% ethylene glycol, 150 mM NaCl and 0.05% DDM), 
using a Superose 6TM Increase 3.2/300 column. The purification trace (280 nm) for non-
crosslinked Ndufs4 (+/+) complex I (WT) from Figure 3.3 is shown as a reference. 
 
The size-exclusion purified complex I was then assessed by BN-PAGE, to determine whether 
it was intact (Figure 5.17). The in-gel activity assay shows that the purified cross-linked Ndufs4 
(-/-) complex I is indeed intact, corresponding in size to complex I in Ndufs4 (+/+) membranes. 
There is a slight shift on the gel in the migration of the Ndufs4 (-/-) complex I, which may be 
due to the cross-linking itself, as opposed to the loss of subunits. However, there is an NADH 
sensitive band migrating below the complex IV band in Ndufs4 (+/+) membranes. There is also 
minor band present where complex V migrates in Ndufs4 (+/+) membranes. These bands were 
not identified because cross-linking affects tryptic digestion, thus complicating identification 
of protein components in the preparation. Nevertheless, because the majority of purified 
enzyme is NADH sensitive and corresponds to the size of complex I, it can be stated that it is 
largely intact. 























Figure 5.17: BN-PAGE of purified cross-linked Ndufs4 (-/-) mouse complex I.  Cross-linked 
Ndufs4 (-/-) complex I (5 µg) and wild type mouse membranes (30 µg) were separated by BN-
PAGE, and stained with 0.5 mg mL-1 NBT and 100 µM NADH in 20 mM Tris-HCl pH 7.55 at 32 
°C. Ndufs4 (+/+) membranes (WT membranes) and NDUFS4 (-/-) complex I. Asterisks indicate 



























5.13 Cryo-EM map of Ndufs4 (-/-) complex I from mouse kidney 
 
The work presented here (with permission) on the cryo-EM map of Ndufs4 (-/-) complex I from 
mouse kidney was prepared by Zhan Yin. Grids were prepared from the purified sample 
according to Blaza et al., (Blaza et al., 2018) that was then imaged at the UK National electron 
Bio-Imaging Centre (eBIC) at the Diamond Light Source. Images were processed according to 
the RELION pipeline procedure by Dr. Hannah Bridges (Fernandez-Leiro and Scheres, 2017). 
 
The cryo-EM density map of Ndufs4 (-/-) complex I reached a global resolution of 8.4 Å 
according to the gold standard FSC = 0.143 criterion (Scheres and Chen, 2012). First, active 
mouse complex I was fitted into the density using the ‘fit-in-map’ function in Chimera 
(Pettersen et al., 2004a). The structure, which is immensely important in understanding how 
mutations in complex I result in neuromuscular disorders, is intact and its distinctive L-shape 
is similar to its wild type counterpart (Figure 5.18). There is an empty cavity in the structure 
(i.e. no density) where NDUFS4 is usually positioned. The relatively low resolution of the 
structure prevents observation of secondary structure features such helices and sheets. 
However, at 8.4 Å it is clear that there are no major shifts in the positions of the subunits, as 
they appear to fit relatively well into density. 
 
Finally, there appears to be no unoccupied densities in the cryo-EM map that account for 
assembly factor(s), such as NDUFAF2 or ACAD9, with most of the empty densities 




Figure 5.18:  Cryo-EM map Ndufs4 (-/-) complex I from mouse kidney. The structure of active 
mouse (secondary structure) fitted into the 8 Å density. NDUFS4 is shown in red while the rest 


















Deletion of Ndufs4 gene in mice results in reduction in complex I content, and substantial loss 
of complex I catalytic activity in both membranes and purified preparation, consistent with 
what other groups have reported in different systems (Calvaruso et al., 2012; Kruse et al., 2008; 
Ugalde et al., 2004; Valsecchi et al., 2012). It was also established by mass spectrometry, cross-
linking experiments and structural analysis that Ndufs4 (-/-) complex I is intact, but unstable, as 
observed during BN-PAGE analyses where complex I destabilised and breaks down into sub-
complexes that were originally thought to be stalled complex I assembly intermediates 
(Valsecchi et al., 2012). Thus, it can be concluded that loss of NDUFS4 from complex I results 
in instability of the mature protein affecting its catalytic function. In order to stabilise Ndufs4 
(-/-) complex I, a purification procedure was successfully established that ensures the enzyme 
is intact even under BN-PAGE conditions, where it would otherwise break apart.  
 
 
5.14.2 Ndufs4 intra-complex interaction and stability   
 
It has been ascertained that Ndufs4 (-/-) complex I degradation is an artefact of BN-PAGE. 
Although NDUFS4 is a small protein (~15 kDa), it forms numerous interactions with other 
complex I subunits (Figure 5.19). 60% of its surface area is buried in interactions with other 
subunits of complex I (Table 4.3), the most amongst the supernumerary subunits alongside 
NDUFA1 (also 60% of its surface area is buried). In total, NDUFS4 interacts with 11 subunits, 
of which 6 are N-domain subunits (NDUFA12, NDUFS1 NDUFS6, NDUFV1, NDUFV2 & 
NDUFV3) and 5 are Q-domain subunits (NDUFA5, NDUFA6, NDUFA9, NDUFS3 and 
NDUFS8). Thus, the loss of NDUFS4 and its numerous interactions destabilises the complex, 
resulting in the loss of the N-domain (6 subunits of which are interacting with NDUFS4) and 
NDUFA7 of the Q-domain from complex I during BN-PAGE (Figure 5.5b). The 5 remaining 
subunits of complex I (NDUFA5, NDUFA6, NDUFA9, NDUFS3 and NDUFS8), which 
interact with NDUFS4, are not lost because they anchored more tightly to the rest of the 
complex (i.e. membrane domain). Nijtmans and co-workers reported that Ndufs4 (-/-) complex 
I is stabilised in the respiratory supercomplex I+III2 (Calvaruso et al., 2012). However, complex 
I interactions with complex III and IV in supercomplexes are mediated by membrane-spanning 
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proteins (Gu et al., 2016; Guo et al., 2017; Letts et al., 2016a; Wu et al., 2016a), whilst NDUFS4 






Figure 5.19: Visualisation of NDUFS4 interaction with other complex I subunits. A surface 
representation of the interaction of NDUFS4 (red) with complex I subunits (NDUFA12, NDUFS1 
NDUFS6, NDUFV1, NDUFV2, NDUFV3, NDUFA5, NDUFA6, NDUFA9, NDUFS3 and NDUFS8) 
(blue), whilst remaining subunits are shown in wheat. The structure is rotated 90 ° about the 














5.14.3 Mechanistic dysfunction of Ndufs4 (-/-) mouse complex I 
 
Catalytic efficiency of complex I has been reduced drastically as a result of deletion, in 
particular, it has been demonstrated that flavin-mediated NADH oxidation is rate limiting in 
the turnover of the enzyme. As there appears to be no major structural rearrangement of Ndufs4 
(-/-) complex I, the changes may be the result of subtle changes in the structure or in the 
biophysical properties of the enzyme. 
 
NDUFS4 spans almost the entire length of the electron transfer pathway of complex I and is in 
close proximity to all of the catalytically active iron-sulphur clusters and FMN (Figure 5.20). 
The protein is highly basic (predicted isoelectric point of 9.5), with most of its positive charge 
facing the iron-sulphur clusters (Figure 5.20b), enabling it to stabilise the reduced state of the 
clusters. It is known that the terminal cluster N2 in mammalian complex I is surrounded by 
three basic residues (Arg85, Arg105 and His190 in NDUFS2) that modulate its midpoint 
potential, in particular, Arg85, the absence of which in T. thermophilus complex I results in a 
lower midpoint potential for the adjacent cluster (less readily reduced) (Hirst and Roessler, 
2016). Analogous to how the midpoint potential of cluster N2 is affected by nearby basic 
residues (Hirst and Roessler, 2016), it can be speculated that the loss of NDUFS4 may result in 
the lowering of the midpoint potentials of adjacent clusters, hindering electron transfer through 
the clusters. Moreover, Zickermann and co-workers observed an overall decrease in the signal 
amplitude of the EPR spectra of ΔNdufs4 Y. lipolytica complex I compared to complex I from 
wild (Kahlhöfer et al., 2017). In agreement with a possible role of NDUFS4 modulating 
potentials of the iron-sulphur clusters, there is a strong conservation of residues adjacent to the 
clusters (Figure 5.20c). 
 
Although it is suggested here that electron transfer through the clusters is severely affected as 
a result of the loss of NDUFS4, more rigorous biochemical and biophysical, particularly EPR 
spectroscopy, to better define the clusters.   
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Figure 5.20: Visualisation of NDUFS4 Interaction with iron-sulphur clusters. (a) A surface 
representation of mouse complex I structure (wheat), with the iron-sulphur clusters (spheres), 
FMN and NDUFS4 highlighted in the red rectangle. (b) Electrostatic potential of NDUFS4 
shown using the APBS plugin in Pymol with default parameters. Blue to white to red denotes 
basic, neutral and acidic residues, respectively. (c) NDUFS4 sequences from various species 
were aligned (using UNIREF90) and mapped onto the subunit using Consurf (Ashkenazy et al., 
2010), with the default parameters. High, medium and low conservation are shown in purple, 





5.14.4 Future prospects  
 
In order to identify subtle changes in the structure (i.e. altered confirmation compared to the 
wild type enzyme), the structure of Ndufs4 (-/-) complex I needs to be solved to a higher 
resolution using Cryo-EM. Ideally, less than 6 Å is required to observe secondary structure 
features such as sheets and helices, and ~4 Å or lower to resolve side chain densities. This will 
require stabilisation of the enzyme using cross-linkers, under similar conditions outlined in this 
chapter (see Chapter 5.12). For comparison, the structure of the wild type enzyme must be 
solved under the same conditions to ensure that the structure obtained is not an artefact of cross-
linking.     
 
Lastly, considering recent experiments demonstrating an improvement of phenotype when 
Ndufs4 (-/-) mice are exposed to chronic hypoxia, it would be interesting to study the effect of 
this treatment (Jain et al., 2016) on the complex I itself. It is not known whether complex I 
expression is adjusted, stability is affected or even modified under these conditions. This would 
require biochemical, biophysical and maybe even structural analyses to determine the 
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